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Look, if you had one shot, one opportunity  
To seize everything you ever wanted  
One moment  
Would you capture it or just let it slip?  
.. 
You better lose yourself in the music,  
the moment.  
You own it; you better never let it go  
You only get one shot,  
do not miss your chance to blow  
This opportunity comes once in a lifetime 
 
(Eminem, Lose yourself) 
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1.1 DNA lesions and their consequences 
DNA is considered the blueprint of life that carries the genetic information, necessary to sustain 
life at both the cellular and organismal level. Although random changes that drive evolution 
occur frequently in the genome, its overall stability is an essential prerequisite for all species. 
Yet, genomic information is constantly attacked by a variety of genotoxic agents, present in the 
environment or otherwise generated as byproducts of natural metabolism. For instance, 
ultraviolet radiation (UV) represents a physical DNA damaging agent that mainly produces helix-
distorting lesions (i.e. cyclobutane pyrimidine dimers, CPDs and pyrimidine-(6,4)-pyrimidone 
products, 6-4PPs) (Buschta-Hedayat et al., 1999; Wood, 1999). Similarly, ionizing radiation (IR), 
induces the formation of double strand breaks (DSBs), as well as single strand breaks (SSBs) 
(van Gent et al., 2001). However, IR can also generate reactive oxygen species (ROS) that in 
turn may induce other oxidative DNA lesions (Cadet et al., 2003). Chemical agents (e.g. in 
cigarette smoke, solvents, dyes) can induce a variety of base modifications in the DNA. In 
addition, superoxide anions, hydroxyl radicals and hydrogen peroxide (referred to as ROS) and 
byproducts of lipid peroxidation can all be produced endogenously inducing a broad spectrum of 
oxidative DNA lesions ranging from simple base modifications (8-oxo-G, thymin glycols and 
cyclopurines) to single and DSBs (Cadet et al., 2003; Hasty et al., 2003). Last but not least, the 
genome is threatened by its intrinsic chemical instability (e.g. spontaneous deamination and 
depurination) (Lindahl, 1993).  
 The presence of damage in our genome can interrupt vital cellular processes with severe 
consequences for the overall organismal survival. For example, lesions present in the 
transcribed strand of an active gene, can block RNA polymerases, thereby resulting in 
transcriptional arrest. The presence of stalled polymerases can trigger programmed cell death, 
known as apoptosis (Bernstein et al., 2002). Similarly, lesions can interfere with the replication 
machinery, thereby inducing replicative arrest, preventing cell division. Overall, the presence of 
damage in the genome could trigger a temporary cell cycle arrest to allow time for repair of the 
damaged DNA. However, in case of unrepairable, persistent DNA lesions, this could lead to 
permanent cell cycle arrest, senescence (cytostatic effect) (Campisi, 2001), or else cell death 
(cytotoxic effect). Examples of cytotoxic or cytostatic lesions are DSBs, bulky adducts (e.g. the 
UV-induced CPD photoproduct), intrastrand crosslinks (ICLs) and certain oxidized bases 
(thymine glycols and cyclopurines). To ensure that replication can continue, cells are equipped 
with a series of translesion synthesis (TLS) polymerases that can bypass replication-blocking 
lesions. However, depending on the fidelity of the TLS polymerase, error-free or error-prone 
bypass of lesions may occur, which in the latter case results in fixation of mutations (mutagenic 
effect). Whereas programmed cell death or permanent growth arrest, induced by cytotoxic and 
cytostatic lesions, is believed to ultimately contribute to aging (Hasty et al., 2003; Mitchell et al., 
2003) (Figure 1), mutagenic lesions (e.g. spontaneous deaminations, depurination, oxidized 
bases and UV-induced lesions) contribute to inborn errors (when occurring in germ cells) and 
carcinogenesis. Although both cancer and aging are consequences of unrepaired DNA 
damage, the focus of this thesis will mainly be on the process of aging.  
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Figure 1. Types of DNA damages and their consequences. DNA damage, inflicted by DNA-damaging agents like UV, IR 
and ROS, can affect cellular processes and have severe consequences for human health. DNA lesions can cause 
misreplication, resulting in mutations, ultimately leading to cancer. DNA lesions can also exert cytotoxic and cytostatic 
effects when they block transcription or replication. Continuous blockage leads to apoptosis or senescence, which 
contributes to aging (adapted from (de Boer and Hoeijmakers 2000)). 
 
1.2 Excision repair pathways 
To counteract the deleterious effects of DNA lesions and guard the vital genetic information, 
cells are equipped with an intricate network of genome-caretaking mechanisms that have 
overlapping as well as distinct functions in lesion recognition (and thus specificity) and timing of 
repair. The main repair pathways in mammals are Nucleotide Excision Repair (NER), Base 
Excison Repair (BER), Transcription-Coupled Repair (TCR), which all have in common that they 
deal with lesions that only affect one strand, allowing the use of the complementary strand as a 
template for repair, Homologous Recombination (HR) and Non-Homologous End-Joining 
(NHEJ) which deal with DNA strand breaks, and Mismatch Repair (MMR) (Friedberg, 2003; 
Hanawalt, 2002; Hanawalt et al., 1994; Hoeijmakers, 2001; van Gent et al., 2001). The 
importance of these repair systems is well illustrated by their evolutionary conservation in 
eukaryotes and the presence of similar mechanisms in prokaryotes, as well as by the 
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occurrence of DNA repair disorders in man. This thesis focuses on the excision repair pathways 
NER, TCR and BER and the NER disorder Cockayne Syndrome.  
 
1.2.1 Nucleotide Excision Repair 
Nucleotide excision repair (NER) is a multistep process that deals mainly with helix-distorting 
lesions, like the UV-induced 6-4PPs and CPDs. Other substrates for NER include bulky 
chemical adducts, intrastrand crosslinks and the oxygen free-radical-induced helix-distorting 
5’,8-purine cyclodeoxynucleotides (Brooks et al., 2000; Kuraoka et al., 2000). NER is an 
evolutionary conserved damage removal mechanism throughout eukaryotes whereas its 
importance is also underscored by the fact that it bears similarities with prokaryotes as well. 
 This ‘cut and patch’ process involves at least 30 proteins and consists of four successive 
steps: (i) lesion recognition, (ii) local opening of the double helix, (iii) excision of the damaged 
strand and (iv) gap-filling DNA synthesis (Aboussekhra et al., 1995; de Laat et al., 1999; Gillet 
and Scharer, 2006; Hoeijmakers, 2001; Wood, 1999). NER consists of two subpathways: global 
genome NER (GG-NER) and transcription-coupled NER (TC-NER). GG-NER recognizes and 
removes lesions in the entire genome. GG-NER has to scan the whole genome for lesions and 
is often regarded as a relatively slow and inefficient process. Furthermore, the efficiency of GG-
NER is lesion-dependent. For instance, in UV-induced lesions, repair of 6-4PPs, which distort 
the DNA double helix severely, is fast throughout the genome and is predominantly done by 
GG-NER. In contrast, GG-NER of CPDs, which mildly distort the double helix, is relatively slow 
(Mitchell and Nairn, 1989). To avoid that slowly repaired lesions block transcription for long, 
mammalian cells have evolved the TC-NER pathway, which selectively removes lesions from 
the transcribed strand of active genes. As it is directly coupled to the transcription machinery, 
TC-NER is considered a fast and efficient process (Bohr et al., 1985; Hanawalt, 2002; Mellon et 
al., 1986; Mellon et al., 1987). In agreement, TC-NER was previously shown to remove CPD 
and 6-4PP lesions with similar rates (van Hoffen et al., 1995). Interestingly, repair of CPDs in 
humans is much faster than in rodents. However, this “human-rodent paradox” may likely reflect 
the absence of GG-NER for this particular lesion (see below).   
 GG-NER and TC-NER are mechanistically the same, except for the initial damage-
recognition step. In GG-NER, the XPC/hHR23B complex and the UV-damaged DNA binding 
protein (UV-DDB; composed of the DDB1 and DDB2/XPE subunits) are involved in lesion 
recognition. In TC-NER, the CSB, CSA, RNApolII and XAB2 proteins are thought to be 
responsible for damage detection. After DNA damage recognition by either GG- or TC-NER 
specific components, TFIIH binds the DNA, followed by XPA and RPA. Together these factors 
allow subsequent helix unwinding by the TFIIH complex, verification and demarcation of the 
damaged site and excision of the damaged strand by the XPG and ERCC1/XPF 
endonucleases. Finally, the repair reaction is completed by the regular replication machinery 
consisting of Pol δ/ε and Pol κ (Ogi and Lehmann, 2006) and Lig I/III, that fills the resulting 25-
30 base long single strand DNA gap (see Figure 2 for a schematic representation of the NER 
reaction). The function of the various NER proteins will be discussed in more detail below.  
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Figure 2. Repair of damaged DNA by nucleotide excision repair (NER). The mechanism consists of two subpathways, 
global genome (GG-) (left) and transcription coupled (TC-) NER (right). DNA damage recognition requires XPC/hHRad23B 
for recognition of helical distortion anywhere in the genome (GG-NER). TC-NER is initiated when RNA polymerase II 
progression is blocked by damage in the transcribed strand of DNA. XPC/hHRad23B or stalled RNA polymerase II complex 
induce the recruitment of basal transcription factor TFIIH followed by XPG to the damaged site. The XPB and XPD 
helicases, which are part of the TFIIH complex, unwind the DNA around the lesion. The XPA/RPA complex is recruited to 
the damaged lesion: XPA verifies the DNA damage and RPA serves to stabilize the open intermediate by binding the 
undamaged strand. Next XPF/ERCC1 is recruited: XPG and ERCC1/XPF respectively cleave at the 3’and 5’ site of the 
damaged strand, thereby removing a 24-32-base oligonucleotide containing the damage. The resulting gap is filled in by 
DNA polymerase δ, ε and κ together with Ligase I and III. 
 
 As mentioned above, a stalled RNA polymerase (RNAP) is considered to trigger TC-NER 
(Tornaletti et al., 1999). Currently, however, there are two models for how TC-NER might 
actually work: 1) When the RNA polymerase is blocked at a particular lesion, it is temporarily 
displaced from the damaged site, without actual removal from the DNA. After repair has 
succeeded, transcription elongation resumes and finishes the incomplete mRNA (Tornaletti et 
al., 1999). 2) Blockage of RNA polymerase can result in polyubiquitination of the largest subunit 
of RNAPII (Rpb1) and its subsequent proteolysis. In this scenario, the unfinished mRNA is 
discarded and the RNA polymerase sacrificed. After repair, reinitiation of transcription will 
produce a new mRNA transcript (Ratner et al., 1998).  
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 Transcription-coupled repair (TCR) also applies to repair of transcription-blocking oxidative 
DNA lesions, e.g. minor base damage induced by oxidizing agents that are generally not helix-
distorting, but still arrest transcription (Dianov et al., 1999; Satoh et al., 1993; Satoh and Lindahl, 
1994). Normally, these types of lesions are removed by Base Excision Repair (BER). It is 
important to note that it is currently unknown whether in the TCR reaction BER is responsible for 
the actual removal of these oxidative lesions or whether the core of NER takes care for this. 
Therefore this thesis refers to TC-NER when only the transcription-coupled repair pathway of 
NER is employed involving helix-distorting damage. TCR is referred to in those cases where all 
transcription-blocking lesions are included, involving either NER and/or BER. 
 
Proteins involved in NER  
Important clues as to which proteins might actually have a crucial role in the mammalian NER 
mechanism originate from three genetic disorders, Xeroderma Pigmentosum (XP), Cockayne 
Syndrome (CS) and Trichothiodystrophy (TTD) (described in more detail below), all with defects 
in repairing UV-induced DNA damage. In addition to patient cells, proteins involved in the NER 
process have been also identified in NER-deficient yeast mutants and Chinese hamster ovary 
cell lines (CHO) by employing methods such as complementation analysis and in vitro 
reconstitution assays involving purified proteins and DNA substrates containing site-specific or 
random damage (Aboussekhra et al., 1995), for reviews see (de Laat et al., 1999; Gillet and 
Scharer, 2006; Hoeijmakers, 2001; Wood, 1999) and references therein. Since NER-deficient 
cells are sensitive to UV, cellular survival after UV exposure is an excellent read-out to test 
sensitivity. However, there are distinct ways to assay UV-sensitivity. Since the final step in the 
NER reaction is filling of the single-stranded gap (Aboussekhra et al., 1995; Shivji et al., 1995), 
unscheduled DNA synthesis (UDS), in which repair-mediated 3H-thymidine incorporation is 
measured after exposure of cells to UV irradiation, is often used as a read-out for the overall 
DNA repair capacity, which is mainly GG-NER. Thus, this method represents a reliable measure 
for functional GG-NER. RNA synthesis recovery (RRS) measures the time it takes for cells to 
repair and have normal levels of RNA synthesis, e.g. after UV exposure. In wild type cells, 
although dependent on which dose is used, transcription resumes after several hours, but in 
TC-NER-deficient cells, the damage in the transcribed strands of active genes cannot be 
repaired and removal is very slow or absent. Therefore transcription, measured by RNA 
synthesis recovery, will remain low, making RRS a good measure for functional TC-NER 
(Mayne and Lehmann, 1982).  
 
The XPC/HR23B and UV-DDB complexes 
Both helical distortion and alteration of DNA chemistry are necessary for lesions to be 
recognized by NER (Hess et al., 1997). XPC is the one of the first essential NER factors that 
takes action in the NER cascade (Sugasawa et al., 1998; Volker et al., 2001). It specifically acts 
in the initial damage recognition step of GG-NER as a complex together with hHR23B and 
centrin2 (designated the XPC-hHR23B complex). Although in vitro studies show that NER is 
functional when XPC alone is present, addition of centrin2 and hHR23B stimulates the NER 
reaction (Ng et al., 2003; Nishi et al., 2005; Sugasawa et al., 1996). The XPC-hHR23B complex 
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is essential for recruitment of other NER components (TFIIH, XPA and RPA) to the site of 
damage to initiate the repair process (Batty et al., 2000; Sugasawa et al., 1996; Sugasawa et 
al., 1997). Although the heterotrimer can bind both single- and double-stranded undamaged 
DNA, it has a much higher affinity for damaged DNA (Masutani et al., 1994; Shivji et al., 1994). 
After binding to the lesion, the XPC-hHR23B complex recruits the subsequent factors of the 
repair machinery to the sites of damage (Volker et al., 2001). It was found that hHR23B 
stabilizes the heterotrimer most probably by inhibiting polyubiquitination of XPC (by DDB2, see 
below), which prevents degradation by the 26S proteasome (Ng et al., 2003; Ortolan et al., 
2000). In vitro studies have previously shown that hHR23A, a protein with high homology to the 
hHR23B protein, can similarly form a complex with XPC. However, although both hHR23 
proteins are functionally interchangeable, the main complex found in vivo is XPC-hHR23B.  
 Another protein, specifically involved in GG-NER, is the UV-damaged DNA binding protein 
(UV-DDB). UV-DDB consists of two subunits; p125 (DDB1) and p48 (XPE/DDB2) (Hwang et al., 
1999; Tang et al., 2000). Although the precise function of this protein is currently unknown, it 
appears to facilitate recognition of lesions that are less well-recognized by the XPC-hHR23B 
complex (i.e. CPDs (Hwang et al., 1999; Keeney et al., 1993) via (poly)ubiquitiylation of XPC 
(Sugasawa et al., 2005; Wang et al., 2005). Following UV exposure, transcription of the gene 
encoding the p48 subunit of UV-DDB is up-regulated in a p53-dependent manner. As a 
consequence, the UV-DDB protein plays an important role in facilitating more efficient repair of 
CPDs. Rodent cells, however, lack the p53 responsive element in the promoter of the p48 
subunit (Tan and Chu, 2002). This might well explain the absence of GG-NER of CPDs in mice 
(Hwang et al., 1999). DDB1 and DDB2 are also part of a larger complex including cullin4a, Roc1 
and the COP9 signalosome (CSN) (Groisman et al., 2003). Cullin4a displays ubiquitin ligase 
activity and was shown to ubiquitylate DDB2 both in vitro and in vivo (Chen et al., 2001; 
Matsuda et al., 2005; Nag et al., 2001), which led to degradation of DDB2 by the 26S 
proteasome (Fitch et al., 2003; Rapic-Otrin et al., 2002). The CSN, on the other hand, displays 
deubiquitilation activity. These observations have led to a model where UV-induced DNA 
damage triggers the (poly)ubiquitylation of both XPC and DDB2. Hence, DDB2 is degraded by 
the 26S proteasome, whereas (as mentioned above) XPC is not. This degradation of DDB2 
most probably prevents further ubiquitylation of XPC, which can also enhance its unspecific 
binding to DNA (Sugasawa et al., 2005), a process that might impede the subsequent steps in 
the NER pathway.  
 
The CSB and CSA proteins 
CSA and CSB proteins are both indispensable for proper functioning of the TC-NER 
subpathway, and are not involved in GG-NER (Henning et al., 1995; Troelstra et al., 1992). In 
agreement, CSA and CSB-deficient cells demonstrate low RRS levels, whereas UDS levels are 
found to be within the normal range. CSB belongs to a family of SWI/SNF-like DNA-dependent 
ATPases. This family of proteins is involved in a wide array of nuclear processes, including 
transcription, chromatin remodeling and various repair and translesion synthesis processes. The 
CSA protein contains five WD repeats, a regulatory rather than catalytic domain that is often 
found in multiprotein complexes involved in processes such as cell cycle regulation and RNA 
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processing (Henning et al., 1995). CSA mainly interacts with CSB, XAB2 (XPA binding protein 
2) and the p44 subunit of TFIIH. Recently, exposure of cells to UV irradiation was shown to 
induce CSA translocation to the nuclear matrix in a CSB-dependent manner (Kamiuchi et al., 
2002). Although the precise function of CSA in TC-NER remains to be identified, this protein  
was previously shown to colocalize with the phosphorylated form of RNApolI and it is, therefore, 
most likely to be required for TCR during elongation of the transcription process (Groisman et 
al., 2003; Kamiuchi et al., 2002). Both CSB and CSA are also components of RNApolII 
associated complexes (CSA not via direct interaction), dealing with transcriptional blocks and 
resumption of transcription, which is most probably linked to their function in TC-(NE)R. 
Interestingly, similar to DDB2, CSA was found to reside in a complex with cullin4a, Roc1 and 
the COP9 signalosome. This finding establishes a link between TC-NER, GG-NER and 
ubiquitin-dependent protein degradation (Groisman et al., 2003). Whereas the DDB2 associated 
ubiquitin ligase activity acts early in the GG-NER process and is inhibited by association with 
CSN at later time, the CSA associated ligase activity is silenced by CSN at the beginning of the 
repair process and becomes active at later stages (Groisman et al., 2003). Recently, it was 
found that CSB becomes ubiquitylated by this CSA ligase complex and is subsequently 
degraded by the 26S proteasome in a UV-dependent manner, an important step necessary for 
the recovery of RNA synthesis after TCR (Groisman et al., 2006). 
 The CSB protein is considered to have a plethora of additional functions outside NER. For 
instance, it can act as an elongation factor for RNApolII, particularly when damaged DNA is 
encountered, thereby, promoting RNApolII transcription past natural pausing sites. Also, it is 
reported to promote transcription of genes with highly structured RNA like U1, U2, snRNA and 
5SrRNA or else it may stimulate rRNA synthesis both in vitro and in vivo. This implicates CSB in 
PolI, PolII and PolIII (ssRNA) transcription, reviewed by (Licht et al., 2003). This is in agreement 
with the previously documented overall reduced level of transcription in CSB-deficient cells 
(Balajee et al., 1997). Additionally, CSB is also a SNF2-like factor, related to hBrg1, hBrm and 
Dros/SWI involved in chromatin remodeling, reviewed by (Licht et al., 2003). Also, Rad26, the 
yeast homologue of CSB, has been implicated in chromatin remodeling (Gregory and Sweder, 
2001). In agreement, CSB can act as a chromatin remodeling factor and can interact with core 
histones, inducing negative supercoiling (Citterio et al., 2000). As it is known that chromatin 
structure changes during transcription regulation and repair, CSB may also likely participate in 
this process. Although under debate, CSB has been implicated in the removal of oxidative DNA 
damage. In CSB-deficient CHO cells (UV61) and CS-B patient fibroblasts (CS1AN), the incision 
by FPG (Formamidopyrimidine DNA glycosylase), a glycosylase involved in BER, turned out to 
be dependent on CSB (Sunesen et al., 2002). This was shown both with an in vitro approach 
involving cellular extracts, as well as an in vivo approach which allows assaying repair of 
intragenomic sequences. Moreover, the same results were confirmed in human CS1AN cells 
(Stevnsner et al., 2002). Also, CSB cells not only have reduced incision activity of 8oxoA(:T) 
and 8oxoA(:C) containing oliginucleotides (Tuo et al., 2002b), they have reduced OGG1 (8-
hydroxyguanine DNA glycosylase) mRNA levels as well (Dianov et al., 1999; Tuo et al., 2002a). 
Recently, by use of a host cell reactivation assay that determines the ability to transcribe an in 
vitro damaged plasmid, it was shown that both CS-A and CS-B human cells are defective in 
TCR of 8-oxo-G and TG (Spivak and Hanawalt, 2006). Finally, CSB cells have been shown to 
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be sensitive to genotoxic agents that give rise to oxidative DNA damage, like IR and paraquat 
(de Waard et al., 2003; Deschavanne et al., 1984). Taken together, CSB represents a versatile 
protein with many different functions involved in a diversity of distinct and overlapping 
processes.  
 
The TFIIH complex 
After lesions are detected by the XPC-hHR23B complex, the TFIIH complex is recruited to the 
site of the damage in an ATP-independent step. In a second, ATP-dependent step, TFIIH 
unwinds the DNA, allowing other DNA repair factors to enter the site of the lesion. TFIIH was 
first identified as a factor involved in basal transcription. Subsequently, however, it was found 
that two of its subunits were XPB (p89) and XPD (p80), which were known before to participate 
in NER revealing a dual function of TFIIH in both transcription and repair (Bootsma and 
Hoeijmakers, 1993; Drapkin et al., 1994; Evans et al., 1997; Schaeffer et al., 1994; Schaeffer et 
al., 1993; Vermeulen et al., 1994; Winkler et al., 2000). XPB and XPD are two DNA helicase 
proteins with opposite ATP-dependent DNA unwinding activity. In transcription, DNA unwinding 
activity is essential for promoter opening and promoter escape, whereas in repair, this activity is 
an obligatory step to permit lesion demarcation and dual incisions (Evans et al., 1997). The 
helicase activity of XPB is essential for transcription initiation. On the contrary, XPD seems to 
have a more structural role in promoter opening and escape, since its helicase activity is 
dispensable for in vitro transcription (Bradsher et al., 2000; Tirode et al., 1999; Winkler et al., 
2000). In yeast, the TFIIH core complex was found to possess ubiquitin ligase activity, which 
seemed to be involved in the transcriptional response to DNA damage (Takagi et al., 2005). It is 
not yet known whether this is the same for TFIIH in mammalian cells. 
 TFIIH is a multifunctional protein complex, consisting of ten subunits (Giglia-Mari et al., 
2004), harboring both helicase and protein kinase activities. Seven of these subunits (XPB, 
XPD, p62, p52, p44, p34 and p8) form a tight ‘core complex’ together. Other subunits are the 
cyclin-dependent kinase Cdk7, cyclin H and MAT1, which together form the cdk-activating 
kinase (CAK) complex, associated with TFIIH. The CAK complex can phosphorylate cyclin-
dependent kinases involved in cell cycle regulation and is essential for the C-terminal 
phosphorylation of RNAPolII during transcription initiation (Nigg, 1995; Svejstrup et al., 1995). 
Furthermore, TFIIH has been found to interact directly with the tumor suppressor p53 (Leveillard 
et al., 1996; Wang et al., 1996), pointing to a potential role of TFIIH in cell cycle regulation as 
well. Considering its essential function in these vital processes (e.g. transcription and repair), it 
is hardly surprising that TFIIH is indispensable for life.  
 
The XPA protein 
After initial opening of the DNA around lesions by TFIIH, a ‘preincision’ complex consisting of 
RPA, XPA and XPG is assembled to the site of the damage. XPA is involved in the lesion 
verification step of NER and in the proper organization of the repair machinery around the 
damage, together with the single-strand DNA binding complex RPA (Sugasawa et al., 1998; 
Volker et al., 2001). As such, XPA is involved in both subpathways of NER (Volker et al., 2001). 
Since XPA has to verify the presence of a particular lesion in the DNA, it is able to bind many 
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different types of damages in DNA. XPA is also involved in open complex formation around the 
damage resulting in lesion demarcation (de Laat et al., 1998; Li et al., 1995). Furthermore, XPA 
interacts with XAB2, TFIIH, XPF/ERCC1, XPC-hHR23B and RPA. XAB2 is a tetratricopeptide 
that is involved in both TCR and transcription, thereby thought to function as a bridge between 
transcription, NER and TCR (Nakatsu et al., 2000). Together, these functions demonstrate the 
central and essential role XPA has in NER.   
 
The XPG protein and the ERCC1/XPF complex 
Following local unwinding and demarcation of the lesion, the damaged DNA has to be excised. 
Both XPG and the ERCC1/XPF complex are involved in this part of the repair process (Mu et 
al., 1996; O'Donovan et al., 1994b; Sijbers et al., 1996). XPG is a structure-specific 3’ 
endonuclease believed to be involved in both stabilization of the preincision complex (Araujo et 
al., 2000) and incision at the 3’ end of the damaged nucleotide (O'Donovan et al., 1994a). The 
incision at the 5’ end of the damaged DNA is made by the ERCC1/XPF complex (Sijbers et al., 
1996). In vitro, the 3’ incision by XPG can be detected in the absence of ERCC1/XPF (Mu et al., 
1996). In contrast, the excision by ERCC1/XPF requires the presence, but not the catalytic 
activity of XPG (Wakasugi et al., 1997). However, in the presence of both proteins, 5’ and 3’ 
uncoupled incisions have been detected, suggesting that both incisions can happen almost 
simultaneously (Matsunaga et al., 1996; Moggs et al., 1996; Mu et al., 1996). The combined 
action of XPG and the ERCC1/XPF complex results in excision of a 24-32 nucleotides long 
ssDNA fragment (containing the lesion) from the locally opened DNA. As mentioned above, 
XPG (like XPA) is also implicated in stabilizing the open complex formation in the NER process 
(Evans et al., 1997; Mu et al., 1996). The role of XPG in this process is likely structural, since its 
nuclease activity is not needed for stabilization of the open complex. Furthermore, XPG has 
been found to interact with XPB, XPD, p62 and p44, subunits of the TFIIH complex. This 
interaction could help stabilizing the open complex that is formed during the NER mechanism. 
Although XPG recruitment does not require the XPA protein, there is no detectable incision 
activity in XPA-deficient cells (Volker et al., 2001). Apart from its function in NER, XPG seems to 
have a function in the removal of oxidative DNA damage. It can stimulate hNTH1 activity on 
thymine glycol, but this stimulation does not depend on the endonuclease function of XPG 
(Bessho, 1999). This suggests that different domains in the XPG protein are responsible for its 
different functions. In addition, XPG has been reported to be involved in TCR of oxidative 
damage as well as in RNApolI and RNApolII transcription (Klungland et al., 1999; Lee et al., 
2002). Similar to CSB, XPG is a multipurpose protein with many different occupations. 
 ERCC1 was the first mammalian NER gene to be cloned (Westerveld et al., 1984) and is 
essential for proper functioning of the NER process. The ERCC1 protein acts in a complex with 
XPF as a structure-specific endonuclease to make the incision at the 5’ end of the damaged 
DNA strand. In contrast to XPG, recruitment of ERCC1/XPF to the damaged site requires XPA. 
Both XPF and ERCC1, like XPG, have functions outside the context of NER. For instance, 
ERCC1/XPF is also involved in interstrand crosslink repair (Niedernhofer et al., 2001), HR and 
potentially immunoglobulin class-switch recombination (CSR). Consequently, both XPF and 
ERCC1 deficient cells are not only sensitive to UV, but also to cross-linking agents like mitomycin C 
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(MMC). Whether the ERCC1/XPF protein complex makes an incision next to a crosslink (similar to 
its function in NER), or whether it is involved in a later step of the crosslink repair reaction, is not yet 
understood. Analysis of different XPF point mutants revealed that the DNA binding activity of the 
ERCC1/XPF complex can be separated from its catalytic activity on the DNA (Enzlin and 
Scharer, 2002). This finding might help to elucidate the role of this protein complex in the 
various DNA repair processes that it is involved in. 
 
1.2.2 BER pathway/proteins 
Base Excision Repair (BER) eliminates chemically altered deoxyribonucleotides, like oxidative 
modifications and deaminations, which are mostly, but not exclusively, caused by DNA 
damaging agents of endogenous origin, such as ROS or methylating agents. 8-oxo-guanine (8-
oxo-G), O6-methyl-guanine (O6-me-G) and thymine glycol (TG) represent typical BER lesions 
(Beckman and Ames, 1997; Fortini et al., 2003; Krokan et al., 2000; Krokan et al., 1997; Wilson 
and Thompson, 1997). Occasionally, BER substrates (e.g. TG) can block transcription, but most 
often they give rise to miscodings in the DNA, that if left unrepaired, may result in mutation 
fixation. To this end, BER is considered a crucial mechanism to prevent mutagenesis.  
 In the mammalian genome, over a hundred different oxidative lesions have been identified 
(Cadet et al., 1997), thereby demanding a high level of versatility from the BER process. To 
cope with this complexity, BER lesions are recognized by a wide range of DNA glycosylases, 
with specific, although overlapping lesion recognition abilities. These glycosylases catalyze the 
release of damaged base residues in free form, leaving behind an abasic site in the DNA 
backbone, for review see (Dodson and Lloyd, 2002) and references therein. Abasic sites are 
very toxic to cells and have to be removed quickly. Thus, subsequent to base removal, a more 
general mechanism, involving APE1/HAP1, XRCC1, LIG1 and Polβ proteins, can deal with the 
abasic site by endonucleolytic cleavage and subsequent gap/filling/ligation activity (Demple et 
al., 1991). The reaction proceeds either via short patch repair, in which the single nucleotide 
gap is filled, or via long patch repair, in which a short stretch of DNA (including the abasic site) 
is removed and replaced, involving in part other proteins (Matsumoto and Kim, 1995; Sobol et 
al., 1996). Although some epidemiological studies claim correlations between certain types of 
cancers (lung, colorectal) and mutations in BER genes, these results are not conclusive and 
mutations in BER genes have not been found to be associated with inherited human disorders 
(Frosina, 2004).  
 
1.3 NER syndromes 
In humans, NER represents the major defense mechanism against the carcinogenic effects of 
UV light. Therefore, it is not surprising that a defect in NER can lead to extreme sun sensitivity 
and an elevated risk of developing skin cancer. Deficiencies in NER genes have been 
associated with three rare autosomal recessive UV-sensitive disorders: Xeroderma 
Pigmentosum (XP), Cockayne Syndrome (CS) and a photosensitive form of the brittle hair 
disorder Trichothiodystrophy (TTD) (Bootsma, 2001; Lehmann, 2003; Nance and Berry, 1992). 
All three disorders share photosensitivity of the skin, but differ markedly in UV-induced skin 
cancer proneness as well as in the occurrence of additional pathology. 
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Figure 3. Human NER-deficient syndromes: XP, TTD, CS and XP/CS. A) Picture of the back of an XP patient. Note the 
increased freckling on the UV-exposed skin. B) Picture of a TTD patient. (adapted from (McCuaig, Marcoux et al. 1993)) C) 
Pictures of a patient with CS at different ages. Note the progressive nature of the disease with close to normal appearance 
at the age of 2 years and the typical CS appearance at the age of 7 years with deep set eyes, prominent ears and profound 
cachexia (adapted from Share and Care Cockayne Syndrome Network, http://www.cockayne-syndrome.org) D) Pictures of 
patient XP20BE with XP/CS at different ages. Note the progressive nature of the disease with normal appearance at the 
age of 4 months and 1.5 years and the typical CS appearance at the age of 6 years with deep set eyes, prominent ears and 
profound cachexia (adapted from Lindenbaum et al., 2001). 
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1.3.1 Xeroderma Pigmentosum  
Xeroderma Pigmentosum is characterized by extreme sun sensitivity, photophobia, and high 
UV-induced cancer susceptibility with early development of malignancies in sun-exposed parts 
of the skin, eyes and tip of the tongue (Bootsma, 2001) (Figure 3A). Benign lesions like freckles 
or hyperpigmented spots are frequently found. The disease is mostly symptomatic in childhood, 
except for the adult variant form (XP-V, see text below).  
 Initial lab diagnosis of XP cells usually involves testing of cultured fibroblasts (obtained from 
skin biopsies) for hypersensitivity towards UV-C exposure. When positive, further molecular 
diagnosis includes determination of the level of UDS. In addition, complementation assays or 
mutation screening can be performed, which revealed that excision-deficient XP is due to a 
mutation in one of seven genes; XPA-XPG. Cells from XP patients are characterized by low 
UDS (in other words deficient GG-NER) and low RRS (defective TC-NER). XP-C and XP-E 
however, are an exception to the latter; patient cells display low UDS, but normal RRS, as a 
consequence of deficient GG-NER but proficient TC-NER (Hwang et al., 1999; Hwang et al., 
1998; Tang et al., 2000; Venema et al., 1991; Venema et al., 1990). The most common forms of 
XP are XP-A and XP-C (Bootsma, 2001).  
 Over 1000 cases of XP have been described. Due to their NER defect, sun exposure of XP 
patients causes degenerative alterations in both skin and eyes (Bootsma, 2001), which can start 
as early as at the age of two (Kraemer, 1997). XP patients have a more than 1000-fold elevated 
risk of getting sun-induced skin cancers strikingly restricted to sun-exposed areas like face, 
neck and head. Most frequently, basal cell or squamous cell carcinomas (45% of XP patients) 
develop, and less frequently melanomas are found. Furthermore, UV can induce eye anomalies 
such as atrophy of the skin around the eye, loss of lashes or even the whole eyelid and corneal 
clouding (Kraemer et al., 1987). The mean age at onset of these neoplasms is 8 years, which is 
extremely early (50 years earlier than in the general population). Apart from the sun-induced 
skin cancers, XP patients have a 10-20 fold increased risk to develop internal cancers before 
the age of 20 years (Kraemer et al., 1984).   
 Neurological degeneration is found in 20% of XP cases, (complementation groups XP-A, G 
and D) and is referred to as XP neurological disease. These neurological abnormalities result 
from the degeneration of neurons that initially develop normally (Rapin et al., 2000). 
Neurological symptoms include microcephaly, peripheral neuropathy, sensorineuronal deafness 
and loss of reflexes, followed by ataxia and mental retardation or dementia. The age at onset 
and rate of progression vary greatly between patients. A possible explanation for the onset of 
neurologic abnormalities in XP patients is that unrepaired endogenous NER lesions in neurons 
trigger apoptosis (Kuraoka et al., 2000). The most severe early-onset neurologic subtype of XP 
(mostly caused by mutations in XPA) is De Sanctis-Cacchione Syndrome (XP-DSC). In addition to 
the neurological symptoms mentioned above, this disease involves dwarfing, hypogonadism and a 
10-20 fold increase in frequency of several types of internal cancers (DeSanctis, 1932; Kraemer et 
al., 1987).  
 In addition, complementation analysis has revealed another class of XP patients, XP-variant. 
Interestingly, a mutation in the responsible gene (XPV) does not cause NER impairment, as 
measured by UDS and RRS, but instead leads to a defect in postreplication repair. The 
Introduction 
23 
responsible XPV gene has been cloned and was previously shown to encode hRad30A, the 
damage-specific DNA polymerase η that is involved in translesion synthesis (Masutani et al., 
1999). As under normal conditions, this polymerase can bypass UV-induced CPDs in a 
relatively error free manner, a defect in this protein can also lead to an XP-like disease, 
including UV-sensitivity and skin cancer predisposition.  
 
1.3.2 Cockayne Syndrome  
Similar to XP, Cockayne Syndrome (CS) is a pleiotropic disorder that is characterized by 
cutaneous photosensitivity. However, CS differs from XP by the occurrence of severe 
progressive postnatal growth failure (cachexia) and progressive neurological dysfunction, as 
well as the absence of UV-induced skin cancer predisposition in all cases reported so far 
(Nance and Berry, 1992) (Figure 3C).  
 CS is specifically associated with defective TC-NER, while GG-NER functions normally, and 
consequently lab diagnostics for CS cells reveal normal UV-induced UDS and low RRS even 
after 24 hours, when exposed to a UV dose from which normal cells recover in 6-8 hours 
(Lehmann et al., 1979). Two complementation groups have been identified in CS, designated 
CS-A and CS-B, of which the majority of studied cases belong to the latter (Lehmann, 1982; 
Tanaka et al., 1981). As seen for XP, CS patients are highly UV-sensitive, and show atrophy of 
sun-exposed skin. Despite the DNA repair defect, CS is not associated with an increased risk of 
skin cancer. This might be explained by the fact that the disease is often noted early in the life of 
patients, because of both growth and neurological defects, which allows adequate protection 
from sun exposure. Another explanation could be that CS patients simply do not get old enough 
to get skin cancer. Finally, the type of repair defect, TC-NER/TCR, may protect from cancer as 
this repair system, when defective, will cause cell death, rather than mutations causing cancer. 
 Patients with CS are divided in different clinical groups according to severity and onset of 
the disease. Type I refers to the ‘classical’ or less severe form of the disorder, with onset in the 
postnatal period and survival into adolescence or young adult life. Type II is a more severe 
infantile form with onset before birth and death by the age of 6 or 7 years (Lowry, 1982), 
reviewed by (Rapin et al., 2000). Both forms of CS are characterized by progressive growth 
failure and multiorgan degeneration. 
  The clinical features are severe and diverse. In CS patients, growth (both height and weight) 
is retarded, but this is more pronounced for weight. This phenomenon, together with the severe 
and progressive nature of the growth retardation, is described by the term cachectic dwarfism. A 
very prominent feature of CS is a ‘birdlike face’, characterized by enophthalmia (sunken eyes), a 
beaked nose and a narrow mouth that results from reduced amounts of subcutaneous fat. 
Furthermore, patients present with dental caries and skeletal abnormalities such as kyphosis. 
The mean age at death of CS patients, ranging from neonatal to 55 years (1 reported patient), is 
12.5 years. The most common cause of death is pneumonia as a result of general atrophy and 
cachexia. 
 CS patients display several neurological symptoms. Delayed psychomotor development, 
mental retardation, microcephaly and ataxia are most commonly associated with this syndrome 
(Rapin et al., 2000). The extremely small size of the brain, together with the fact that head 
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circumference is relatively normal at birth, indicates that the failure of brain growth is mainly of 
postnatal origin. Neuropathological examination revealed multifocal patchy demyelination in 
cerebral and cerebellar cortex, dilated ventricles, calcium deposits in basal ganglia and cerebral 
cortex, and loss of neurons (moderately near calcium deposits), which is most pronounced in 
the cerebellum (Itoh et al., 1999). Nerve defects, such as reduced velocity of nerve conduction 
and changes in muscle innervation are also often observed. Additionally, most patients have 
sensorineuronal hearing loss and structural eye abnormalities, including cataracts, ciliary body 
defects and pigmentary degeneration of the retina (60-100% of the reported cases). 
Furthermore, patients have a ‘salt and pepper’ like fundus that progresses throughout life. If 
cataracts are detected within the first three years of life, this usually points to a poor prognosis. 
(Dollfus et al., 2003).  
 In 10% of reported CS cases, the disease is caused by mutations in the XPD, XPB or XPG 
gene, resulting in a combined form of XP and CS (Lindenbaum et al., 2001). XP/CS patients 
differ from classical CS patients in that GG-NER is also affected. So far, nine XP/CS cases have 
been reported with skin features of XP combined with the systemic and neurological features of CS. 
Although the few known XP/CS patients all have XP skin disease (dry skin and abnormally 
pigmented sun-exposed areas), only two of them actually have developed skin cancer (Dupuy et 
al., 1974; Lindenbaum et al., 2001). XP/CS, like CS, has a variable phenotype with respect to age 
at onset, symptoms displayed and severity of the defect (Figure 3D). 
 A syndrome that shares similarity with CS (type II) is Cerebro-Oculo-Facio-Skeletal 
Syndrome (COFS). This is a recessive, progressive brain and eye disorder with symptoms 
including dramatic growth failure, severe mental retardation, facial dysmorphisms (deep-set 
eyes, large ears, prominent nose), cataracts, progressive joint contractures, microcephaly and 
cerebral atrophy. Most patients die before the age of 3 years (Longman et al., 2004; Meira et al., 
2000). The eye abnormalities in COFS are usually more severe than in CS, but no cutaneous 
photosensitivity has been described. Since this disease shares many overlaps with CS, they are 
often difficult to distinguish from one another. COFS can actually be regarded as an early infantile 
form of CS and in some of these patients, mutations have been found in the CSB, XPG and 
XPD gene, arguing that they constitute part of one continuing clinical spectrum (Graham et al., 
2001; Meira et al., 2000). 
 The severe developmental and neurological features observed in CS patients can not be 
attributed to a NER defect alone (Bootsma and Hoeijmakers, 1993). In agreement with the 
previously suggested role of CSA and CSB in transcription, transcriptional deficiency, 
presumably induced by DNA damage, may also contribute to the clinical picture. Cells from CS 
patients are not only sensitive to UV, but also to IR (Deschavanne et al., 1984) suggesting that 
CSB is also involved in repair of other types of damages (e.g. oxidative damage). Therefore, an 
inability to repair both UV- and endogenous DNA lesions combined with transcriptional 
deficiency likely underlies the CS phenotype as well as the observed heterogeneity. 
Since many of the features observed in CS (e.g. neurologic degeneration, kyphosis, cataracts) 
are also found in the naturally aging population, this disease has been classified as a segmental 
premature aging syndrome (Martin, 2005). The term segmental is often used to point out that 
some, but not all, of the features associated with normal aging are found to be accelerated. 
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1.3.3 Trichothiodystrophy  
The hallmarks of Trichothiodystrophy (TTD) are Photosensitivity, Ichthyosis, Brittle hair and 
nails, Intellectual impairment, Decreased fertility and Short stature (referred to by the acronym 
PIBIDS) (Itin et al., 2001; Lehmann, 2001) (Figure 3B). Other prominent features are an aged 
appearance and shortened lifespan. Also, skeletal abnormalities like osteopenia, axial 
osteosclerosis, peripheral osteoporosis (McCuaig et al., 1993), kyphosis (Norwood, 1964) and 
retardation of skeletal age are often observed. Whereas the brittle hair and nails are unique to 
TTD patients, other features are strikingly similar to CS, including the absence of cancer 
predisposition. The abnormalities typical for this disease are generally noted around birth. The 
brittle hair is caused by a reduction of cystein-rich matrix proteins that normally provide strength 
to the hair shaft by crosslinking the keratin filament (Itin and Pittelkow, 1990; Stefanini et al., 
1993). Furthermore, lab diagnosis of UV-sensitive TTD cells shows UDS levels at about 50% of 
WT. Hence, by measuring UDS in cells and isolated hair follicles, a positive diagnosis for UV-
sensitive TTD can be made. Up to now, mutations in three genes have been found to cause 
TTD, namely XPD, XPB and TTDA. Since most of the symptoms are quite similar to that of CS, 
TTD has likewise been classified as a segmental premature aging syndrome (Martin, 2005).  
 Fascinatingly, non-UV-sensitive forms of TTD also exist. As the name suggests, patients 
display all TTD features except for cutaneous photosensitivity. Recently, the first gene that 
causes this form of TTD was identified: C7orf11. Although no UV-sensitivity could be detected, 
this gene was found to localize to the nucleus and is therefore thought be involved in 
transcription rather than DNA repair (Nakabayashi et al., 2005). 
 Interestingly, mutations in either the XPD or XPB gene can give rise to three disorders, 
namely XP, XP/CS or TTD (de Boer and Hoeijmakers, 2000; Lehmann, 2001). This, together 
with the fact that the XPB and XPD proteins are not only involved in NER, but (as part of the 
TFIIH complex) are also involved in transcription, and the fact that mutations causing TTD are 
all found in components of the TFIIH complex, caused Bootsma and Hoeijmakers to speculate 
that the TTD phenotype is a combination of a repair deficiency together with a transcription 
deficiency (Bootsma and Hoeijmakers, 1993). The transcriptional defect in TTD is likely 
responsible for the brittle hair and ichthyosis phenotype of (Bootsma et al., 1995; Stefanini et al., 
1993) as TTD mutations in XPD are found to cause instability of the TFIIH complex, which 
results in depletion of this transcription initiation factor prior to completion of terminal 
differentiation of hair and skin, which are consequently unfinished. The occurrence of non-UV 
sensitive forms of TTD in which repair is not affected, strengthens this hypothesis. In addition, 
the TCR hypothesis suggests that proteins involved in CS are not only needed for TC-NER, but 
also for a more general TCR pathway that deals with the removal of any lesion that would block 
transcription, which includes oxidative lesions that are normally repaired by BER (Citterio et al., 
2000; Cooper et al., 1997). The fact that CS cells are sensitive to oxidative DNA damaging 
agents supports this notion (de Waard et al., 2003; Deschavanne et al., 1984; Spivak and 
Hanawalt, 2006).  
 
The complex involvement of NER genes in these different inherited human disorders that 
display cancer and/or segmental aging features, underscores the importance of this repair 
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pathway for both processes. Whereas the UV sensitivity and cancer predisposition of these 
patients can be well explained by the gene defect, it poorly explains many of the non-UV related 
features, which have been, so far, puzzling. To this end, the generation of mouse models 
mimicking these disorders has shed some light on the underlying pathogenic mechanism as 
well as the cause of the non-UV related phenotype.  
 
1.4 Mouse models for NER disorders 
To study the consequences of mutations in NER genes, as well as the etiology of NER 
disorders at the level of the intact organism, mouse models were generated mimicking existing 
human NER mutations or else deletion of a few exons. Since NER is involved in the repair of 
several, potentially mutagenic and/or carcinogenic DNA lesions, these models represent 
powerful tools to screen for sensitivity to a variety of genotoxic substances. However, certain 
factors need to be taken into account when studying mouse models for human diseases. For 
instance, there are documented differences between the repair characteristics of mouse and 
man, one of them being that CPDs are less efficiently removed from the non-transcribed strands 
of active genes and the remainder of the genome in rodents as compared to humans (Bohr et 
al., 1985). Next, there is a substantial difference between the lifespan of mice and men, and 
many of the observed clinical features of human NER syndromes are age-dependent evolving in 
a time period considerably longer than the mouse lifespan. Also, distinct genetic backgrounds of 
mouse strains demonstrate a high phenotypic diversity. This can influence both embryonic 
lethality as well as the lifespan of a given NER mutation in a specific background. The latter 
represents an important factor that should be taken into account at all times, especially when 
comparing phenotypes of the same mouse model between different labs. Finally, considerable 
differences have been documented between human and mouse fibroblasts cultured under 20% 
oxygen in respect to onset of their replicative senescence and/or spontaneous transformation 
(Parrinello et al., 2003). This suggests that it is challenging (or even impossible) to make 
parallels between the growth characteristics of human and mouse cells.  
 
Nevertheless, the substantial contribution of existing NER mouse models in elucidating the 
underlying causes of human NER diseases is widely acknowledged.  
 
1.4.1 XPA 
Two independent XPA knock-out mouse models have been generated, both of which  are viable 
and develop normally (de Vries et al., 1995; Nakane et al., 1995) (Figure 4A). Xpa-/- MEFs are 
impaired in the expected NER characteristics UDS and RRS. In addition survival of Xpa-/- 
fibroblasts is extremely low after exposure to UV or dimethyl-benz[a]anthracene (DMBA). Xpa-/- 
animals do not show enhanced spontaneous mortality up to 1.5 years of age, yet a slightly 
enhanced level of spontaneous liver carcinomas and lymphomas has been reported (de Vries et 
al., 1997). Importantly, Xpa-/- mice are an excellent model to study UV-induced carcinogenesis 
in the skin as observed in XP patients. UV exposure of Xpa-/- mice first leads to hyperkeratosis 
and erythema (sunburn) together with massive epidermal hyperplasia. Long-term UV exposure 
of Xpa-/- mice leads to a high incidence of skin tumours, especially squamous cell carcinomas. 
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In agreement with these findings, an enhanced mutation frequency is observed in DNA from 
spleen, lung and liver of Xpa-/- mice, not only after treatment with the DNA-damaging agent 
benzo[a]pyrene (B[a]P)  (de Vries et al., 1997), but also spontaneously with age in DNA of the 
liver (Giese et al., 1999). Additionally, XPA-deficient animals are sensitive to a broad class of 
DNA damaging agents such as the carcinogen DMBA, benzo[a]pyrene B[a]P, N-OH-AAF 
(2AAF) and 2-amino-1-methyl-phenylimidazo[4.5-b]-pyridine (PhIP). For example, treatment 
with DMBA by topical administration leads to acute skin defects like acanthosis, epidermal 
hyperplasia and an increase in papillomas, and oral B[a]P treatment results in increased levels 
of lymphomas (de Vries et al., 1995; Nakane et al., 1995). This suggests that a wide variety of 
DNA lesions is repaired by NER, thereby making Xpa-/- mice a very important mouse model in 
the identification of new carcinogens and their effects on different tissues (van Steeg et al., 
1998). Taken together, Xpa-/- mice show a strong cancer predisposition, but lack prominent 
features of accelerated aging.  
 
1.4.2 XPC 
Similar to the Xpa-/- mice, two independent XPC knockout mice were generated that are both 
viable and develop normally. In contrast to Xpa-/- mice, however, Xpc-/- animals have not been 
noted to display an increase in spontaneous tumor frequency (Cheo et al., 1997; Sands et al., 
1995). Consistent with the role of XPC in GG-NER, Xpc-/- MEFs demonstrate impaired UDS, 
and normal RRS. Similar to Xpa-/- mice, Xpc-/- animals develop skin tumors upon UV exposure. 
(Berg et al., 1998; Cheo et al., 2000). Although the GG-NER defect leads to skin cancer 
susceptibility, the acute effects of sun sensitivity as seen for the Csbm/m mouse are not 
influenced (see below), which means that this must be due to a TC-NER defect. Additionally, 
Xpc-/- mice are sensitive to various chemical genotoxic agents like 2AAF (or N-OH-AAF), DMBA 
and PhIP (Cheo et al., 1999). Furthermore, an age-related elevation in spontaneous mutation 
frequency has been found in Xpc-/- mice, as opposed to both Xpa-/- and Csbm/m mice (Wijnhoven 
et al., 2000). Although previous reports fail to demonstrate increased spontaneous 
tumorigenesis in Xpc-/- animals, it was recently found that these GG-NER deficient animals do 
develop multiple spontaneous long tumors (Hollander et al., 2005), (van Steeg et al., personal 
communication). Surprisingly, Xpc+/- animals also demonstrate a higher spontaneous mutation 
frequency and increased skin cancer predisposition as a result of UV exposure. The latter 
suggests that haplo-insufficiency of the XPC gene is present, at least in the mouse (Cheo et al., 
2000). This could also imply an important risk factor for UV-induced skin cancer in humans. In 
support of this notion, inactivation of one XPC allele in Csa-/- mice results in enhanced UV-
mediated skin cancer sensitivity (van der Horst et al., 2002). This observation might point to the 
fact that XPC is a rate-limiting factor for GG-NER, consistent with findings reported at the 
cellular level.  
  
1.4.3 CSB and CSA 
An animal model for CS-B was generated by mimicking a mutation found in a CSB patient 
(CS1AN mutation: Lys337→stop), resulting in a N-terminal truncation of the CSB protein at 
amino acid 343 in the mouse, rendering the TC-NER pathway inactive (van der Horst et al., 1997) 
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(figure 4B). Csbm/m MEFs and mice exhibit all CS repair characteristics: both are sensitive to 
UV, have defective TC-NER yet they are normal in GG-NER. Csbm/m mice show a mild UV- and 
DMBA-induced cancer predisposition (van der Horst et al., 1997). This seems to be in contrast 
to CS-B patients, which do not show elevated UV-induced skin cancer predisposition. This 
discrepancy could be attributed to the man-mouse differences in the efficiency of GG-NER of 
some types of lesions. Alternatively, it could also be explained by the fact that the diagnosis for 
CS is made early in the life of a patient so that there has not been sufficient exposure to UV to 
induce cancer whereas after the diagnosis has been made, measures are taken to avoid further 
exposure, together with the fact that the doses to which Csbm/m mice were exposed are much 
higher than those that humans are normally exposed to. 
 In addition to UV sensitivity, Csbm/m mice also display mild CS symptoms such as reduced 
body weight, photoreceptor loss and slightly abnormal behavior in various tests, pointing to mild 
neurological impairment (van der Horst et al., 1997). Furthermore, a cohort study of Csbm/m 
animals revealed karyomegaly and/or polyploidy in the kidney of aging mutant animals, all 
hallmarks of natural aging in wild type mice (van Steeg et al., unpublished). Importantly, cells 
from Csbm/m mice are sensitive towards IR and other types of oxidative stress producing 
chemicals, like paraquat (de Waard et al., 2003). Csbm/m animals show slightly increased 
sensitivity upon exposure to X-rays and the peroxisome proliferator di (2-ethylhexyl) phthalate 
(DEHP) (de Waard et al., 2004). In agreement, the presence of (UV-induced) DNA lesions in 
actively transcribed genes is very toxic to the cell (Berg et al., 2000; Wijnhoven et al., 2001). 
This suggests that the accumulation of endogenous (oxidative) damage could contribute to the 
(mild) aging phenotype observed in Csbm/m mice (and CS patients). Yet, the levels of unrepaired 
endogenous DNA damage in Csbm/m mice may be too low to have an effect on their life span or 
otherwise to induce a severe phenotype. Other (redundant) pathways might take over 
minimizing the repair defect. 
 The CS-A mouse model was made by disrupting exon 2 of the Csa gene, giving rise to a 
complete null mutant, thereby (like in the Csbm/m mouse) inactivating the TC-NER pathway (van der 
Horst et al., 2002). As seen for the Csbm/m mouse, Csa-/- mice appear not only sensitive to UV 
and DMBA, but similarly demonstrate mild growth failure and neurological abnormalities. An 
important difference between both models, however, is that Csa-/- mice are not sensitive to 
DEHP as Csbm/m mice and that Csa-/- cells are less sensitive to IR and paraquat than Csbm/m 
cells (de Waard et al., 2003). Csa-/- cells, however, appear more sensitive to mitomycin C (de 
Waard et al., 2004). Therefore, it could be that both CSA and CSB are involved in TC-(NE)R of 
UV-lesions and endogenous lesions, but exhibit variation in lesion specificity.  
 
Taken together, both mouse models demonstrate mild progeria with rather mild cancer 
predisposition, only observed after exposure.  
 
1.4.4 TTD 
So far, attempts to make viable knock-out mouse models (or even cells) for XP-B or XP-D by 
complete inactivation of the XPB or XPD gene have failed, thereby supporting the crucial role of 
TFIIH in transcription (de Boer et al., 1998b). A viable TTD mouse model was generated by 
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mimicking a causative TTD point mutation in man within the Xpd gene (TTD1BEL; Arg722→Trp) 
(de Boer et al., 1998a) (Figure 4C). These animals faithfully recapitulate many symptoms 
present in the patient; XpdTTD mice have a reduction of hair-specific cysteine-rich matrix proteins 
resulting in brittle hairs, which is a hallmark feature of the disorder. Additionally, XpdTTD animals 
develop progeroid symptoms like growth delay, osteoporosis (trabecular bone loss in the 
femur), osteosclerosis, kyphosis, gray hair, cachexia and a reduced fertility and lifespan (de 
Boer et al., 1998a), (Diderich et al., submitted). It was hypothesized that the observed aging 
features were caused by unrepaired DNA damage that compromises transcription, leading to 
functional inactivation of critical genes and enhanced apoptosis (de Boer et al., 2002). Apart 
from the observed aging phenotype, XpdTTD animals are mildly UV and DMBA sensitive, 
although recent findings suggest that this feature is not noted when the animals are maintained 
in a hairless background (Rebel et al., unpublished results). In accordance with their NER 
defect, XpdTTD cells have reduced NER capacity and are mildly sensitive to UV and DMBA. 
XpdTTD animals have also been observed to have induced skin carcinogenesis (in contrast to 
human TTD patients), but much less than Xpa-/- mice. Similar to Csbm/m mice, this may be 
attributed to the inability of rodents to repair certain types of UV-induced DNA lesions by GG-
NER (Bohr et al., 1985). Wijnhoven et al. extensively studied the pathology of a cohort of 45 
XpdTTD females, which revealed that the XpdTTD phenotype consists of 1) aging-related, 2) TTD-
specific and (paradoxically) 3) caloric restriction (CR) features. The aging-related phenotype 
consisted of a reduced body weight (noticed from 13 weeks onwards) and a reduced lifespan, 
confirming the previously observed phenotype. Furthermore, aging-related pathology, including 
reduced amounts of subcutaneous fat in the skin and abdominal cavity, cachexia, anemia and 
ovarian dysfunction were found. The premature aging phenotype of XpdTTD mice is further 
underlined by the enhanced accumulation of lipofuscine (a known marker for aging) in liver 
Kupffer cells (Wijnhoven et al., 2005). They hypothesized that the aging-related features are 
caused by a defect in DNA repair, whereas the TTD specific characteristics are most probably 
due to a transcription defect. Interestingly, XpdTTD mice also showed signs suggestive of caloric 
restriction (CR), like diminished incidence of cataract and pituitary adenomas. CR is a condition 
in which mice are limited in their caloric intake of food, and this type of intervention has been 
associated with retardation of age-related pathology and life extension. Since the CR related 
phenotype is not caused by a decreased food intake, the authors speculate that this might 
represent an attempt to lower ROS (Wijnhoven et al., 2005). From the above studies, it has 
become evident that many of the TTD features are reminiscent of premature aging (de Boer et 
al., 2002; Hasty et al., 2003), again pointing to the involvement of unrepaired DNA damage in 
inducing an aging phenotype.  
 A knock-in mouse model for the rare combined cancer and progeroid disorder XPCS was 
recently generated (XpdXPCS mice) by mimicking a patient-derived point mutation in XPD 
(XPDG602D). Strikingly, XpdXPCS mice are more skin cancer prone than Xpa-/- animals. Moreover, 
XpdXPCS mice also displayed symptoms of segmental progeria including cachexia and 
progressive loss of germinal epithelium. These data indicate that cancer and segmental 
progeria can be experimentally modulated by different point mutations in a single DNA repair-
associated gene as was previously discussed for the human XPD gene (Andressoo et al., 
2006). 
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Figure 4. Mouse models for human NER-deficient syndromes: XPA, CSB, and TTD. Picture of an adult Xpa-/- mouse 
together with its wt littermate (left). The Xpa-/- mouse has no obvious aberrant phenotype (courtesy of Harry van Steeg). 
Picture of an adult Csbm/m mouse together with its wt littermate (middle). Note the erythema on the skin of UV-irradiated 
Csbm/m mice (adapted from (van der Horst, van Steeg et al. 1997)). Picture of an adult XpdTTD mouse together with its wt 
littermate (right). Note the brittle hair, which is a hallmark feature of TTD in humans. Progeroid symptoms (cachexia and 
kyphosis) start to develop in TTD mice at age 3 to 4 months onward and become increasingly severe (adapted from (de 
Boer and Hoeijmakers 1999)). 
 
1.4.5 XPG 
Xpg-/- animals were made by knocking out exon 3 of the XPG gene resulting in a null mutant 
(Harada et al., 1999). The animals suffered from postnatal growth failure and premature death 
varying from day 3 to 24 postpartum. Additionally, the intestine and spleen were found to be 
relatively small and the liver displayed remarkably small hepatocytes. Also, primary MEFs 
experienced premature senescence, early onset of immortalization and accumulation of p53. 
Since, apart from its role in NER, XPG is required for TCR of thymine glycol by BER and is 
thought to be involved in TCR of oxidative DNA damage, it is surprising to find that Xpg-/- MEFs 
are not sensitive to H2O2 or γ-irradiation (Harada et al., 1999). A similarly severe phenotype was 
found in the XpgD811STOP/D811STOP mouse, in which the last 360 amino acids of the XPG protein 
were deleted (Shiomi et al., 2004). In yet another XPG mutant mouse, a point mutation was 
introduced into exon 11, rendering the nuclease catalytic site inactive (XpgD811A/D811A) (Shiomi et 
al., 2004). This mutation did not result in the severe phenotype as observed for the Xpg-/- 
mouse. However, it did result in hypersensitivity of these XpgD811A/D811A mice to UV. Similarly, 
deletion of exon 15 of the XPG gene (Xpg Δex15/Δex15) resulted in UV-sensitivity without any 
severe phenotype observed in the mouse (Wang et al., 2006). Since both the D811A and Δex15 
mutation only affected the NER function of XPG, these results suggest that the severe 
phenotype observed in the Xpg-/- mouse is due to a function of XPG outside the context of NER.  
 
1.4.6 Ercc1 
So far, mutations in the human ERCC1 gene have not been reported to be associated with 
human disease. Yet, a defect in the mouse Ercc1 gene (giving rise to a complete null mutant) 
results in viable mice with a severe phenotype (McWhir et al., 1993; Weeda et al., 1997) (Figure 
5C). Ercc1-/- mice are born at Mendelian frequency (in a hybrid Fvb|C57Bl6/J F1 background) 
and, apart from a 10% reduction in size and body weight, are indistinguishable from wild-type 
littermates at birth and through the first week of life. However, soon after that they develop an 
accelerated, segmental aging phenotype. Besides cachexia and sarcopenia, Ercc1-/- mice 
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display characteristics of dystonia and progressive ataxia. In addition, ferritin deposition in 
spleen, progressive renal and liver dysfunction as well as hepatocellular polyploidization and 
intra-nuclear inclusions in the liver were observed, which are considered symptoms associated 
with age-related pathology in mammals (McWhir et al., 1993; Weeda et al., 1997). Additionally, 
Ercc1-/- mice demonstrate multilineage cytopenia and fatty replacement of bone marrow, similar 
to old wild-type mice, together with reduced hematopoietic progenitors and stress erythropoiesis 
(Prasher et al., 2005). Ercc1-/- mutant cells are not only compromised in NER and crosslink 
repair, but also undergo rapid, premature replicative senescence. In line with this observation, 
p53 accumulation has been detected in liver, kidney and brain and p21 accumulation was 
observed in Ercc1-/- MEFs (Chipchase et al., 2003; Melton et al., 1998), (Niedernhofer et al., 
unpublished observations).  
 Another ERCC1 mouse model, Ercc1Δ7/Δ7, expresses the ERCC1 protein with a 7 amino-
acid carboxy terminal truncation (Weeda et al., 1997), resulting in a milder phenotype, when 
compared to the Ercc1-/- mouse (Niedernhofer et al., unpublished results). Interestingly, this 
mutation partially inactivates the repair function of ERCC1 but does not cause dramatic protein 
instability. Initial experiments with a limited number of Ercc1Δ7/- mice revealed Ercc1-/- features 
like kyphosis, infertility, progressive cachexia, sarcopenia and liver polyploidy, but with onset at 
an older age. Although these animals also exhibit retarded growth and premature death (about 
6 months of age), this is not considered as pronounced as that observed in the Ercc1-/- mouse. 
Moreover, the Ercc1Δ7/- mouse show signs of progressive neurodegeneration, e.g. dystonia, 
ataxia and priapism (Niedernhofer, unpublished results).  
Since Xpa-/- mice -that are totally NER-deficient-, do not show signs of aging, the progeria 
observed in the Ercc1-/- or Ercc1Δ7/- mouse can not be due solely to their NER defect. Instead, 
the involvement of ERCC1 in crosslink repair could give rise to the accumulation of interstrand 
crosslinks in these Ercc1-/- or Ercc1Δ7/- animals, that are extremely toxic DNA lesions for cells 
and organisms.  
 
1.4.7 XPF 
XP-F patients have only mild symptoms of photosensitivity. However, in these patients the 
causative XPF mutations usually do not give rise to complete loss of functions, resulting in 
residual repair activity. Most probably, complete null mutants are incompatible with life. 
Therefore, an XPF knockout mouse was created by mimicking a point mutation (XP23OS) 
reported to be found in XP-F patients, which resulted in an early STOP (with the other allele 
being a null), and which was presumed to be compatible with human life. Although initial 
development seemed normal, Xpfm/m pups lagged behind in growth. At about 3 weeks of age 
the animals died of unknown cause. As was observed for the Ercc1-/- mouse, the liver showed 
cells with enlarged nuclei. MEFs showed no obvious growth defects, but were sensitive to UV 
and also MMC (Tian et al., 2004).  
 
1.4.8 NER double mutant mouse models and the link with aging 
It is interesting to note that Csbm/m, Csa-/- (TC-NER deficient), Ercc1-/-, Ercc1Δ7/- and XpdTTD mice 
(partial NER defect), display aging symptoms, whereas both Xpc-/- and Xpa-/- mice, defective in 
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GG-NER and the entire NER process respectively, do not have any overt aging phenotype. This 
would suggest that CSA, CSB and XPD proteins have additional functions outside the context of 
NER, which, when defective, result in an aging phenotype. Interestingly, when XpdTTD mice 
were crossed to Xpa-/- animals in order to generate double mutant mice and study the effect of a 
total NER deficiency in the XpdTTD mouse model, this resulted in an accelerated premature 
aging phenotype (de Boer et al., 2002) (Figure 5A), which included retarded growth, cachexia, 
disturbed gait, excessive hypodermal keratosis, spinal kyphosis and severely shortened 
lifespan. Likewise, when Csbm/m or Csa-/- mice were crossed to either Xpa-/- or Xpc-/- mice, this 
resulted in a very severe phenotype, including growth retardation, neurological abnormalities 
and an extremely short life span. (Murai et al., 2001) (Figure 5B). In contrast, Xpc-/-/Xpa-/-, 
Csbm/m/Csa-/- and Xpc-/-/XpdTTD animals were viable and quite normal. 
 Taken together, these findings suggest that a complete NER deficiency in combination with 
a CSA, CSB or XPD is necessary to induce this premature aging phenotype. Similar, but not 
always identical, phenotypes have been observed for the previously mentioned Ercc1-/-, Xpfm/m 
and Xpg-/- mice, and this could indicate that these animals too display aging features. Moreover, 
when the previously mentioned XpgΔex15/Δex15 mouse was crossed to Xpa-/- mice to generate 
double mutant mice, this also resulted in a similarly severe phenotype (Shiomi et al., 2005).  
The above-mentioned mouse models have in common that DNA repair is impaired and some of 
them have been shown to display signs of a premature aging phenotype (de Boer et al., 2002; 
Weeda et al., 1997). Because these animals have not been subjected to exogenous DNA-
damaging agents, this could point toward the contribution of unrepaired endogenous DNA 
damage to the observed aging phenotypes.  
 
 
 
Figure 5. Mouse models with accelerated progeroid symptoms: XpdTTDXpa-/-, Csbm/mXpa-/- and Ercc1-/-. Photograph of a 3-
week-old XpdTTDXpa-/- double-mutant, XpdTTD, and Xpa-/- mouse (left). These XpdTTDXpa-/- double mutants develop severe 
growth retardation, neurologic abnormalities, kyphosis (indicative of osteoporosis), and extreme cachectic appearance. 
(adapted from de (de Boer, Andressoo et al. 2002)) Photograph of a 3-week-old Csbm/mXpa-/- double-mutant and  an age-
matched Xpa-/- mouse (middle). These Csbm/mXpa-/- double mutants develop growth retardation, neurological abnormalities 
and an extremely short life span. Photograph of a 3-week-old Ercc1-/- mouse and wt control (right). Ercc1-/- mice develop an 
accelerated, segmental aging phenotype, including cachexia, sarcopenia and progressive ataxia (courtesy of Laura 
Niedernhofer). 
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1.5 Other genome instability syndromes and mouse models with 
progeria 
1.5.1 Human syndromes with progeria 
Progeroid features are not an exclusive hallmark of the NER disorders CS, COFS, XP/CS and 
TTD. Other well-known examples of progeroid syndromes are Werner Syndrome, Bloom 
Syndrome and Hutchinson-Gilford progeria.  
 About 1300 cases of Werner Syndrome (WS) have been described, making it the most 
commonly known progeroid syndrome (Shimamoto et al., 2004). Patients with WS suffer from 
cancer predisposition and segmental progeria, including short stature, alopecia, atrophic skin, 
thin gray hair, type II diabetes, osteoporosis, cataracts, arteriosclerosis and atherosclerosis. WS 
patients die usually in their fifth decade of life from cardiovascular disease or cancer (Kipling et 
al., 2004). The mutated gene responsible for this severe disease is WRN, which encodes a 
RecQ-like helicase with 3’-5’ exonuclease activity and 3’-5’ helicase activity, involved in resolving 
secondary DNA structures (Gray et al., 1997). One of the major functions of WRN is thought to be 
the reinitiation of stalled replication forks. When WRN is absent, these structures are resolved by a 
complex mechanism involving illegitimate recombination causing deletions, resulting in cell cycle 
arrest in the S phase (Rodriguez-Lopez et al., 2002). Therefore, a defect in this gene disrupts 
primarily DNA synthesis, resulting in genomic instability. Accordingly, WS cells cultured in vitro 
have a limited capacity to replicate, having on average only 20 population doublings (PD), whereas 
WT cells can reach 40-100 PDs, a process that is called replicative senescence. In addition, WRN 
has been implicated in telomere metabolism. A comparative cDNA microarray study performed on 
cells of WS patients and those of ‘normal’ young and old individuals revealed a high similarity 
between WS and natural aging. A large percentage of genes that showed similarity have a function 
in the processing of either RNA or DNA (Kyng et al., 2003), reviewed in (Puzianowska-Kuznicka 
and Kuznicki, 2005). Although it is still unclear what exactly causes the premature aging 
phenotype in WS patients, one possibility could be that the combination of defective genome 
maintenance with the mutator phenotype and replicative senescence of WS cells give rise to the 
observed WS phenotype. 
 Bloom Syndrome (BS) is characterized by growth deficiency with prenatal onset, resulting in 
short stature. Other important features are a birdlike face, sensitivity to sunlight, skin lesions, 
disproportionally long extremities, hyper- and hypopigmentation, immunodeficiency at a variable 
degree, diabetes mellitus, fertility problems and an unusually high incidence (150-300 fold) of 
many types of cancer at an early age (Risinger and Groden, 2004). BS is believed to be the 
most malignancy prone chromosomal disorder (Kaneko and Kondo, 2004). The affected gene is 
BLM, which belongs to the same RecQ-like helicase family as WRN and encodes a 3’ to 5’ DNA 
helicase (Karow et al., 1997). BLM is necessary for normal double strand break (DSB) repair 
and is particularly involved in the unwinding of DNA structures like Holiday junctions and D-
loops (Karow et al., 2000; Sun et al., 1998). Its function is to maintain genome stability by 
suppressing illegitimate recombination between imperfect homologous sequences (Kaneko and 
Kondo, 2004) and in the resolution of DNA intermediates that arise during homologous 
recombination reactions (Wu et al., 2005). The majority of mutated BLM proteins fails to 
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translocate to the nucleus, resulting in increased sister chromatid exchange (SCE) and an 
abnormal profile of DNA replication intermediates (Risinger and Groden, 2004), which results in 
defective replication and repair. Furthermore, defective p53 dependent apoptosis and absence 
of p53 were detected in BS cells. Most probably this abnormal regulation of p53 together with 
the observed genome instability is involved in the cancer-prone phenotype of BLM patients 
(from (Puzianowska-Kuznicka and Kuznicki, 2005)).  
 Most people recognize progeria from having seen children with Hutchinson-Gilford progeria 
(HGPS) (Figure 6), of which about 100 cases have been described in medical journals. 
Although HGPS patients have a normal appearance at birth, the typical manifestations of the 
disease develop gradually in the next 6-12 months. These features are: short stature, prominent 
eyes, alopecia, atrophic skin, reduced subcutaneous fat, osteoporosis with pathologic fractures 
and cardiovascular disease (Sarkar and Shinton, 2001). Signs of brain aging are not apparent, 
as both the intelligent and emotional development are normal. Importantly, like CS, no 
increased risk of malignancies has been found. The median age at death is about 13.4 years 
(for review see (Baker et al., 1981; Pollex and Hegele, 2004)). Recently, the gene mutated in 
this disease was found to be LMNA, which encodes both the lamin A and C protein (Cao and 
Hegele, 2003; De Sandre-Giovannoli et al., 2003; Eriksson et al., 2003; Novelli et al., 2002). 
Both proteins are components of the nuclear lamina, a structure near the inner nuclear 
membrane that is involved in many genome maintenance processes, like chromatin 
organization, cell cycle and apoptosis regulation and the processing of DNA and RNA. 
Considering the many functions of the nuclear lamina, it is not difficult to envision that disruption 
of this structure leads to genomic instability, reviewed in (Lans and Hoeijmakers, 2006; 
Puzianowska-Kuznicka and Kuznicki, 2005; Vijg and Calder, 2004). 
 
 
 
Figure 6. Patient with Hutchinson-Gilford progeria. Picture of a patient with HGPS. These patients have a normal 
appearance at birth; the typical manifestations of the disease develop gradually in the next 6-12 months. These features 
include short stature, prominent eyes, alopecia, atrophic skin and reduced subcutaneous fat. 
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Although it is not generally believed that the above-mentioned progeroid syndromes represent 
true physiological aging, they all do show many hallmarks of accelerated aging. Therefore, 
taking a closer look at the mutated genes that are responsible for these segmental aging 
syndromes might learn us more about the actual aging process. It is striking that in most 
progeroid syndromes, protein defects affect one or more functions in the maintenance or 
caretaking of the genome. This suggests that failure to maintain genome integrity underlies at 
least some aging phenotypes or aging-related pathologies. 
 
1.5.2 Mouse models with progeria 
Besides the previously mentioned mouse models for NER genes, other mouse models for 
genes involved in genome stability also display progeroid features.  
 P53 plays a very important role in different cellular functions like cell cycle control, 
apoptosis, and transcription. It has been known for a long time as a tumour suppressor gene 
and inactivation of this gene both in cells as well as in the mouse (p53-/- animals) logically gives 
rise to cancer (Jacks et al., 1994). P53 can also promote repair and has recently been 
connected to aging. A p53m/+ mouse that expressed a mutant p53 protein which enhanced 
wildtype p53 activity (Tyner et al., 2002) displayed dwarfism, osteopenia, generalized organ 
atrophy, lymphoid atrophy, osteoporosis, atrophic skin, diminished stress tolerance, decreased 
cancer incidence and a decreased longevity. Thus, modulated forms of p53 can either give rise 
to cancer or a decreased lifespan, which is reminiscent of NER-deficient disorders.  
 Ku80-/- mice, defective in NHEJ, have several aging symptoms including osteoporosis, 
premature growth failure, incomplete plate closure, atrophic skin, liver pathology, sepsis, cancer 
and a shortened life-span. Furthermore, their sensitivity to ROS is also increased (Gu et al., 2000; 
Nussenzweig et al., 1996; Zhu et al., 1996).  
 mTR knockout mice are defective in the catalytic subunit of telomerase. Normally, when 
telomeres become too short, cell division stops and replicative senescence follows (Blasco et al., 
1997). Hence, mTR-/- present with alopecia, skin ulcerations, impaired wound healing, cancer and a 
shortened lifespan in their fifth generation, when telomeres are sufficiently shortened (Herrera et al., 
1999; Rudolph et al., 1999). Interestingly, a WRN knock-out mouse was generated to model WS, 
and although it mimicked the cellular phenotypes observed in WS (mutator phenotype and 
sensitivity to DNA-damaging agents), it did not at all show a premature aging phenotype (Lombard 
et al., 2000). However, when this mouse model was ‘humanized’ by crossing it to mTR-/- animals 
(thereby shortening their telomeres considerably) they did show an aging phenotype similar to that 
observed in WS patients (Du et al., 2004). This observation might signify a role for telomere 
shortening in the premature aging phenotype of WS patients. 
 
The above mentioned mouse models together with the previously described NER deficient mouse 
models all have in common that they are defective in a process involved in genome maintenance 
and as a result suffer from age-related pathologies. It is striking that defects in genes involved in the 
maintenance of DNA give rise to progeroid features. This again, points to the fact that DNA integrity 
plays an important role in the aging process.  
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1.6 The DNA damage-aging connection 
1.6.1 Current aging theories 
Helfand and Rogina defined aging as the inevitable consequence of being a multicellular 
organism, associated with a random, passive decline in function, leading to global loss of 
homeostasis and increased mortality with advancing age (Helfand and Rogina, 2003). This 
notion suggests that aging is a complex multifactorial process, responsible for the deterioration 
of an organism over time and inevitably leading to organismal death. However, an accurate 
description of aging is currently lacking. For example, aging, senescence and age-related 
diseases are often interchangeably used, though they do not always represent the same thing. 
Interestingly, the maximum organismal lifespan is directly linked to aging, whereas lifespan 
extension is often perceived as an anti-aging strategy (Liang et al., 2003; Longo and Finch, 
2003). However, defeating a disease that would otherwise severely limit organismal life span, 
(e.g. cancer) does not necessarily imply an anti-aging strategy itself. Even more, secondary 
effects may often obscure the primary source of aging, which might not be consistent in its 
nature or unique in its origin. For example, when trying to find the cause of aging, one should 
bear in mind that different organisms, tissues or even types of cells might actually age differently 
underlying the possibility that one unifying aging theory might not exist. Many distinct and 
overlapping theories attempt to explain the complicated mechanism of aging (For a 
comprehensive review see (Kirkwood and Austad, 2000)). The genetic imprinting theory (first 
postulated by (Weismann, 1889)) and the mutation accumulation theory of aging (first 
postulated by (Medawar, 1952)) appear as two representative, entirely different, examples. 
 Developmental geneticists believe that aging is genetically imprinted, as are development 
and maturation (Weismann, 1889). This implies that aging is an active process, initiated by the 
organism itself. Nevertheless, it seems unlikely that genes contributing to aging were positively 
selected for in evolution and evidence for this theory is scarce. In the mutation accumulation 
theory (Medawar, 1952), it is hypothesized that aging results from random accumulation of 
mutations in genes ultimately leading to pathology and senescence. Since these mutations 
would be expected to act late in the life of an organism, they might have escaped selective 
pressure. Although this theory seems unquestionable for cancer, it is unlikely that age-related 
disease such as neurodegeneration is also caused by accumulation of mutations, since the 
brain is a post-mitotic tissue. Also, the fact that XPC mice have a high spontaneous mutation 
frequency, but do not experience aging features (Cheo et al., 2000), argues against this theory. 
Other more generally accepted theories of aging are discussed in further detail below. 
 The disposable soma theory argues that the “soma” is maintained to ensure reproductive 
success (Kirkwood and Rose, 1991). It is hypothesized that aging results from the gradual 
accumulation of damage in cells and tissues during this process. Organisms are not 
programmed to age, but rather to survive long enough to ensure successful reproduction by 
using their intricate network of cell-maintenance and stress-response systems. One could 
simplify this theory by saying that the mere reason for the soma to exist is to ensure 
reproduction. Once reproductive capacity has ceased, there is no further reason to maintain the 
‘disposable soma’. This theory is paralleled by the Antagonistic Pleiotropy Theory (Kirkwood 
and Rose, 1991), which states that some genes that may be selected for their beneficial effects 
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early in life, have unselected deleterious defects later in life, thereby contributing directly to the 
aging process. In this regard the process of replicative senescence could be considered as an 
antagonistic pleiotropic process that avoids malignant transformation, but by doing so, 
contributes to aging. 
 The ‘rate of living’ theory (Pearl, 1928; Sohal, 1976) states that the lifespan of an organism 
is dependent on its energy utilization or metabolic rate and the amount of energy consumed 
during adult life or metabolic potential, which ultimately determines its life expectancy (Finkel 
and Holbrook, 2000; Sohal and Weindruch, 1996). In line with this, Harman’s ‘free-radical theory 
of aging’ implies that endogenous ROS, generated by cellular metabolism, continually damage 
macromolecules, like proteins, lipids and DNA, ultimately contributing to the physical decline of 
an organism (Harman, 1956). A faster rate of respiration leads to higher energy consumption by 
which more radicals are formed and therefore results in faster aging, which would imply that 
organisms with a higher metabolic rate experience a shorter lifespan. Evidence for this theory 
comes from the fact that increased resistance to oxidative stress can extend the lifespan of C. 
elegans, Drosophila, and rodents (Melov et al., 2001; Melov et al., 2000; Orr and Sohal, 1994; 
Schriner et al., 2005). Hypersensitivity to oxygen, on the other hand, significantly reduces the 
lifespan of nematodes. Furthermore, caloric restriction (CR) (or limited food intake) has been 
proven a potent lifespan enhancer in worms, flies and rodents (Lakowski and Hekimi, 1998; 
Longo and Finch, 2003; Mair et al., 2003). This positive effect of CR on lifespan is most 
probably due to the attenuation of the oxidative stress by lowering metabolism and increasing 
antioxidant defense.  
 Eventually, although not every theory is supported by the same amount of convincing 
evidence, most of them are not necessarily mutually exclusive. In fact, it is equally convincing to 
assume that combinations of certain currently existing theories are the best way to explain 
aging. 
 
1.6.2 Oxidative DNA damage and antioxidant defense 
Although it is apparent that many different theories exist to explain the causes of aging, many of 
them seem to involve the damaging of macromolecules, in particular the damaging of DNA. 
Moreover, in the previously mentioned double knock out mouse models, which display many 
premature aging features, unrepaired endogenous DNA damage could be a major contributing 
factor to the observed phenotype. IR, UVA, ROS, and endogenously produced metabolic 
products can lead to oxidative DNA damage, which can disrupt transcription and DNA 
replication and give rise to mutations (Bernstein et al., 2002; Campisi, 2001; Hasty et al., 2003). 
H2O2 and IR can induce oxidative base damage or single stranded (SS) breaks, which are 
thought to be removed by BER. Other examples of oxidative DNA lesions are 8-oxo-guanine (8-
oxo-G) and thymin glycol (TG), which are thought to be transcription-blocking lesions (Hatahet 
et al., 1994; Htun and Johnston, 1992). Under normal conditions 1 base modification per 
130.000 bases is induced in nuclear DNA. For mitochondrial DNA this number is even higher: 
approximately 1 damage per 8000 bases is found (Ames, 1989; Beckman and Ames, 1997).  
 Inevitable byproducts of cellular metabolism are reactive oxygen species (ROS), e.g. 
superoxide anion (O2-x), singlet oxygen (1O2), hydrogen peroxide (H2O2) and hydroxyl radical 
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(xOH) (Davies, 1995; Fridovich, 1995). Endogenous oxygen radical generation occurs in vivo as 
a by-product of enzymatic redox chemistry and, accordingly, mitochondria are the principal 
source of endogenous oxidants (Beckman and Ames, 1998; Halliwell, 1989). Other sources of 
ROS are the cytochrome P450 detoxification system, phagocytic oxidative bursts and 
peroxisomal leakage (Balaban et al., 2005; Finkel and Holbrook, 2000). The location of DNA 
close to sites of ROS generation increases its susceptibility, which explains why mitochondrial 
DNA suffers more oxidative DNA damages than nuclear DNA. Superoxide is a precursor to 
various other ROS, whereas hydroxyl free radicals are the primary DNA-damaging species. 
ROS can cause adducts to bases (all four can be oxidatively modified) and sugar groups, as 
well as single and double strand breaks in the DNA backbone, DNA-DNA or DNA-protein 
crosslinks (Hoeijmakers, 2001). Given the amount of repair processes, present in the cell, to 
remove oxidative DNA lesions, it seems likely that they pose a significant threat to the genome. 
Additionally, ROS can damage other macromolecules like RNA, lipids and proteins. However, 
these can always be replaced by de novo synthesis, a non-applicable option for DNA. Since 
ROS form a necessary constituent of cellular processes (for example signal transduction) 
(Finkel, 2001), and are inherent to life, they are an unavoidable hazard. 
 Fortunately, organisms have different defense mechanisms against radicals. To the first 
category of defense systems against radicals belong molecules that directly quench radicals 
before they can confer damage to cellular components. Examples are vitamin E or C and ß-
carotene (Ames et al., 1995; Yu, 1994). The second category of defense mechanisms 
encompasses enzymes that catalyze the decomposition of radicals/oxidants. Examples are 
catalases, gluthatione peroxidases and superoxide dismutases (Beckman and Ames, 1998). 
Furthermore, enzymes involved in the reduction of antioxidant enzymes (for example GSH 
reductase) and the cellular machinery that maintains a reductive environment, provide a strong 
barricade against radicals. Radical scavenging (either by small molecules or enzymes) can be 
represented as follows: Xy + IH Æ XH + Iy (antioxidant derived radical). A potent radical 
scavenger/antioxidant involves a quick reaction and the resulting antioxidant-derived radical is 
not stable enough to form a chain reaction, reviewed by (Beckman and Ames, 1998; Niki, 2000). 
The more reactive a radical is the less scavenging of that radical is dependent on the chemical 
reactivity of the antioxidant. Instead concentration becomes far more important. An antioxidant 
can only scavenge free aqueous radicals if the antioxidant itself is water-soluble, so it cannot 
suppress lipophilic oxidation, which will also induce a chain reaction. Examples of water-soluble 
radical scavenging molecules are vitamin C, uric acid and bilirubin (Niki et al., 1988). Vitamin C, 
which by itself is not a very good antioxidant, can act synergistic with vitamin E (fat-soluble) 
(Burton et al., 1985; Sato et al., 1990). Other lipid-soluble radical scavengers are ubiquinol and 
probucol. Their activity depends both on the local concentration and their mobility at a specific 
site. The most common radical scavenging enzymes are superoxide dismutase (SOD, very 
highly conserved between species), GSH peroxidase and catalase. (Beckman and Ames, 1998) 
SOD converts O2- to H2O2, which is converted to H2O by catalase. SOD levels increase as a 
result of oxidative stress, but the enzyme can be irreversibly inactivated by its product H2O2  
(Niki, 2000).  
 Unfortunately, the defense mechanisms mentioned above are not foolproof, because over 
time all organisms accumulate damaged lipids, proteins, carbohydrates and nucleic acids. To 
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remove these oxidized products different oxidant repair systems exist; 1) enzymes that restore 
biomolecules to their native conformation (e.g. DNA repair) 2) catabolic enzymes that 
specifically degrade non-functional proteins, lipids and nucleic acids 3) the degradation of 
oxidatively damaged cell components (indirectly). Production of ROS, without proper defense, is 
a major rate-limiting factor of lifespan, which is illustrated by Sod2-/- mice. These mice lack the 
mitochondrial SOD2 enzyme, which is a major player in the protection against radicals in 
mitochondria, and as a result they die within the first week of life. Sod2-/- mice have dilated 
cardiomyopathy, liver dysfunction, metabolic acidosis, mitochondrial enzyme abnormalities and 
a mean lifespan of 8 days (Melov et al., 1998). The cause of this phenotype is most probably 
toxicity of mitochondrial oxidants derived from normal cellular metabolism. Consequently, 
modulation of metabolic ROS can have a profound effect on the lifespan of Sod2-/- mice: 
synthetic SOD mimetics increase their lifespan dramatically and rescue part of the phenotype 
(Melov et al., 2001). 
 As mentioned before, defective TCR of oxidative lesions may contribute to CS features. 
Moreover, defective DNA repair seems to be a hallmark of many progeroid syndromes and 
oxidative stress has been implicated in neurodegenerative diseases (e.g. Alzheimer’s disease), 
atherosclerosis and retinal degeneration (Betarbet et al., 2002). Finally, the amount of oxidative 
DNA damage increases by as much as two-fold with age in a number of species and tissues 
(Hamilton et al., 2001; Hirano et al., 1995; Kaneko et al., 1996). This may point to the fact that a 
50-100% increase in the steady state levels of oxidative DNA damage are physiologically 
relevant, but such an elevation is difficult to quantify due to artifacts in background levels 
introduced during the process of DNA extraction (Beckman and Ames., 2000; Poulsen., 2005). 
Taken together, it is reasonable to assume that endogenously generated oxidative DNA 
damage contributes to aging.  
 
1.6.3 Mouse models to study aging 
Currently, the most frequently used mouse models to study aging are the ones that, either due 
to mutations or due to caloric restriction (CR), have an extended lifespan. The best known 
examples are the Snell and Ames dwarf mice, which have a mutation in the pit-1 or prop-1 
gene, respectively (Andersen et al., 1995; Li et al., 1990; Liang et al., 2003). As a result of these 
mutations, pituitary cells that produce growth, thyroid stimulating and prolactin hormones (GH, 
TSH and Prl) are not developed properly, causing these animals to have reduced serum levels 
of GH, TSH and Prl. As a consequence, they have alterations in IGF1 signaling with reduced 
levels of plasma insulin, IGF1 and glucose. Hence, Ames and Snell dwarf mice have severe 
growth retardation (size is only 1/3 of their wt littermates), reduced metabolism and a life span 
extension of 25-65%, reviewed by (Liang et al., 2003; Longo and Finch, 2003). In addition, less 
oxidative damage to proteins and DNA together with upregulated antioxidant defense was 
observed in these animals when compared to wt mice (Brown-Borg et al., 1999; Brown-Borg, 
2001; Hauck, 2001). Ames and Snell dwarf mice even seem to have a delayed occurrence of 
presumably fatal neoplastic disease and lung adenocarcinomas, although these data are 
controversial, reviewed by (Liang et al., 2003). Additionally, behavioral aspects, like learning, 
memory and locomotor activities are improved. On the contrary, mice with elevated GH levels 
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(throughout life) have low expression of catalase mRNA and low activity of the corresponding 
protein, high levels of ROS, increased oxidative damage to tissues and a shortened lifespan 
(Sonntag et al., 1980). The GH/IGF1 axis is conserved from nematodes to mammals and it has 
been shown that mutations in C. elegans and Drosophila similar to pit-1 and prop-1 extend the 
lifespan of these organisms (Longo and Finch, 2003). Therefore, the GH/IGF1 axis is an 
important determinant of organismal lifespan. However, the exact mechanism by which it acts is 
not yet known. 
 Another well-known mechanism to extend lifespan is caloric restriction (CR), which means 
under-nutrition, not malnutrition. CR prolongs both mean and maximal lifespan of laboratory rats 
and also retards and reduces most of the age-related diseases and physiological changes that 
occur with age, reviewed by (Koubova and Guarente, 2003). Rodents subjected to CR have 
lower serum glucose and IGF1 levels (Mobbs et al., 2001). CR also reduces production of 
metabolic toxins, increases the free-radical scavenging function and induces protein synthesis 
both in liver and skeletal muscle so that the number of oxidized proteins is reduced which all 
together leads to reduction of the amount of endogenous damage (Longo and Finch, 2003).  
 Although CR mice display significant overlap with Snell and Ames dwarf mice, they are not 
identical, since CR of these animals further extends their lifespan (Bartke et al., 2001; Liang et 
al., 2003). As mentioned before, the exact mechanism by which the GH/IGF1 axis and CR have 
an effect on lifespan and aging is not yet clear. Since both mouse models have a lowered 
metabolism and an up-regulated antioxidant defense, it is tempting to speculate that the 
underlying cause of the lifespan extension is the lowering of damage to macromolecules. In this 
respect, it is not surprising that animals with a defect in DNA repair would suffer from premature 
aging features and a shortened lifespan. Therefore, a more detailed study of these prematurely 
aging animals with a shortened lifespan could provide a powerful tool in studying the complex 
mechanism of aging, equivalent to the long-lived animal models that are now used to study 
aging.  
 
1.7 Scope of this thesis 
It is known that deficiencies in NER lead to a repair deficiency that result in UV sensitivity. 
However, in addition to this, human syndromes and mouse models with a NER or TC-NER 
defect display features reminiscent of aging, of which the cause is largely unknown. In this 
thesis, we set out to study the etiology of CS aging features further by use of both Csbm/m and 
Csbm/mXpa-/- mouse models. First, we describe the aging phenotype of NER mice, in particular 
that of the Csbm/m and Csbm/mXpa-/- mouse models in more detail (Chapter 3 and 2). 
Furthermore, we investigated the mechanism behind the aging phenotype of the Csbm/mXpa-/- 
mouse by means of transcriptome profiling (Chapter 2). In addition, we developed a conditional 
Xpa mouse, in order to study the phenotype of Csbm/mXpa-/- mice in a (Cre-recombinase-
mediated) tissue-specific and time-dependent manner (Chapter 4), with special emphasis on the 
brain. Finally, we address the question whether it is possible to interfere with aging by means of 
radical scavenger intervention (Chapter 5). 
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Abstract 
Cockayne syndrome (CS) is a photosensitive, DNA repair disorder associated with progeria 
caused by a defect in the transcription-coupled repair (TCR) subpathway of nucleotide excision 
repair (NER). Here, complete inactivation of NER in Csbm/m/Xpa-/- mutants causes a phenotype 
that reliably mimics the human progeroid CS syndrome. Newborn Csbm/m/Xpa-/- mice display 
attenuated growth, progressive neurological dysfunction, retinal degeneration, cachexia, 
kyphosis and die before weaning. Mouse liver transcriptome analysis and several physiological 
endpoints revealed systemic suppression of the GH/IGF1 somatotroph axis and oxidative 
metabolism, increased antioxidant responses, hypoglycemia together with hepatic glycogen and 
fat accumulation. Broad genome-wide parallels between Csbm/m/Xpa-/- and naturally aged 
mouse liver transcriptomes suggested that these changes are intrinsic to natural aging and to 
DNA repair-deficient mice. Importantly, wild type mice exposed to a low dose of chronic 
genotoxic stress recapitulated this response, thereby pointing to a novel link between genome 
instability and the age-related decline of the somatotroph axis.  
.. 
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Introduction 
A prevailing hypothesis to explain the molecular basis of aging is Harman’s “free-radical theory 
of aging”, which states that endogenous reactive oxygen species (ROS), resulting from cellular 
metabolism, continually damage biomolecules (Harman, 1956). In line with this hypothesis, it 
has been shown that increased resistance to oxidative stress (e.g. by improved antioxidant 
defense) extends the life span of C. elegans, Drosophila, and rodents (Melov et al., 2000; Orr 
and Sohal, 1994; Schriner et al., 2005), whereas oppositely, hypersensitivity to oxygen 
considerably reduces the life span of nematodes (Ishii et al., 1998). A key macromolecule at risk 
for ROS-mediated damage is nuclear DNA (Harman, 1956), as evident from the wide range of 
oxidative DNA lesions that accumulate gradually in rodents and humans with advancing age 
(Hamilton et al., 2001; Lu et al., 2004).  
 In humans, the causative role of DNA damage in aging is supported by a variety of 
progeroid disorders with defects in DNA repair pathways (de Boer et al., 2002; Martin, 2005). 
One such condition is Cockayne Syndrome (CS; affected genes: CSA or CSB), a photosensitive 
disorder, originating from a defect in transcription-coupled repair (TCR) that specifically removes 
DNA lesions, which obstruct RNA polymerases, to allow resumption of transcription and 
promote cellular survival from DNA damage. TCR of helix-distorting DNA damage is a dedicated 
subpathway of the multi-step ‘cut-and-patch’ nucleotide excision repair (NER) system, and is 
designated TC-NER (Hanawalt, 2002) to distinguish it from the so-called global genome NER 
(GG-NER) subpathway that operates genome-wide to eliminate distorting damage. Available 
evidence suggests that CS cells are also defective in TCR of non-helix distorting DNA lesions 
that block transcription such as transcription-blocking oxidative DNA lesions (de Waard et al., 
2003; Spivak and Hanawalt, 2005), which are normally removed genome-wide by base excision 
repair. We will use TCR, when referring to transcription-coupled repair in general. CS patients 
present with growth failure (cachectic dwarfism), progressive neurological abnormalities 
(including delayed psychomotor development, mental retardation, microcephaly, gait ataxia, 
sensorineural hearing loss, retinal degeneration), along with impaired sexual development, 
kyphosis, osteoporosis and severely reduced life span (mean age of death: 12.5 years) 
(Bootsma et al., 2002; Nance and Berry, 1992). A related yet distinct disorder is 
Trichothiodystrophy (TTD; affected genes: XPB, XPD or TTDA). TTD patients are partially 
defective in TCR, as well as in the global genome repair subpathway of NER, and share the 
symptoms associated with CS. In addition, these patients have a partial defect in transcription 
itself, causing additional symptoms such as ichthyosis and brittle hair and nails (Vermeulen et 
al., 2001). Many of the CS and TTD features are progressive and resemble premature aging. As 
patients develop some but not all aspects of normal aging in an accelerated manner, CS and 
TTD are considered “segmental progeroid syndromes” (Martin, 2005)  
 Mouse mutants for CS-A and CS-B reliably mimic the UV-sensitivity of CS patients and 
show accelerated photoreceptor loss, reduced body weight, and mild neurologic abnormalities 
(van der Horst et al., 2002; van der Horst et al., 1997). Similarly, mice homozygous for a 
causative TTD point mutation in the Xpd gene faithfully mirror the symptoms in TTD patients (de 
Boer et al., 2002) whereas complete inactivation of NER (by concurrent inactivation of the Xpa 
gene) dramatically aggravates the CS features of partially NER-defective TTD mice (de Boer et 
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al., 2002). These observations, together with the notion that DNA lesions can provoke a 
permanent cell cycle arrest or apoptosis, led us to propose that aging can result from (oxidative) 
DNA lesions that interfere with transcription and/or replication causing cell death or cellular 
senescence, ultimately leading to loss of tissue homeostasis and onset of age-related diseases 
(de Boer and Hoeijmakers, 2000; Hasty et al., 2003; Mitchell et al., 2003).  
 Here, we report that mice with engineered mutations in both Csb and Xpa genes display 
many CS features in a dramatic form, including postnatal growth attenuation, progressive 
kyphosis, ataxia, retinal degeneration, motor dysfunction and premature death. Importantly, full 
genome transcriptome analysis of the Csbm/m/Xpa-/- mouse liver at the age of 15 days 
uncovered a systemic response seen also in wt mice exposed to chronic oxidative stress. These 
findings disclose a novel link between DNA damage, compromised genome maintenance and 
the somatotrophic axis that determines life span and shed new light on the etiology of Cockayne 
Syndrome and natural aging. 
 
Results 
Attenuated growth and perinatal death in Csbm/m/Xpa-/- and Csbm/m/Xpc-/- mice   
TCR-defective Csbm/m mutant mice (van der Horst et al., 1997) were intercrossed with GG-NER-
defective Xpc-/- (Cheo et al., 1997) and GG/TC-NER-defective Xpa-/- (de Vries et al., 1995) 
animals to investigate whether an increase in the endogenous burden of unrepaired DNA damage, 
as provoked by inactivation of GG-NER, enhances the phenotype, including progeroid features. 
Analysis of UV-induced repair synthesis and RNA synthesis recovery (indicative for GG-NER 
and TC-NER capacity, respectively) confirmed complete inactivation of NER in Csbm/m/Xpa-/- 
and Csbm/m/Xpc-/- animals (Fig. 1A). As expected on the basis of previous work, Xpa-/- cells 
display highest UV-sensitivity, whereas Xpc-/- and Csbm/m cells show intermediate sensitivities 
(Xpa-/- > Csbm/m > Xpc-/- > wt; see Fig. 1B). Interestingly, inactivation of GG-NER in Csbm/m 
MEFs (resulting in Csbm/m/Xpa-/- and Csbm/m/Xpc-/- cells) renders cells more UV-sensitive than 
already completely NER-deficient Xpa-/- MEFs. We attribute this enhanced sensitivity to the 
absence of CSB-mediated TCR of UV-induced lesions that do not form a substrate for NER. 
Thus the repair defect in the double mutant appears to be more severe than that of the single 
mutants. We could not detect a similar increased sensitivity to ionizing radiation in double 
mutant cells above that of Csbm/m cells ((de Waard et al., 2003), data not shown), supporting the 
notion that MEFs in culture are already under high oxygen stress. 
 As evident from their overall appearance and weight (Fig. 1C to E), Csbm/m/Xpa-/- and 
Csbm/m/Xpc-/- pups (hybrid C57BL/6Jx129ola genetic background) displayed a strikingly 
attenuated growth, resulting in pronounced dwarfism. Whereas the number of double mutant 
pups was ~3-fold below that expected for Mendelian inheritance (data not shown), E18.5 
Csbm/m/Xpa-/- and Csbm/m/Xpc-/- embryos were present at Mendelian frequency, pointing to 
considerable lethality during or shortly after birth. Importantly, double mutant embryos were 
morpho- and histologically indistinguishable from wt and single mutant embryos (Fig. 1F, data 
not shown), indicating that the growth defect was postnatal and did not reflect impaired 
embryonic development per se. Approximately around the third week of life, however, 
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Csbm/m/Xpa-/- and Csbm/m/Xpc-/- pups developed progressive cachexia (evident from the weight 
loss after day 15; see Fig. 1E), ultimately resulting in death before postnatal day 22.  
 
 
 
Figure 1. Growth retardation, cachexia, and premature death in Csbm/m/Xpa-/- and Csbm/m/Xpc-/- mice. A) UV repair 
characteristics of wild type, single mutant, and double mutant primary mouse embryonic fibroblasts (MEFs). UV-induced 
Unscheduled DNA Synthesis (UDS; left panel) and Recovery of RNA Synthesis (RRS, right panel) are indicative for GG-
NER and TC-NER capacity, respectively. Error bars indicate s.e.m. B) Survival of primary MEFs exposed to increasing 
doses of UV-C light (254 nm). Error bars (in most cases smaller than symbols used) indicate s.e.m. C) Photograph of a 14-
day old Csbm/m/Xpa-/- mouse with an Xpa-/- littermate (hybrid 129Ola/C57BL/6J background). D) Photograph of an 8-day old 
Csbm/m/Xpa-/- mouse with a Csbm/m littermate (hybrid 129Ola/C57BL/6J background). E) Body weight curve of Csbm/m/Xpa-/- 
and Csbm/m/Xpc-/- mice (n=7) compared to those defective in a single NER gene (n=7) all in a hybrid 129Ola/C57BL/6J 
background. The arrow indicates birth. Error bars (in most cases smaller than symbols used) indicate s.e.m. F) 
Photographs of day 18.5 Csbm/m/Xpa-/- and Xpa-/- embryos (C57BL/6J).  
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Neither removal of wt or single mutant pups from the litter (to reduce competition for breast 
milk), nor moistened food pellets (to facilitate intake of solids), improved the physical condition 
or the lifespan of Csbm/m/Xpa-/- and Csbm/m/Xpc-/- pups. Necropsy revealed milk or solid food in 
the stomach, indicating that insufficient access to supplied nutrition was not the underlying 
cause of growth retardation, weight loss, and early death. Importantly, progressive growth 
retardation, cachexia and short life expectation (~12.5 years) are also observed in CS patients 
(Nance and Berry, 1992). Combined inactivation of Xpa and Xpc rendered mice without any 
overt phenotype (data not shown), leading us to conclude that the dramatic phenotype of 
Csbm/m/Xpa-/- and Csbm/m/Xpc-/- pups results from a combined GG-NER/TC-NER/TCR defect. 
 
Growth and neurological abnormalities in Csbm/m/Xpa-/- mice 
Further analysis of the Csbm/m/Xpa-/- phenotype, performed in an isogenic C57BL/6J background, 
revealed a near to normal size of the skull at day 11 and 21 (autoradiographs shown in Fig. 2A), 
implying that the (postnatal) growth defect is restricted to the trunk, and to a lesser extent, the 
extremities. All 21-day old double mutant animals showed kyphosis (abnormal curvature of the 
spinal column, Fig. 2A, middle left and bottom right), which was also observed in Csbm/m/Xpa-/- 
pups younger than 21 days, indicating that it is not determined by terminal illness. The normal 
appearance of the spine in 11-day old double mutant pups excluded a prenatal developmental 
defect and further pointed to an extremely accelerated onset of kyphosis, a feature observed in 
naturally aged (2-year old) C57BL/6J mice (see Fig. 2A, bottom left panel). Two-dimensional 
images of proximal end-to-mid-diaphysis micro-computed tomography (micro-CT) scans of fixed 
tibiae from 10-, 15- and 20-day old wt and Csbm/m/Xpa-/- mice revealed retarded, yet steady 
longitudinal as well as radial (perimeter) growth, along with a thinner bone cortex and a less 
developed growth plate (Fig. 2B). In line with this observation, we observed a reduction in tibia 
length (Fig. 2C). Notably, while Csbm/m/Xpa-/- pups lose weight in the third week of life, bone 
growth proceeds, resulting in relatively large extremities, a representative feature of CS and TTD 
(Nance and Berry, 1992). 
 Motor coordination problems, manifesting as tremors and abnormal posture of the hind limbs 
(flexion rather than extension in tail suspension test), became evident around day 10 in 
Csbm/m/Xpa-/- mice (data not shown). Foot print analysis revealed a disturbed gait from day 15 
onwards. While wt and single mutant animals maintained a straight path with regular alternating 
strides, Csbm/m/Xpa-/- mice demonstrated a non-uniform alternating left-right step pattern and 
unevenly spaced shorter strides (Fig. 2D). Despite their runted size, the front base width of 
Csbm/m/Xpa-/- animals was significantly greater than that of wt and single mutant littermates, 
which likely illustrates an attempt to maintain balance (Fig. 2D). These data are consistent with 
the profound early postnatal ataxia, abnormal cerebellar development in Csbm/m/Xpa-/- mice 
(Murai et al., 2001), and the progressive neurodegeneration observed in CS patients (Itoh et al., 
1999). 
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Figure 2. Skeletal and neurological abnormalities in Csbm/m/Xpa-/- mice. A) Radiographs of wt and Csbm/m/Xpa-/- mice and 
photograph of a 15-day old Csbm/m/Xpa-/- mouse. B) 2D micro-CT scans of tibiae taken from Csbm/m/Xpa-/- animals and wt 
littermates. I = section through smaller part, II = section through broader part of the diaphysis; e = epiphysis, g = growth 
plate and d = diaphysis. C) Growth of tibiae in time of Csbm/m/Xpa-/- animals (light squares) and wt littermates (dark 
squares). D) Representative footprint patterns of 19-day old wt and Csbm/m/Xpa-/- mice. Arrows indicate the trajectory of 
each mouse. Stride length and front base width measurements on 15-day old wt, Xpa-/-, Csbm/m and Csbm/m/Xpa-/- mice. The 
significantly (*; p<0.001) greater base width in the double mutant mouse indicates ataxia. E) Representative pictures of a 
TUNEL staining in the retina of wt and Csbm/m/Xpa-/- mice and quantification of the number of TUNEL positive cells. Arrows 
indicate TUNEL positive cells in the outer nuclear layer (ONL) and inner nuclear layer (INL). Note the significantly higher 
number of TUNEL-positive cells in both the ONL and the INL in the retina of Csbm/m/Xpa-/- compared to wt mice (*; p<0.05). 
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 We next examined the retina of 15-day old Csbm/m/Xpa-/- pups for the presence of apoptotic cells 
as retinal degeneration is a prominent neurological feature of CS patients (Traboulsi et al., 1992) 
and adult CS mice (Chapter 3). At this age, cell loss occurs as part of the normal development of 
the retina. Yet, as shown by TUNEL (Fig. 2E) and caspase-3 staining (data not shown), the 
number of apoptotic cells in the outer (ONL) and inner nuclear (INL) layers of the retina of 
Csbm/m/Xpa-/- pups was significantly increased (ANOVA, S-N-K posthoc test, p<0.05), as compared 
to wt and single mutant littermates (Fig. 2E). Thus, the Xpa defect enhanced the apoptotic 
sensitivity of photoreceptor cells in Csbm/m mice, thereby pointing to DNA damage as a trigger 
for age-related retinal degeneration. As 15-day old Csbm/m mice still have wt levels of apoptotic 
cells, spontaneous photoreceptor loss in the Csbm/m mouse initiates in the second/third month of 
life. 
 With the exception of substantial loss of abdominal fat, visual inspection and histological 
analysis of most internal organs of 15-day old Csbm/m/Xpa-/- mice did not reveal any obvious 
pathological abnormalities (data not shown). As we did not find any sign of infections, necrosis, 
or abnormal cellular proliferation (as determined by BrdU staining) in the gastrointestinal tract of 
15- and 21-day old Csbm/m/Xpa-/- animals, intestinal malfunction is an unlikely cause of the 
growth defect (Fig. 3A). In addition, the liver has a normal histological appearance (Fig. 3B), and 
neither BrdU (Fig. 3C), PCNA (Fig. 3D), and Ki67 staining (data not shown), nor TUNEL (Fig. 
3E) and caspase 3 staining (data not shown) revealed any significant difference between 
Csbm/m/Xpa-/- and wt livers. This finding indicates that aberrant cell proliferation or apoptosis in 
the liver does not likely contribute to the Csbm/m/Xpa-/- phenotype. Moreover, inactivation of the 
p53 tumor suppressor gene failed to rescue the mutant phenotype, as Csbm/m/Xpa-/-/p53-/- triple 
mutant pups appeared indistinguishable from Csbm/m/Xpa-/- pups (data not shown). Thus, the 
precise etiology of the overall physical deterioration and the cause of death of Csbm/m/Xpa-/- mice 
remain unknown.  
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Figure 3. Histological examination of Csbm/m/Xpa-/- tissues. A) BrdU staining of the jejunum of Csbm/m/Xpa-/- and littermate 
control mice, showing normal proliferative capacity of the intestine in the double mutant mouse. B-E) Histological 
examination of liver sections of 15-day old Csbm/m/Xpa-/- and littermate control mice, stained with HE (B), immunostained for 
the proliferation markers (incorporated) BrdU (C) and PCNA protein (D), or TUNEL-stained for the presence of apoptotic 
cells (E) Quantification of the number of proliferative or apoptotic cells did not reveal significant differences between 
Csbm/m/Xpa-/- and wild type littermate mice. F) HE staining of the pituitary pars distalis of Csbm/m/Xpa-/- and littermate control 
mice. 
Chapter 2 
52 
Enhanced ionizing radiation sensitivity of the Csbm/m/Xpa-/- mouse retina 
The spontaneous age-related and ionizing radiation (IR)-induced loss of post-mitotic 
photoreceptor cells in Csbm/m mice underscores the relevance of DNA repair in the removal of 
(oxidative) DNA damage for the long-term survival of terminally differentiated cells in the retina 
(Chapter 3).  
 
 
  
 
Figure 4. Enhanced sensitivity of Csbm/m/Xpa-/- retinal photoreceptor cells to genotoxic insults. Representative pictures of 
TUNEL stained retinas of 19-day old wt, Csbm/m, Xpa-/- and Csbm/m/Xpa-/- mice (lower panel), 20 hours after exposure of 
animals to 10 Gy of ionizing radiation, together with quantification of the number of TUNEL positive cells in the ONL (upper 
panel). Note the significantly higher number of TUNEL-positive cells in the retina of Csbm/m/Xpa-/- mice, as compared to wt 
and single mutant littermate controls (* indicates statistically significant differences between unirradiated Csbm/m/Xpa-/- mice 
and littermate controls, ** indicates statistically significant differences between unirradiated and irradiated Csbm/m/Xpa-/- 
mice; p<0.05).  
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 To test whether Csbm/m/Xpa-/- animals are more sensitive to genotoxic insults than single 
mutant Csbm/m and Xpa-/- animals, we next examined if the additional Xpa defect further 
enhances the IR sensitivity of the Csbm/m retina. To this end, we exposed 19-day old 
Csbm/m/Xpa-/- pups and wild type and single mutant littermates to γ-rays to a dose of 10 Gy and 
quantified the number of apoptotic cells in the by TUNEL staining 20 hours after exposure. As 
shown in Fig. 4, the number of apoptotic cells in the ONL of untreated (20-day old) Csbm/m/Xpa-/- 
pups further increased, as compared to 15-day old double mutant animals (see Fig. 2E). While 
IR exposure did not increase the frequency of apoptotic photoreceptors in the ONL of wt and 
Xpa-/- animals, Csbm/m mice already show a tendency to increased photoreceptor loss, as 
characteristic for mature Csbm/m animals (Chapter 3). In contrast, the retina of IR-exposed 
Csbm/m/Xpa-/- animals showed an almost two-fold increase in the level of TUNEL-positive 
photoreceptor cells (Student’s t-test p=0.021). Taken together, these findings not only further 
point to unrepaired DNA damage (likely originating from oxidative stress) as the underlying 
trigger for photoreceptor loss, but importantly, also show that inactivation of Xpa further 
enhances the sensitivity of Csbm/m mice to genotoxic stress.  
 
Analysis of the Csbm/m/Xpa-/- mouse liver transcriptome  
To investigate whether a disturbance in growth and metabolism could explain the pronounced 
accelerated organismal deterioration seen in Csbm/m/Xpa-/- mice, we evaluated the liver 
transcriptome of 15-day old wt, single and double mutant mice (n=4). At this age, the 
Csbm/m/Xpa-/- pups have not yet become cachectic. Two-tail, pair wise analysis of variance of 
Affymetrix full mouse genome arrays revealed 1865 genes with significantly changed 
expression patterns between wt and Csbm/m/Xpa-/- livers (p≤0.01, 1.2 fold change up- or down 
regulated, for summary see table 1), a number that significantly exceeds the 80 genes that are 
expected to occur by chance under these selection criteria. Among the set of 1865 genes, we 
identified those GO-classified biological processes with a significantly disproportionate number 
of responsive genes relative to those printed on microarrays (False detection rate ≤ 0.10). This 
unbiased approach revealed processes implicated in the derivation of energy from oxidation of 
organic compounds, homeostasis of energy reserves, cell growth and maintenance and the 
redox status of the cell.  
 Subsequent analysis of these processes led us to identify:  
1. a profound attenuation of the somatotroph axis as evidenced by the consistent down-
regulation of genes encoding main components of the GH/IGF1 axis (e.g. IGF1, Igfbp3, Igfbp4, 
Igfals, Ghr), as well as lactotroph (e.g. Prlr) and thyrotroph functions (e.g. Dio1) in Csbm/m/Xpa-/- 
livers, in addition to a decrease in the expression of several genes associated with a variety of 
mitogenic signals (e.g. Esr1, Fgf1, Fgfr3, Fgfr4).  
2. an extensive suppression of catabolic metabolism in the Csbm/m/Xpa-/- liver, as evident from the 
significant down-regulation of key genes involved in glycolysis, tricarboxylic acid cycle and 
oxidative phosphorylation pathways (summarized in Table 1), coupled with a significant up-
regulation of genes associated with glycogen synthesis (e.g. Gyg1 and Gys2 and down-
regulation of glycogen phosphorylase, Pygl) suggesting that the Csbm/m/Xpa-/- liver stores glucose 
into glycogen, rather than burn it for energy derivation. These changes were further accompanied 
Chapter 2 
54 
by the broad down-regulation of genes associated with electron transport and oxidative 
phosphorylation (e.g. several cytochrome P450 monooxygenases, the NADH dehydrogenase 
complex and the NADPH-dependent oxidative metabolism; Table 1) and the significant down-
regulation of several genes associated with peroxisomal biosynthesis (Table 1). Apparently, the 
complete catabolic metabolism is restrained in the Csbm/m/Xpa-/- liver. 
3. a broad upregulation of genes associated with fatty acid synthesis and transport (several genes 
listed in Table 1), the up-regulation of the receptor for the adipocyte hormone leptin (Lepr) and 
the central fat regulator peroxisome proliferator-activated receptor-gamma (Pparγ). Thus, similar 
to reserved glucose utilization and enhanced glycogen synthesis, Csbm/m/Xpa-/- mice attempt to 
store rather than burn fat. 
4. an up-regulation of genes encoding key enzymatic and non-enzymatic low molecular mass 
scavengers and antioxidant defense enzymes (e.g. Sod1, Prdx2 and 3, Txnip, Ephx1, Hmox1 
and 5 components of the glutathione system; Table 1), suggesting that Csbm/m/Xpa-/- mice try to 
minimize the induction of (DNA) damage by counteracting ROS.  
 Importantly, none of these genes were identified as significantly differentially expressed in 
the livers of Csbm/m or Xpa-/- littermate controls (Table 1). Quantitative real-time PCR (Q-PCR) 
evaluation of the expression levels of key genes involved in the somatotroph axis, energy 
metabolism and antioxidant defense in the liver of Csbm/m/Xpa-/- mice, and wt, Csbm/m and Xpa-/- 
littermates, as well as further biochemical analysis (see below), confirmed the validity of the 
microarray data (Fig. 5A, upper left panel).  
 
Postnatal systemic changes in somatotroph axis, energy metabolism, and 
antioxidant defense in Csbm/m/Xpa-/- mice 
Next, we analyzed whether the onset of aforementioned transcriptional changes paralleled the 
progressive postnatal growth attenuation, as well as the weight loss observed later. Consistent 
with the normal embryonic development, the expression levels of genes involved in the 
somatotroph axis (Ghr, Igf1, Prlr), antioxidant defense (Gstt2, Hmox1, Ephx1) and oxidative 
metabolism (Gck, Gyg1, Cs, Ndufs8) did not differ significantly between wt and Csbm/m/Xpa-/- 
livers at postnatal day 1 (Fig. 5B). In contrast, during the first two weeks of life, wt mice 
exhibited a robust up-regulation in Igf1, Ghr, Prlr gene expression, a response that was virtually 
absent in Csbm/m/Xpa-/- animals (Fig. 5B, left panels) and well explains the severe growth 
retardation of double mutant pups after birth. Analysis of Gstt2, Hmox1, and Ephx1 mRNA 
levels revealed that the up-regulation of the antioxidant defense system in the Csbm/m/Xpa-/- liver 
already initiated before postnatal day 10, and thus well ahead of the initiation of the 
physiological decline (i.e. weight loss) (Fig. 5B, middle panels). When comparing mRNA levels 
of key genes in glycolysis (Gck), TCA cycle (Cs), and mitochondrial oxidative phosphorylation 
(Ndufs8), we noticed that beginning postnatal day 10, Csbm/m/Xpa-/- livers do not show the 
prominent up-regulation of these catabolic genes seen in the wt liver (instead expression levels 
continued to decline), while they up-regulate glycogen synthesis (Gyg1, Fig. 2B, right panels). In 
agreement, the enzymatic activity of citrate synthase was significantly lower (p≤0.01) in the liver 
of 15-day old Csbm/m/Xpa-/- mice (119 ± 15 mU/mg protein), as compared to wt littermate 
controls (70 ± 13 mU/mg protein). 
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Table 1. Significant gene expression changes in the livers of Csbm/m/Xpa-/-, Csbm/m and Xpa-/- mice compared to wt controls. 
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Figure 5. Expression levels of genes associated with the somatotroph axis, antioxidant defense, and metabolism in mutant 
and wt mouse liver and other organ at various ages. A) Q-PCR evaluation of mRNA levels of genes associated with 
antioxidant defense (dark gray bars), oxidative metabolism (light gray bars) and the GH/IGF1 axis (black bars) in the liver, 
kidney, heart and spleen of 15-day old Csbm/m/Xpa-/-, Csbm/m, and Xpa-/- pups. For each gene, expression levels in the 
mutant tissue are plotted relative to that of age-matched wt control tissues (dotted line). Error bars indicate S.E.M between 
replicates (n ≥ 3). B) Relative mRNA expression levels (fold changes, relative to embryonic day 18) of genes involved in the 
GH/IGF1 growth axis, antioxidant defense, and oxidative metabolism in the liver of wt and Csbm/m/Xpa-/- pups, plotted as a 
function of time. Error bars indicate S.E.M between replicates (n ≥ 3). 
 
We next determined the expression levels of aforementioned genes in the kidney, heart and 
spleen of the same set of animals employed in the microarray experiment. Expression levels 
markedly mirrored the deviant expression patterns observed in the liver, while mRNA levels in 
Csbm/m and Xpa-/- tissues were not significantly different from wt animals (Fig. 5A). Thus, 
attenuation of the GH/IGF1 axis and down-regulation of metabolism, along with the enhanced 
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antioxidant/detoxification response, represents a systemic, rather than liver-specific response of 
the Csbm/m/Xpa-/- pups to the DNA repair defect. Interestingly, when 96-week old wild type livers 
were tested for expression levels of this same set of Csbm/m/Xpa-/- responsive genes, we noticed 
a remarkable resemblance (data not shown). 
 
Comparison of the Csbm/m/Xpa-/- and naturally aged mouse liver transcriptomes 
The previous result prompted us to investigate whether and to which extent the gene expression 
changes in the Csbm/m/Xpa-/- mouse liver overlap with those observed in a natural aged liver. To 
this end, we first compared the full mouse liver transcriptome of adult 16-, 96- and 130-week old 
wt C57Bl/6J mice (n=4) with that of adult 8-week old wt C57Bl/6J mice (n=4). Using the same 
analytical method as applied to the Csbm/m/Xpa-/- mouse livers, we identified homeostasis of energy 
reserves, oxidative metabolism along with cell growth and maintenance to be significantly 
overrepresented in 96- and 130-week old wt mice, but not in 16-week old animals (for summary, 
see Fig 6C). These findings fit well with previous studies suggesting the repression of oxidative 
metabolism to represent a conserved response shared by highly diverged species (McCarroll et al., 
2004).  
 Next, we implemented a previously described method (Fraser et al., 2005) to evaluate the 
extent of genome-wide similarity between the liver transcriptomes of 2-week old Csbm/m/Xpa-/-
mice and, wt animals of various ages. We first classified all significantly differentially expressed 
genes in the Csbm/m/Xpa-/- liver transcriptome as having increased or decreased expression (as 
compared to wt), and asked how many of these genes respond in a similar direction in the 16/8 
wk, 96/8 wk, and 130/8 wk data sets. If the Csbm/m/Xpa-/- liver resembles an aged liver, one 
expects the Spearman’s rank correlation coefficient rho (r +1.0 or -1.0 in case of perfect 
similarity or dissimilarity, respectively, and 0.0 in case of no correlation) to increase with age. 
Notably, whereas the liver transcriptome of Csbm/m/Xpa-/- mutant mice was dissimilar to that of 
16-week old wt mice (Spearman’s r = -0.28), as it was with 15-day old littermates, this turned 
into a significant positive correlation when the comparison was made between the Csbm/m/Xpa-/- 
and 96-week old mouse liver transcriptomes (r = +0.15) and even more with the 130-week old 
wt mouse group (r = +0.44, p ≤ 0.0001, Fig. 6A). Comparable results were obtained when the 
same approach was applied over the whole mouse transcriptome (including all Affymetrix probe 
sets with signals above the detection cut-off value; see Methods), thus avoiding any initial pre-
selection or introduction of bias. Using the same approach, we did not find a significant 
correlation between the liver transcriptomes of 15-day old Csbm/m or Xpa-/-mice and aged wt 
mice.  
 The genome-wide resemblance between the short-lived Csbm/m/Xpa-/- mice and the 130-week 
old mice was substantially higher (>90%) when the comparison was restricted to those 
functional categories that were significantly overrepresented in the double mutant and 130-week 
old mice, such as the GH/IGF1 axis, oxidative metabolism (i.e. glycolysis, Krebs and oxidative 
phosphorylation), cytochrome P450 electron transport and peroxisomal biogenesis (Fig. 6B and 
C). Despite the occurrence of dissimilarities between the liver transcriptome of Csbm/m/Xpa-/- 
pups and aged wt mice (the latter animals showing over-representation of genes involved in the 
immune and inflammatory responses, ATP biosynthesis and protein glycosylation, along with a 
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lack of the anti-oxidant response), these findings strongly underline the genome-wide parallels 
between the Csbm/m/Xpa-/- repair mutants and natural aging, thereby validating the progeria in the 
double mutant pups.  
 
 
 
Figure 6. Transcriptome similarities between Csbm/m/Xpa-/- and naturally aged mice. A) Spearman’s r correlation of 16-, 96- 
and 130-week old mice with 15-day old Csbm/m/Xpa-/- mice, where -1.0 is a perfect negative (inverse) correlation, 0.0 is no 
correlation, and 1.0 is a perfect positive correlation. B) Similarities between significantly overrepresented biological 
processes of Csbm/m/Xpa-/- and naturally aged mice. Note that in both Csbm/m/Xpa-/- and naturally aged mice transcriptional 
changes were mostly associated with metabolic processes. C) Correlation in significant expression changes of genes 
associated with the GH/IGF1 axis and oxidative metabolism in the livers of Csbm/m/Xpa-/- and naturally aged (96- and 130-
week old) mice. 
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Reduced IGF1 serum levels, glucose and fat utilization in Csbm/m/Xpa-/- mice  
In agreement with the down-regulation of Igf1 gene expression in the liver (the main source of 
circulating IGF1 (Frystyk, 2004)), we observed a significant reduction (p<0.004) in serum IGF1 
levels in 7-, 10- and 15-day old Csbm/m/Xpa-/- mice (Fig. 7A) together with significantly lower 
blood glucose levels (p<0.04, Fig. 7B). Following an initial reduction of ~30% (p<0.04) in 7-, 10- 
and 15-day old Csbm/m/Xpa-/- mice, blood glucose levels further dropped at day 16, gradually 
reaching very low levels in 20-day old Csbm/m/Xpa-/- mice (~3 mM) contrasting the steady blood 
glucose levels (~ 9 mM) in wt and single mutant pups (data not shown). The presence of milk 
and food in the stomach of the double mutant pups along with the normal appearance of the 
intestinal epithelium (Fig. 3A) indicates that the hypoglycemia is not due to impaired food intake. 
Even more, the suppression of the somatotroph axis and subsequent decreased IGF1 
production in 15-day old Csbm/m/Xpa-/- mice appeared not to originate from a pituitary dysfunction 
as histological examination (Fig 3F) and TUNEL staining of sections from the pituitary pars 
distalis, intermedia and nervosa did not reveal any abnormalities (data not shown). Moreover, 
serum GH levels in 15-day old Csbm/m/Xpa-/- mice (15.2 +/- 4.2 ng/ml, n=8) did not differ 
significantly from wt littermates (12.8 +/- 2.8 ng/ml, n=6). Interestingly, the normal serum GH 
levels together with the significant systemic down regulation of Gh receptor gene expression, 
likely points to growth hormone resistance in 15-day old Csbm/m/Xpa-/- mice.  
 PAS staining of liver sections from 10- to 20-day old pups and naturally aged mice revealed 
enhanced accumulation of glycogen in unusually large vesicles in Csbm/m/Xpa-/- pups and 96-
week old mice when compared to wt littermates and 8-week old wt mice (Fig. 7C). This 
observation fits our microarray data, suggesting that both the Csbm/m/Xpa-/- and naturally aged 
mice store, rather than utilize glucose. Overnight fasting of Csbm/m/Xpa-/- pups and littermate 
controls resulted in a near-to-complete depletion of liver glycogen (Fig. 7D) indicating that the 
glycogen accumulation is not due to inability to split glycogen into its constitutive glucose 
monomers.  
 Consistent with the broad up-regulation of genes associated with fatty acid synthesis (Table 
1), oil Red O staining of liver sections from 15-day old pups and naturally aged mice revealed 
enhanced accumulation of triacylglycerides in both compared to control littermates and 8-week 
old mice (Fig. 7C), indicating hepatic steatosis.  This and the absence of adipose tissue suggest 
that Csbm/m/Xpa-/- mice display generalized lipodystrophy (loss and abnormal redistribution of 
body fat) (Ahima and Osei, 2004). 
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Figure 7. Carbohydrate/fat metabolism and IGF1 serum levels. A) IGF1 (ng/ml) and B) glucose (mmol/l) levels in the serum 
of 15-day old Csbm/m/Xpa-/- mice and control littermates (n=6). The levels of IGF1 and glucose in the serum of Csbm/m/Xpa-/- 
mice are significantly lower than that of control littermates (p<0.0004 and p< 0.04, respectively). C) PAS staining for 
glycogen (left) and Oil Red O staining for triglycerides (right) in livers of 15-day old wt and Csbm/m/Xpa-/- mice and 96-week 
old wt mice. Pictures were taken at 100x magnification. Note the large polyploid nuclei in the 96-week old wt mouse liver. 
PAS staining for glycogen (middle) in livers of 15-day old wt and Csbm/m/Xpa-/- mice after overnight starvation. Pictures were 
taken at 100x magnification. 
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Systemic Changes in Somatotroph Axis and Antioxidant Defense in DEHP-
Treated wt Mice  
To test whether the presence of endogenous (oxidative) DNA damage can provoke the 
somatotrophic drop and enhanced antioxidant potential, wt C57BL/6J mice (n=6; 4-week old) 
were fed ad libitum for 9 weeks with standard food containing sub-toxic levels of an oxidative 
DNA damage-inducing agent; di(2-ethylhexyl)phthalate, DEHP, 1500 ppm (Seth, 1982). Neither 
body weight nor appetite and food intake of DEHP-exposed animals deviated from that of 
untreated control animals. As shown in Figure 8, subsequent analysis revealed suppression of 
the expression of genes associated with the somatotroph axis (Igf1, Igfbp3, Ghr, and Dio1) and 
oxidative metabolism (Gck, Cs and Ndufs8), along with the up-regulation of glycogenin 1 (Gyg1, 
Fig 5A) in DEHP-exposed animals. Consistent with the ability of DEHP to generate ROS-
induced DNA damage in the liver, we also noticed a significant up-regulation of genes 
associated with the antioxidant and detoxification responses (Hmox1, Ephx1, Gsr, Sod1, Gstt2). 
These findings suggest that accumulation of unrepaired (oxidative) DNA damage likely 
comprises one of the causes underlying the observed suppression of the GH/IGF1 and 
oxidative metabolism in Csbm/m/Xpa-/- mice. 
 
 
 
Figure 8. Expression levels of genes associated with the GH/IGF1 axis, oxidative metabolism and antioxidant defense in 
livers of DEHP-treated wild type mice. Relative mRNA expression levels of genes involved in the GH/IGF1 growth axis, 
oxidative metabolism and antioxidant defense in 13-week old wt mice treated with a low dose of the pro-oxidant DEHP. For 
each gene, expression levels in the treated wt mouse livers are plotted relative to that of untreated wt littermate controls 
(dotted line) (*; p≤ 0.05). 
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Discussion 
Csbm/m mice exhibit several CS features (e.g. attenuated growth, blindness, neurological 
dysfunction), but their phenotype is overall milder than the human syndrome (van der Horst et 
al., 1997) despite that the truncation in the N-terminal part (mimicking a mutant allele of CS-B 
patient CS1AN) completely inactivates the protein and TC-NER (van der Horst et al., 1997). 
Although the severity of clinical features in humans does not seem to correlate with the severity 
of the molecular defect (Horibata et al., 2004), the absence of the complete spectrum of CS 
features in the Csbm/m mouse model likely originates from man-mouse differences (i.e. 
adaptation to stress, tolerance to DNA damage/genome instability), rather than from the nature 
of the Csbm/m mutation. This idea is supported by our observations that XpdTTD and XpdXPCS 
mice (all carrying causative point mutations) also fail to show the severe CS features associated 
with XPCS and TTD (Andressoo et al., 2006; de Boer et al., 2002). 
 Yet, the present study reveals that inactivation of GG-NER or complete abrogation of NER 
(through inactivation of Xpc or Xpa, respectively) in TCR-deficient Csbm/m mice dramatically 
aggravates the Csbm/m mouse phenotype. As animals were not exposed to exogenous genotoxic 
agents, we attribute this effect to enhanced levels of unrepaired endogenous (oxidative) DNA 
damage. In further support of this, we have shown that Csbm/m/Xpc-/- and Csbm/m/Xpa-/- MEFs, as 
well as Csbm/m/Xpa-/- retinal photoreceptor cells, are more sensitive to environmental genotoxic 
insults (i.e. UV-light, ionizing radiation) than their single mutant counterparts. A comparable 
phenotypic deterioration has been noticed when Xpa was inactivated in XpdTTD (de Boer et al., 
2002), XpdXPCS (Andressoo et al., 2006), compound heterozygous XpdTTD/XPCS animals (carrying 
causative mutations for TTD and combined XP/CS; van de Ven et al., pending revision), and 
XpgdeltaEx15 mice (Shiomi et al., 2005).  
 Importantly, Csbm/m/Xpa-/- mice appeared normal at birth, indicating a normal intra-uterine 
development and ruling out that this condition is an embryonic developmental disorder. Instead, 
after birth, the Csbm/m/Xpa-/- pups displayed progressive kyphosis, cachexia, photoreceptor loss, 
and motor dysfunction, all common postnatal manifestations of CS (Nance and Berry, 1992), as 
well as of natural mammalian aging (Arking, 1998; Kalu, 1995; Weiss et al., 1991). Also similar 
to CS patients (average age at death 12.5 years), Csbm/m/Xpa-/- pups fail to grow into adulthood 
and die before weaning. The relation between (residual) repair capacity, time and severity of a 
particular phenotype is well illustrated by the retinal photoreceptor loss in the Csbm/m mouse 
models. While aging C57Bl/6J mice lose about 5-10% of their rods and cones in 30 months, TCR-
deficient Csbm/m mice have already lost about 50% of their photoreceptor cells by the age of 16 
months (Chapter 3). This spontaneous retinal degeneration in Csbm/m mice originates from 
enhanced apoptotic sensitivity of photoreceptor cells (Chapter 3), evolving in the first one or two 
months after weaning (this study). Interestingly, further crippling of NER in Csbm/m animals by 
inactivation of Xpa accelerates the onset of photoreceptor loss, now becoming visible as early as 
postnatal day 15, and progressively increasing thereafter. The strong correlation between the 
severity of the repair deficiency and the onset of photoreceptor loss, as well as the enhanced 
ionizing radiation hypersensitivity of photoreceptor cells of Csbm/m/Xpa-/- mice (as compared to 
age-matched Csbm/m animals), well support the hypothesis that (oxidative) DNA damage likely 
underlies the retinal degeneration.  
Impaired Genome Maintenance Suppresses the GH/IGF1 Axis in CS Mice 
63 
 Full genome transcriptome analysis of the Csbm/m/Xpa-/- mouse liver, aiming at unraveling the 
etiology of the severe double mutant phenotype, led us to identify significant genome-wide 
parallels between the 2-week old Csbm/m/Xpa-/- and 130-week (but not 16-week) old wt animals at 
the fundamental level of gene expression. Importantly, this resemblance was largely attributable to 
the substantial down regulation of genes associated with processes implicated in oxidative energy 
and growth metabolism, previously revealed by others to represent a conserved transcriptional 
response in aging (McCarroll et al., 2004).  
 The down-regulation of genes associated with the GH/IGF1 growth axis in the liver, the 
systemic reduction in GH receptor mRNA levels and the impaired Igf1 gene expression in liver 
and other tissues (resulting in low serum IGF1 levels) likely underlies the postnatal growth 
defect in Csbm/m/Xpa-/- pups. These changes were not due to reduced GH serum levels or 
pituitary abnormalities. Importantly, a steady decline in the GH/IGF1 somatotroph axis is also 
observed in rodents and humans during natural aging (Carter et al., 2002). Furthermore, 
Csbm/m/Xpa-/- pups failed to up-regulate metabolism; instead they displayed a sharp, systemic 
reduction in the expression levels of genes involved in glycolysis, tricarboxylic acid cycle 
(including decreased citrate synthase activity), and oxidative respiration, which coincided with 
the onset of weight loss (cachexia). In addition, Csbm/m/Xpa-/- pups up-regulated genes 
associated with glycogen and fatty acid synthesis, leading to increased hepatic glycogen 
storage and fat accumulation (steatosis) and pronounced hypoglycemia. Simultaneously 
subcutaneous fat tissue was virtually absent. Given that, in mammals, the GH/IGF1 signaling 
pathway comprises one of the major regulators of energy homeostasis to integrate metabolism 
with growth (Frystyk, 2004; Longo and Finch, 2003; Puigserver et al., 2003), it is tempting to 
speculate that reduced IGF1 signaling is responsible for the postnatal metabolic shift and 
growth defect seen in Csbm/m/Xpa-/- mice. Interestingly, several CS patients have been 
previously reported with hypoglycemia and low IGF1 serum levels (Fujimoto et al., 1969; Park et 
al., 1994), low metabolic rate (Ellaway et al., 2000) and abnormal fat deposition (Laszlo and 
Simon, 1986).  
 Paradoxically, however, the systemic suppression of the somatotrophic axis and energy 
metabolism, along with the up-regulation of antioxidant defenses, low IGF1 serum and blood 
glucose levels, observed in the Csbm/m/Xpa-/- mouse, are all associated with increased longevity, 
rather than with the short lifespan of this mouse model. In lower paradigms for life span 
extension (C. elegans, D. melanogaster), genetic interference in the insulin-signaling pathway 
can prolong life multi-fold (Kenyon, 2005; Partridge et al., 2005). In mammals, IGF1-deficient, 
Ames and Snell dwarf mice (characterized by defects in the development of the anterior pituitary 
due to mutations in the Prop-1 and Pit1 loci and diminished levels of GH, thyroid stimulating and 
prolactin hormones) combine hypoglycemia, low body temperature, and increased storage of 
carbohydrates and lipids (Carter et al., 2002; Longo and Finch, 2003) with up-regulation of 
antioxidant defense capacity and extended lifespan (Brown-Borg et al., 1999; Brown-Borg and 
Rakoczy, 2000). Conversely, GH-overexpressing transgenic mice display reduced lifespan and 
antioxidant responses (Bartke et al., 2002). These findings have also been recently confirmed 
by our identification of genome-wide parallels between the extremely short-lived DNA repair 
mutants (i.e. Csbm/m/Xpa-/-, Ercc1-/-) and the extremely long-lived Ames and Snell dwarfs and 
growth hormone receptor knockout (Ghr-/-) mice (Garinis et al. manuscript in preparation). Last 
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but not least, IGF1 plasma levels decline with age in humans and rodents (Florini et al., 1981; 
Johanson and Blizzard, 1981; Rudman et al., 1981). Along with this hormonal shift, aging cells 
surmount an intricate antioxidant defense response (Camougrand and Rigoulet, 2001; Ji et al., 
1998) that is thought to prevent the detrimental consequences of oxidative stress. Interestingly, 
the progressive, age-related decrease in the somatotroph axis has been suggested to confer a 
selective advantage by postponing the onset of age-related disease and prolonging life span 
through the reduction of toxic free radicals (Carter et al., 2002).  
 How would repair-deficient mice benefit from such a response? During development, the 
mitogenic action of GH and IGF1 fuels cellular metabolism, thereby promoting tissue growth and 
function (Bartke, 2003; Carter et al., 2002; Chandrashekar et al., 2004). A high metabolic 
activity, however, leads to higher oxygen consumption (Carter et al., 2002) and may also 
increase the ROS burden through the parallel increase of mitochondrial electron transport, 
peroxisomal fatty acid metabolism and/or microsomal cytochrome P-450 enzymes (Beckman 
and Ames, 1998). Despite antioxidant defense and DNA repair, oxidative DNA damage will still 
accumulate, leading to transcriptional stress, impaired replication, cellular senescence, 
malfunction or death and eventually to progressive loss of tissue homeostasis and organismal 
decline (see model, Fig. 9). We hypothesize that complete abrogation of NER (by inactivation of 
Xpa) renders TCR-deficient Csbm/m mice unable to adequately cope with the increased burden 
of DNA damage in the transcribed strand of active genes. This triggers an adaptive response 
i.e. reduction of metabolic activity through down-regulation of the GH/IGF1 axis to relieve the 
pressure on their genome. We interpret this as an attempt to limit the deleterious effects of 
arrested transcription, such as cellular senescence and death causing accelerated aging. As a 
consequence, the initially normal growth becomes arrested soon after birth, leading to severe 
growth retardation. This scenario provides a plausible explanation for the growth defect in CS 
patients. However, this response is unable to fully compensate for the repair defect, thus 
damage still accumulates to critical levels and triggers apoptosis and/or senescence, thereby 
leading to aging-associated pathology such as neurodegeneration (as illustrated by the 
photoreceptor cells in Csbm/m/Xpa-/- mice). 
 The conceptual link between DNA damage and the systemic adaptive response is supported 
by our observation that chronic exposure of wt mice to a sub-toxic dose of DEHP (a pro-oxidant 
that enhances the DNA damage load; see de Waard et al, 2004) triggers a response similar to 
that observed in (untreated) Csbm/m/Xpa-/- mice. Although DEHP at much higher concentrations 
has been previously documented to affect the endocrine function of the pituitary, proteome 
analysis revealed that synthesis of prolactin and growth hormone appears unaffected in DEHP-
treated rats (Hirosawa et al., 2006). This suggests that the observed suppression of genes 
associated with the somatotroph axis and oxidative metabolism in the liver of DEHP-exposed 
mice is triggered by DNA damage in the liver, rather than by a pituitary defect or hypothalamic 
defect.  
 As one would predict, other short-lived NER mouse models (e.g. Xpg, Xpf mice, (Harada et 
al., 1999; Tian et al., 2004)) or NER mutant mice with a milder progeroid phenotype could also 
show accelerated attenuation of the somatotrophic axis in response to their DNA repair defect. 
Indeed, Ercc1-/- animals, carrying a combined NER/crosslink DNA repair defect and a life span 
of only a few weeks, demonstrate a remarkable genome-wide similarity in liver gene expression 
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profiles with Csbm/m/Xpa-/- mice (Niedernhofer et al., pending revision), while XpdXPCS/Xpa-/- and 
compound heterozygous XpdTTD/XPCS/Xpa-/- mice contain lower serum IGF1 levels (van de Ven 
et al., submitted). Furthermore, XpdTTD mice, which manifest accelerated aging in many (but not 
all) organs and tissues, have recently been shown to display features related to a caloric 
restricted-like phenotype and suppression of the GH/IGF1 axis in a limited set of organs and 
tissues, stressing the segmental nature that is characteristic of all progeroid syndromes and the 
systemic nature of the response (Wijnhoven et al., 2005). Finally, proper glucose homeostasis 
and normal IGF1 levels were recently shown to require Sirt6 activity, a chromatin deacetylase 
that may promote DNA repair (Mostoslavsky et al., 2006). As ROS-mediated DNA damage 
appears to be the underlying cause of the Csbm/m/Xpa-/- progeria, it is tempting to speculate that 
one can attenuate the premature onset of age-related features by directly counteracting the 
harmful byproducts of metabolism (i.e. ROS), and consequently DNA damage. Interestingly, an 
antioxidant-based nutraceutical intervention pilot study with Csbm/m/Xpa-/- mice, aiming at 
extending life span and delaying onset of pathology, yielded promising results (Chapter 5). 
 
 
 
Figure 9. The proposed link between DNA damage and the decline of the GH/IGF1 somatotroph axis. ROS are natural 
byproducts of metabolism and can injure several macromolecules including DNA, thus contributing to a slow but steady 
accumulation of damage, transcriptional stress, impaired replication and eventually the progressive loss of tissue 
homeostasis and gradual organismal deterioration. Cells and tissues will respond by (1) up regulating their antioxidant 
defense responses that would moderate the harmful effects of ROS, (2) employing a battery of genome maintenance 
pathways that would repair or remove damaged macromolecules and help to resist the oxidative stress, and (3) 
suppressing their GH/IGF1 somatotroph axis along with the oxidative metabolism, thus substantially moderating their 
metabolic activity that would otherwise lead to high oxygen consumption and increased generation of oxidants. To this end, 
the physiologic reduction of the somatotroph axis and oxidative metabolism is envisaged to be beneficial in terms of net life 
span. 
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Materials and Methods  
Animals  
The generation and characterization of NER-deficient Xpa-/-, Xpc-/-, and Csbm/m mice has been 
previously described (Cheo et al., 1996; de Vries et al., 1995; Nakane et al., 1995; van der 
Horst et al., 1997) p53-/- mice (Lowe et al., 1993) were kindly provided by Dr. T. Jacks (MIT, 
Cambridge, MA). Unless stated otherwise, all mice were kept in a C57BL/6J genetic 
background. In the DEHP exposure study, 4-week old male wt mice (C57BL/6J; n=6) were put on a 
di(2-ethylhexyl)phthalate (DEHP; 1500 ppm; Sigma) containing diet or on a regular diet for 9 weeks. 
Animals were daily screened for discomfort and weighed once a week. Food consumption was 
registered by weighing the food. In the ionizing irradiation exposure study, 18-day old Csbm/m/Xpa-/- 
and littermate control animals (n=4-6/genotype) were exposed to 10 Gy, sacrificed 20 hours 
after exposure (age 19 days) and eyes were further processed. As required by Dutch law, all 
animal studies were approved by an independent Animal Ethical Committee (Dutch equivalent of 
the IACUC).  
 
Cellular sensitivity studies 
UV sensitivity was determined as described (Sijbers et al., 1996). Sparsely seeded petri dish 
cultures were exposed to different doses of UV (254 nm, Philips TUV lamp). After 4 days, the 
number of proliferating cells was estimated from the amount of radioactivity incorporated during 
a 2 hr pulse with [3H] thymidine. Cell survival was expressed as the percentage of radioactivity 
in exposed cells in relation to the radioactivity in untreated cells. UV-induced global genome 
repair was assayed using the UDS method described by (Vermeulen et al., 1994). In brief, 
coverslip-grown cells were exposed to 16 J/m2 of 254 nm UV light and labeled with [3H] 
thymidine. Repair capacity was quantified by grain counting after autoradiography. RNA 
synthesis recovery was measured according to (Ma et al., 1997). In short, coverslip-grown cells 
were exposed to 10 J/m2 of 254 nm UV light, allowed to recover for 16 hr, labeled with [3H] 
uridine, and processed for autoradiography. The relative rate of RNA synthesis was expressed 
as GUV/GC (percentage), where GUV and GC represent the number of grains over UV-exposed 
and non-exposed nuclei, respectively. 
 Ionizing radiation sensitivity of immortalized MEFs was determined using a colony assay. 
Cells were plated in 6-cm-diameter dishes at various densities. After 16 h, cells were exposed to 
a single dose of ionizing radiation (137Cs source; dose range of 0 to 8 Gy. Cells were grown for 
another 5 to 14 days, and after fixation and staining, colonies were counted. All experiments 
were performed in triplicate.  
 
Immunohistological examination and blood parameters 
Detailed histopathological examination was performed on all organs and tissues. Internal organs 
were isolated and either fixed in 10% phosphate-buffered formalin and paraffin-embedded 
(histopathological analysis) or snap-frozen in liquid N2 (for transcription profiling by microarray 
analysis or quantitative PCR). Paraffin-embedded tissues were sectioned at 5 μm and stained 
with haematoxylin/eosin solution. Liver sections were stained with Periodic Acid Schiff (PAS) or 
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Oil Red O (cryosections) to detect glycogen and triglycerides respectively. Apoptotic cells were 
detected using a TdT-mediated dUTP Nick-End Labeling (TUNEL) assay as described by the 
manufacturer (Apoptag Plus Peroxidase In Situ Apoptosis Detection Kit, Chemicon). For 
immunohistochemical procedures, paraffin sections (5 μm) were dewaxed and rehydrated, 
followed by an antigen retrieval step, comprising 1 x 7 minute and 2 x 3 minute incubations of 
tissue sections with a 0.01M sodium citrate buffer in a 800 Watt microwave. Sections were 
washed in phosphate buffered saline (PBS) for 2 minutes. Endogenous peroxidase activity was 
blocked by incubating the sections for 30 minutes in PBS, containing 30% H2O2 and 12.5% 
sodiumazide. Sections were washed in PBS (1 x 2 minutes) and PBS, containing 0.5% milk 
powder, and 0.15% glycine (PBS+ buffer, 2 x 2 minutes). Immunohistochemical staining was 
performed by incubating sections with primary antibodies against PCNA (PC10, Abcam, dilution 
1:1000) or BrdU (Bu20a, DAKO, dilution 1:100) in PBS+ (16 hr; 4 oC). In case of BrdU, sections 
were first covered with 0.1M HCl for 60 minutes at 37 oC and rinsed with PBS, prior to 
incubation with the primary antibody. Next, sections were washed in PBS+ (3 x 5 minutes) and 
incubated for 1 hour at room temperature with rat-anti-mouse Immunoglobulins antibody 
(1:1000) coupled to horseradish peroxidase (DAKO). After sections were washed in PBS+ (3 X 
5 minutes) and PBS 1 x 2 minutes), color was developed for 8 minutes in 3,3’-diaminobenzidine 
solution (DAKO Liquid DAB substrate-chromogen system), all according to the instructions of 
the manufacturer. Sections were counterstained in haematoxylin before dehydration and 
mounting. All histology images were acquired at 40x objective magnification on an Olympus 
BX40 microscope (London, United Kingdom), equipped with a CCD camera.  
 For retinal evaluation, eyes were marked nasally with Alcian blue (5% Alcian blue in 96% 
ethanol), enucleated, fixed in 4 % paraformaldehyde in 0.1M phosphate buffer, washed in PBS 
and embedded in paraffin. Horizontal sections (5 μm thick) of the retina were cut and sections in 
the middle of the retina were selected by Alcian blue marking and proximity of the optic nerve. 
Sections were stained for degenerating cells by TdT-mediated dUTP Nick-End Labeling 
(TUNEL), according to the manufacturer’s instructions (Apoptag Plus Peroxidase In Situ 
Apoptosis Detection Kit, Chemicon). For quantification, the number of TUNEL-positive cells in 
the inner nuclear layer (INL) and outer nuclear layer (ONL) were counted in 6 whole sections 
per mouse. Differences between the genotypes were tested for statistical significance using 
multivariate analysis of variance (ANOVA), followed by a posthoc test of Student-Newman-
Keuls (S-N-K). Significance was set at p<0.05. Serum IGF1 and GH levels were determined 
with the Active mouse/rat IGF1 ELISA and Active mouse/rat GH ELISA kits respectively, as 
described by the manufacturer (Diagnostic Systems Laboratories Inc., Texas). Blood glucose 
was measured using a Freestyle mini blood glucose measurement device (Abbott Diabetes 
Care).  
 
Radiography and micro-computed tomography  
Mice were anaesthetized by intraperitoneal injection of ketalin and rompun (120 and 7.5 μg/g 
body weight). Lateral films were taken at 2x magnification using a CGR Senograph 500T X ray 
system operated at 30 kV and 32 mAS (de Boer et al., 2002). Formalin fixed tibiae from wt and 
mutant mice were scanned from proximal end to mid-diaphysis, using a SkyScan 1072 
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microtomograph (SkyScan, Antwerp, Belgium) with a foxel size of 8.82 μm. Scans were 
processed, and 2D images of the bones were obtained.  
 
Citrate synthase enzyme activity 
Frozen livers were transferred into ice-cold buffer (SHE) consisting of 250 mM sucrose, 10 mM 
HEPES, pH 7.4, and minced. Fresh SHE was added and homogenized by 12 passes in a tight-
fitting glass/Teflon power-driven Potter-Elvejehem homogenizer. Citrate synthase activity of the 
homogenate was measured by monitoring the CoA-coupled conversion of Ellman’s reagent into 
TNB at 412 nm at 37ºC in the presence of 0.005% (v/v) Lubrol-WX to solubilize the 
mitochondrial inner membrane and expressed in mU as nmol 5-thio-2-nitrobenzoate (TNB)/min 
per mg protein. Protein concentrations were determined by the Bio-Rad DC protein assay (Bio-
Rad Laboratories, Inc., Veenendaal, The Netherlands) with BSA as a standard. 
 
Footprint studies 
Footprint analysis was performed by painting the hind and fore paws of the mice with different 
colors of water-soluble non-toxic paints. Animals were allowed to walk along a 30 x 7 cm walled 
runway, lined with paper, into a darkened, enclosed space. Tests were performed in duplicate at 
day 15 and 19. Footprint patterns were analyzed for (1) stride length, measured as the average 
distance between each stride, (2) front base width and (3) hind base width, measured as the 
average distance between contralateral footprints (Carter et al., 1999). 
 
Microarray Analysis  
Standard procedures were used to obtain total RNA (Qiagen) from the liver of wt, Xpa-/-, Csbm/m, 
and Csbm/m/Xpa-/- mice (4 animals per genotype) at postnatal day 15 and from the liver of 8-, 16-
, 96- and 130-week old mice (5 animals per genotype). Synthesis of double stranded cDNA and 
biotin labeled cRNA was performed according to the instructions of the manufacturer 
(Affymetrix, USA). Fragmented cRNA preparations were hybridized to full mouse genome 
oligonucleotide arrays (Affymetrix, mouse expression 430 V2.0 arrays), using Affymetrix 
hybridization Oven 640 (Affymetrix, USA), washed, and subsequently scanned on a GeneChip 
Scanner 3000 (Affymetrix, USA). Initial data extraction and normalization within each array was 
performed by means of the GCOS software (Affymetrix). Data intensities were Log transformed 
and normalized within and between arrays by means of the quantile normalization method as 
previously described (Peeters et al. 2004). Based on the quality report files generated by the 
manufacturer (Affymetrix, USA), the threshold background noise was set at 40. For each probe 
set, signals were considered to be valid when they were marked as “Present” and exhibit a 
signal higher than 40 in at least one microarray experiment. All probe sets with a signal below 
40 were set to be equal to 40. Where appropriate, two-tail, pair wise analysis or two-way 
analysis of variance was employed by means of the Spotfire Decision Site software package 7.2 
v10.0 (Spotfire Inc., MA, USA) to extract the statistically significant data from each of the four 
individual microarrays obtained for each genotype (wt, Xpa-/-, Csbm/m, and Csbm/m/Xpa-/- livers) 
as well as from the four microarrays in each of four groups of normally aged mice (8-, 16-, 96- 
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and 130-week old mice, n=4). The criteria for significance were set at p≤0.010 and a ≥ ±1.2-fold 
change with the exception of glycogenin 1 where after quantitative real-time PCR the difference 
in expression (1.26-fold upregulation) was considered to be significant despite the slightly 
deviant p-value of 0.012 (the cut-off was set at 0.010). All correlations reported here were 
calculated by Pearson’s correlation coefficient and significance was calculated by Fisher’s exact 
test.  
 
Gene Ontology Classification and Overrepresentation of Biological Themes  
All significant gene entries were subjected to GO classification (http://www.geneontology.org). 
Significant over-representation of GO-classified biological processes was assessed by 
comparing the number of pertinent genes in a given biological process to the total number of the 
relevant genes printed on the array for that particular biological process (Fisher exact test, 
p≤0.01 False discovery rate (FDR) ≤0.1) using the publicly accessible software Ease (Hosack et 
al. 2003).  
 
Quantitative PCR Evaluation 
Total RNA was isolated from liver, heart, kidney and spleen of wt, Xpa-/-, Csbm/m, Csbm/m/Xpa-/- 
mice at postnatal day 15 using a Total RNA isolation kit (Qiagen) as described by the 
manufacturer. Quantitative PCR (Q-PCR) was performed with a DNA Engine Opticon device 
according to the instructions of the manufacturer (MJ Research). Primer pair designed to 
generate intron-spanning products of 180-210bp were as follows: Sod1: 5’-GGG ACA ATA CAC 
AAG GCT GT-3’ and 5’-GCC AAT GAT GGA ATG CTC TC-3’; Gsr1: 5’- CCG CCT GAA CAC 
CAT CTA T -3’ and 5’-TTC CCA TTG ACT TCC ACC G-3’; Ghr: 5’-ATT CAC CAA GTG TCG 
TTC CC-3’ and 5’-TCC ATT CCT GGG TCC ATT CA-3’; Igf1: 5’-TGC TTG CTC ACC TTC ACC 
A-3’ and 5’-CAA CAC TCA TCC ACA ATG CC-3’; Prlr: 5’-GCA TCT TTC CAC CAG TTC CG-3’ 
and 5’-GCT CGT CCT CAT TGT CAT CC-3’; Gstt2: 5’-GCC CAA GTC CAC GAA TAC CT-3’ 
and 5’-CTC TGT TCC GTT CCA CCT TC-3’; Ephx1: 5’-CAG CCA AAG AAG ATG AGA GCA-3’ 
and 5’-AGC CAT AGT GGA AGC GAC T-3’; Hmox1: 5’-AAC ACT CTG GAG ATG ACA CCT-3’ 
and 5’-TGT GAG GGA CTC TGG TCT TTG-3’; ApoA4: 5’-CAC CGT TTC TTC TGA CTC CG-3’ 
and 5’-AAT CCC ACA CCA CAT TGG C-3’; Igfbp3: 5’-GTG ACC GAT TCC AAG TTC CA-3’ 
and 5’-TGT CCT CCA TTT CTC TGC GG-3’; Dio1: 5’-CCC TGG TGT TGA ACT TTG GC-3’ and 
5’-TGA GGA AAT CGG CTG TGG A-3’. The generation of specific PCR products was 
confirmed by melting curve analysis (which measures product specificity by the decrease in 
fluorescence signal when the PCR product is denatured) and gel electrophoresis (using Roche 
Agarose MS for analyzing small PCR products). Each primer pair was tested with a logarithmic 
dilution of a cDNA mix to generate a linear standard curve (crossing point (CP) plotted versus 
log of template concentration), which was used to calculate the primer pair efficiency (E = 10(-
1/slope)). Hypoxanthine guanine phosphoribosyltransferase1 (Hprt-1) mRNA was used as an 
external standard. For data analysis, the second derivative maximum method was applied: 
(E1gene of interest ΔCP (cDNA of wt mice - cDNA of Xpa-/- or Csbm/m or Csbm/m/Xpa-/-) gene of interest)/ (Ehprt-1 ΔCP (cDNA wt mice- 
cDNA of Xpa-/- or Csbm/m or Csbm/m/Xpa-/-) hprt-1). 
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Abstract 
Mutations in the CSB gene cause Cockayne Syndrome (CS), a DNA repair disorder 
characterized by UV-sensitivity and severe physical and neurological impairment. CSB functions 
in the transcription-coupled repair subpathway of nucleotide excision repair (NER). This function 
may explain the UV-sensitivity, but hardly clarifies the other CS symptoms. Many of these, 
among which retinopathy, are associated with premature aging. We studied the eye pathology 
in a mouse model for CS. Csbm/m mice were hypersensitive to ultraviolet light and developed 
epithelial hyperplasia and squamous cell carcinomas in the cornea, which underscores the 
importance of transcription-coupled repair of photolesions in the mouse. In addition, we 
observed a spontaneous loss of retinal photoreceptor cells with age in the Csbm/m retina, 
resulting in a 60% decrease in the number of rods by the age of 18 months. Importantly, when 
Csbm/m mice were exposed to a low dose of ionizing radiation (10 Gy), we noticed an increase in 
apoptotic photoreceptor cells, which was not observed in wild type animals. The ionizing 
radiation hypersensitivity of the retina of the Csbm/m mouse suggests that (endogenous) 
oxidative DNA lesions play a role in this CS-specific premature aging feature and supports the 
oxidative DNA damage theory of aging.  
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Introduction 
Cockayne Syndrome (CS; complementation group A and B) is a rare, autosomal recessive DNA 
repair disorder, characterized by a photosensitive skin and severely impaired physical and 
intellectual development (Nance and Berry, 1992). Patients generally show a postnatal growth 
defect (leading to cachectic dwarfism) and develop skeletal abnormalities such as a bird-like 
face (sunken eyes and a beaked nose), kyphosis and, in older patients, osteoporosis. 
Characteristic neurological features are delayed psychomotor development, microcephaly, 
disturbed gait, ataxia, sensorineuronal hearing loss, and pigmentary retinopathy. Other CS 
features include dental caries, impaired sexual development, and cataract. The mean age of 
death in reported cases is 12.5 years (although patients as old as 55 years have been 
described), with the most common cause of death being pneumonia resulting from general 
atrophy and cachexia. Many of the CS features are progressive and resemble premature aging, 
for which reason CS is regarded a progeroid syndrome (Martin, 2005). In contrast to other 
photosensitive DNA repair disorders (i.e. Xeroderma Pigmentosum), CS is not associated with 
increased UV-induced skin cancer proneness. 
 CS originates from mutations in the CSA or CSB gene, which encode components of the 
Nucleotide Excision Repair (NER) pathway. This DNA repair mechanism removes a wide 
variety of helix-distorting DNA lesions from the genome, including UV-induced cross-links 
between adjacent pyrimidines (Hoeijmakers, 2001). The repair process involves the concerted 
action of more than 25 proteins that sequentially recognize the damaged nucleotide, locally 
unwind the helix, excise a 22-31-mer oligonucleotide containing the damage, and fill in the gap 
by DNA synthesis and ligation (de Laat et al., 1999; Lindahl and Wood, 1999). Two sub-
pathways of NER are recognized: (i) global genome NER (GG-NER), which scans and repairs 
damage throughout the entire genome which is thought to serve mainly to prevent mutations, 
and (ii) transcription-coupled NER (TC-NER), which selectively repairs lesions in the transcribed 
strand of active genes and thus may enable the cell to quickly resume transcription and prevent 
cell death (Hanawalt, 2002). Cells from CS-A and CS-B patients are specifically defective in TC-
NER, while GG-NER remains functional (van Hoffen et al., 1993; Venema et al., 1990). This 
may well provide an explanation for the cutaneous UV sensitivity and absence of skin cancer 
predisposition. However, the partial NER defect hardly clarifies the etiology of the other CS 
symptoms, since these features are absent in the related syndrome Xeroderma Pigmentosum 
(XP), even in those XP patients that completely lack both NER subpathways (XP-A patients). 
The CS-specific features may be attributed to other roles of CSA and CSB proteins outside the 
context of NER. There are indications that these proteins are involved in transcription elongation 
(Balajee et al., 1997; Dianov et al., 1997; Licht et al., 2003; Selby and Sancar, 1997) and in 
repair of other, non-NER types of DNA damage, e.g. oxidative DNA lesions (de Waard et al., 
2004; de Waard et al., 2003; Dianov et al., 1999; Osterod et al., 2002; Spivak and Hanawalt, 
2006; Tuo et al., 2003).  
 To facilitate experimental research on the etiology of CS, we have previously generated 
animal models for CS-A and CS-B by complete inactivation of the mouse Csa gene (Csa-/- mice) 
(van der Horst et al., 2002) and by mimicking a specific truncation (as found in CS-B patient 
CS1AN) in the mouse Csb gene (Csbm/m mice) (van der Horst et al., 1997). Both mouse models 
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display a specific TC-NER defect and show increased photosensitivity of the skin (van der Horst 
et al., 2002; van der Horst et al., 1997). In contrast to human CS patients, Csa-/- and Csbm/m 
mice display modest skin cancer susceptibility, which becomes apparent after chronic exposure 
of animals to daily dose of ultraviolet light (Berg et al., 2000; van der Horst et al., 1997). This 
paradox is well explained by the fact that UV-induced cyclobutane pyrimidine dimers are the 
major causative lesion for UV-skin cancer (Jans et al., 2005) and that rodents lack efficient GG-
NER for removal of this lesion from the DNA and thus primarily rely on TC-NER (Bohr et al., 
1985). Other CS features, like growth failure and neurological abnormalities, are only present in 
a mild form (van der Horst et al., 2002; van der Horst et al., 1997). Interestingly, complete 
inactivation of NER (by concurrent inactivation of the Xpa gene) in the Csbm/m mouse 
dramatically aggravates the CS features (including premature aging). Csbm/m/Xpa-/- double 
mutant animals display dramatic postnatal growth retardation, kyphosis, ataxia, abnormal 
locomotor activity, as well as progressive weight loss, and die before weaning (Murai et al., 
2001). In view of the premature aging features in DNA repair disorders and elaborating on 
Harman’s “free-radical theory of aging” (Harman, 1956), we recently postulated that aging can 
result from (oxidative) DNA lesions that interfere with transcription and/or replication and cause 
cell death and/or cellular senescence, ultimately leading to loss of tissue homeostasis and onset 
of age-related disease (Hasty et al., 2003; Mitchell et al., 2003). According to this theory, 
oxidation of DNA by endogenous free radicals, generated as by-product of cellular metabolism, 
plays an important role in the etiology of the CS-specific features, notably premature aging. In 
line with this, Csbm/m animals and cells are susceptible to oxidative damage producing agents 
like ionizing radiation and paraquat, which points to a defect in repair of oxidative DNA lesions, 
in addition to a TC-NER deficiency (de Waard et al., 2003). 
 The present study addresses the eye pathology of CS, which includes photosensitivity and 
pigmentary retinopathy. The latter feature was first described by Cockayne in 1936 (Cockayne, 
1936) and has since been considered a hallmark of the disease. Moreover, it is reported in at 
least 55% of the published cases (Nance and Berry, 1992). The CS retinopathy is one of the yet 
unexplained CS-specific features, which suggests that accelerated aging occurs in CS. Here, 
we show that the defect in the Csbm/m mouse not only causes corneal UV sensitivity and cancer 
susceptibility, but also predisposes to age-related retinopathy, as evident from the spontaneous 
photoreceptor loss. Importantly, we show that the Csbm/m mouse retina is hypersensitive to low 
doses of ionizing radiation, which suggests that oxidative lesions are at the basis of this 
premature aging phenotype. 
 
Results 
Csb deficiency predisposes to UV-induced cornea pathology  
Chronically UV-B exposed Csbm/m mice have been shown to develop skin cancer, notably 
squamous cell carcinomas (Berg et al., 2000; van der Horst et al., 1997). To establish the effect 
of chronic UV exposure on the eyes of wild type (Csb+/+), heterozygous (Csb+/m) and 
homozygous mutant (Csbm/m) mice, animals (n=7-9 mice per genotype) were exposed to low 
daily doses of UV-B light for up to 38 weeks. After five weeks, Csbm/m mice started to develop 
photophobia, while eyes appeared irritated with red eyelids. Ten weeks after the first exposure 
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(cumulative UV dose ± 9 kJ/m2), the cornea of Csbm/m mice started to become opaque (Fig. 1A), 
while some eyes became enlarged and bulging.  
 
 
 
Figure 1. Increased UV-sensitivity of the eyes of Csbm/m mice. A) Representative example of a UV-B exposed Csbm/m 
mouse with macroscopic ocular abnormalities. The photograph was taken 29 weeks after the start of the experiment 
(cumulative dose: ± 35 kJ/m2). The right eye is enlarged and opaque; the left eye is red with an irregular corneal surface. 
B-D) Micrographs of toluidine blue stained plastic sections of eyes of UV-exposed Csbm/m mice. B) Histopathology of an eye 
with an opaque macroscopic appearance, revealing epithelial hyperplasia in the central part of the cornea. C) One of the 
enlarged, bulging eyes showed extensive vascularization of the corneal stroma. D) Example of a corneal squamous cell 
carcinoma, infiltrating into other parts of the eye (arrows point at remnants of the retina). 
 
After 29 weeks (cumulative UV dose ± 35 kJ/m2), the corneal surface of 3 Csbm/m mice became 
distorted and bleedings occurred (Fig. 1A). These animals were euthanized, and their eyes 
were processed for histology. After 38 weeks of UV exposure (cumulative dose ± 50 kJ/m2), the 
experiment was terminated and all animals remaining were euthanized. By that time, all 
irradiated Csbm/m mice had developed macroscopic eye abnormalities (Table 1). In marked 
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contrast, UV-exposed Csb+/+ and Csb+/m animals, as well as non-UV-treated Csbm/m mice did 
not show any eye abnormalities visible to the naked eye.  
 Subsequent histopathological analysis of eyes collected from UV-exposed Csb+/+ and Csb+/m 
animals did not show any abnormalities, except for the presence of a few capillaries in the 
corneal stroma in one out of 7 Csb+/+ eyes investigated (Table 1).  
 
 
 
Table 1. UV-induced pathology of the cornea of wt and Csbm/m mice. 
 
 Similarly, the cornea of untreated Csbm/m mice appeared normal. In marked contrast, UV-
exposed Csbm/m eyes disclosed many abnormalities. Opaque Csbm/m eyes revealed epithelial 
hyperplasia in the central part of the cornea, along with a reactive stroma and 
neovascularization. In addition, Bowman’s membrane was increased in thickness. Enlarged, 
bulging eyes generally displayed severe hyperplasia of the corneal epithelium (Fig. 1B), 
accompanied by local disruptions and hemorrhages at the corneal surface. At least 4 of the 
bulging eyes carried a corneal squamous cell carcinoma with infiltrations into other regions of 
the eye, including the retina (Fig. 1D). One of the enlarged bulging eyes showed a different 
pathology. In this eye, there was only a modest hyperplasia of the epithelium. Most striking in 
this eye was the extensive vascularization of the corneal stroma (Fig. 1C).  
 These findings demonstrate that the TC-NER defect renders the eyes of Csbm/m mice 
sensitive to semi-acute (hyperplasia) and long-term (carcinogenesis) effects of UV exposure. 
 
Csb deficiency predisposes to age-related retinal degeneration  
While analyzing the UV-induced eye pathology in the CS mouse model, we noticed a severe 
reduction in the number of photoreceptor cells (hereafter referred to as photoreceptors) in the 
eyes of UV-exposed as well as in non-exposed (58-week old) Csbm/m mice (data not shown). 
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This finding, together with the notion that retinal degeneration is a characteristic clinical feature 
of Cockayne patients (Nance and Berry, 1992), prompted us to study the spontaneous changes 
in the morphology of the retina of Csbm/m mice. To this end, we isolated the eyes of wild type 
(wt) and Csbm/m mutant mice of defined age (all in a C57Bl/6J genetic background and housed 
under identical light-conditions) and quantified the number of photoreceptors and other cell 
types in defined regions of stained sections of the eye. At 3 months of age, we could not detect 
any difference between the wt and Csbm/m retina, which excludes developmental abnormalities 
as primary cause of the reduced number of photoreceptors in the retina of old  Csbm/m animals. 
However, in 18-month old Csbm/m mice, the outer nuclear layer (ONL; containing the nuclei of 
the photoreceptor cells) and the outer segment layer (containing the rod and cone moiety of the 
photoreceptor cells) was clearly reduced in thickness, when compared to wt mice (Fig. 2A). 
  
 
 
Figure 2. Progressive loss of photoreceptors with age in the Csbm/m mouse. A) Representative micrographs of the central 
region of the retina of young (3 months) and old (18 months) wt and Csbm/m mice. Note the specific loss of ONL nuclei and 
distortion of the outer segment layer in the 18-month-old Csbm/m mouse. Bar 25 μm. B) Quantification of the number of 
nuclei in the various layers of the retina of 18-month old wt and Csbm/m mice, demonstrating specific loss of rods in the aged 
Csbm/m retina (ANOVA, followed by t-test). C) Kinetics of photoreceptor cell loss in Csbm/m mice. The relative number of rod 
nuclei in wt and Csbm/m mice is plotted as the percentage of nuclei, relative to that observed in 3-month old wt mice. Open 
squares: wt; closed diamonds: Csbm/m. Error bars indicate standard deviation D) Micrographs of the retina of 3-month old wt 
and Csbm/m mice, stained for apoptosis using the TUNEL method. Arrows indicate FITC staining for TUNEL positive cells in 
the ONL (right panels). Nuclei are visualized using the DAPI staining method (left panels). 
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Quantification of the number of nuclei in the various layers of the retina did not yield significant 
differences between wt and Csbm/m mice with respect to cell number in the ganglion cell layer 
and the inner nuclear layer (INL, containing the cell bodies of bipolar, horizontal, amacrine and 
Müller cells) (Fig. 2B). In marked contrast, the number of rod nuclei in the ONL of Csbm/m mice 
was significantly reduced (p<0.01) to less than 40 % of the wt level. The number of cones, 
identified on the basis of their characteristic distribution of heterochromatin in the nucleus, 
appeared unchanged. We next determined the kinetics of photoreceptor loss in the retina of 
Csbm/m animals. Quantification of the ONL nuclei showed that the number of photoreceptors 
gradually decreased with age in Csbm/m mice (Fig. 2C). We did not observe an obvious 
photoreceptor loss in wt mice, although there may be a tendency (yet not statistically significant) 
of an aging-related decline in the number of ONL nuclei (Fig. 2C). Other retinal layers appeared 
unaffected (data not shown). Thus, Csbm/m mice specifically lose rods during aging. 
 To investigate whether the process of spontaneous photoreceptor loss involves cell death 
via apoptosis, we next performed a TUNEL staining on horizontal sections of the retina of 3 and 
11.5 months old wt and Csbm/m mice. In line with the near constant number of nuclei in the ONL 
and other layers of the retina of aging wt animals, we could hardly detect any TUNEL positive 
cells (0.3 ± 0.2 and 0.6 ± 0.1 stained nuclei per section at 3 and 11.5 month respectively; mean 
± s.e.m.). In marked contrast, the retina of 3-month old Csbm/m mice contains 14.1 ± 1.6 TUNEL-
positive cells per section, which localized almost exclusively to the ONL (Fig. 2D) without overt 
regional specificity for the central or peripheral retina. In the retina of 11.5-month old Csbm/m 
mice we observed 10.7 ± 2.3 positive cells, which translates into approximately 17 positive cells 
when corrected for the loss of photoreceptors at this age (≈40 %, see Fig. 2C), and does not 
significantly differ from the number of apoptotic photoreceptor cells in 3 month old mutant 
animals (t-test, p=0.48). Similar results were obtained when cells were stained for caspase 3 
(data not shown). 
 Taken together, these findings indicate that a CSB deficiency makes retinal photoreceptors 
(notably the rods) more sensitive to apoptosis, resulting in age-related photoreceptor loss.  
 
The Csbm/m retina is hypersensitive to ionizing radiation  
Since oxidative DNA damage may play a role in CS as well as in aging, we next explored the 
ionizing radiation (IR) sensitivity of the retina of wt and Csbm/m mice. In addition to DNA strand 
breaks (which are repaired normally in CS cells (Spivak and Hanawalt, 2006)), IR is known to 
induce oxidative DNA damage via reactive free radicals that originate from the radiolysis of 
water (Cooke et al., 2003; Ward, 1975). Animals were locally exposed to various doses of X-
rays and sacrificed 7 days after treatment. Next, eye pathology was examined in horizontal 
sections of the retina. For wt mice, no overt pathology was noticed in the retina at any time point 
after irradiation at 10 or 15 Gy. In marked contrast, damage to photoreceptors became apparent 
7 days after exposure to 18.5 Gy, culminating in extensive photoreceptor loss at doses of 22 
and 25 Gy (Fig. 3A). The cell loss was most prominent in the periphery, where hardly any 
photoreceptor cells were left. This observation is well explained by the fact that the periphery 
has been the closest to the irradiation source, and accordingly has received the highest dose of 
X-rays. In addition to photoreceptor damage, we noticed the appearance of swollen RPE cells, 
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containing large vacuoles, in the retina of animals exposed to 22.5 and 25 Gy of X-rays (Fig. 
3A). These findings fit well with a previous study on the acute effects of ionizing radiation on the 
rat retina, which identified photoreceptors as the most sensitive cell type, followed by the RPE 
cell (Amoaku et al., 1989). Surprisingly, Csbm/m mice essentially showed the same pathology at 
each given dose. Quantification of the cell loss (by counting the surviving cells in the periphery), 
did not reveal a statistically significant difference in photoreceptor loss between Csbm/m mice 
and wild type mice (Fig 3B). 
 
 
 
Figure 3. Hypersensitivity of the Csbm/m retina to low doses of ionizing radiation. A) Micrographs of the retina of wt and 
Csbm/m mice before, and seven days after focused exposure of the eye to a high dose of ionizing radiation (25 Gy;  X-rays). 
Note the near complete loss of photoreceptors in the exposed wt and Csbm/m retina. Arrows indicate swollen RPE cells with 
large vacuoles. (B) Quantification of photoreceptor cell loss in wt and Csbm/m mice, exposed to various doses (15-25 Gy) of 
X-rays. ONL nuclei were counted in the peripheral retina and expressed as percentage of the number of ONL nuclei 
present in the unexposed wt retina. Open squares: wt; closed diamonds: Csbm/m. C-D) Effect of low dose (10 Gy; γ-rays) 
whole body ionizing radiation exposure on the retina of wt and Csbm/m mice (6 animals/genotype; 8-10 weeks of age). C) 
Example of apoptotic cells (recognized by a dark nucleus), as visualized by TUNEL staining. D) Quantification of apoptotic 
(TUNEL-positive) cells in the retinal layers. Two-way ANOVA was used to test the independent effects of γ-rays and 
genotype on the number of TUNEL positive cells, as well as the interaction between these variables. 
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 We reasoned that the failure to detect a difference in ionizing radiation sensitivity between 
the wt and Csbm/m retina might have been caused by the design of the experiment: at a high IR 
dose, the heavy damage load could have masked a possible subtle effect of the Csb deficiency, 
whereas at a lower IR dose the method of counting surviving cells may not be sensitive enough. 
To overcome this problem, we performed a whole body γ-ray exposure experiment (10 Gy) with 
wt and Csbm/m animals, and quantified the number of apoptotic cells in sections stained with the 
TUNEL assay. As shown in Fig. 3C and D, the frequency of apoptotic cells in the ONL 
(photoreceptor cells), INL and GCL of the wt retina did not significantly increase after exposure 
(p > 0.5 for each layer), indicating that the wt mouse eye is not sensitive to a single dose of 
ionizing radiation at doses ≤10 Gy. In marked contrast, the already higher frequency of 
apoptotic photoreceptors in the ONL of the Csbm/m retina (as compared to the wt retina; two-way 
ANOVA, followed by t-test, p = 0.0003) increased over two-fold (p = 0.002) after exposure. 
Similarly, IR exposure of the Csbm/m retina resulted in a higher frequency of apoptotic INL cells 
(p = 0.024). These findings clearly indicate that retinal cells in Csbm/m mice are hypersensitive to 
ionizing radiation (two-way ANOVA, followed by t-test p<0.05) and point to unrepaired DNA 
damage (originating from oxidative stress) as the underlying trigger. 
 
Discussion 
The present study shows that the absence of a functional CSB protein in the Csbm/m mouse 
model for the progeroid DNA repair disorder Cockayne syndrome increases the UV-sensitivity of 
the cornea. Effects are noticed both in the stroma and epithelium, with epithelial hyperplasia and 
carcinoma formation as the most prominent pathologic consequence. This finding fits well with 
our previous observation that Csbm/m (and Csa-/-) mice are photosensitive and predisposed to 
develop skin cancer upon UV irradiation (Berg et al., 2000; van der Horst et al., 1997), and 
underscores the potential carcinogenicity of photolesions in sun/UV-exposed areas of the body.  
 Yet, neither skin nor corneal neoplasms have been reported to occur in human CS patients. 
This human-rodent paradox is believed to originate at least in part from the inability of rodent 
cells to upregulate the p48 subunit of the XP-E p48-p125 UV-DDB (DNA Damage Binding) 
heterodimer, required to enhance CPD recognition by the GG-NER machinery (Hwang et al., 
1999; Tang et al., 2000). TC-NER deficient rodents, like Csbm/m mice, thus lack the slower GG-
NER back-up mechanism to remove CPDs from transcribed strands of active genes, allowing 
this lesion to contribute to mutagenesis and carcinogenesis at doses that do not yet give 
apoptosis. 
Retinal degeneration is regarded a hallmark of CS. Based on the fundus appearance, the 
retinopathy of CS patients is generally referred to as a pigmentary retinopathy. Yet, case reports 
with detailed morphological data on CS eye pathology are scarce (Nance and Berry, 1992). To 
our knowledge, literature contains only one report on a 44-month-old boy documenting loss of 
photoreceptors, in addition to other pathological changes such as ganglion cells and nerve fiber 
loss, and irregular RPE pigmentation (Levin et al., 1983). We have shown here that, similar to 
this patient, Csbm/m mice undergo spontaneous retinal degeneration, which consists of a gradual 
loss of rods with age. Other cell types, like cones and ganglion cells are spared, at least up to 
an age of 18 months. As such, the Csbm/m mouse model does not exactly mimic the retinopathy 
Photoreceptor loss in Cockayne syndrome B mice 
83 
of the human syndrome, although it currently can not be excluded that additional aging-related 
pathology (e.g. in the RPE) will develop at a later age.  
 CS is considered a progeroid syndrome, since many of the CS symptoms resemble 
premature aging. In this respect, it is interesting to note that a gradual and selective loss of 
photoreceptors with age (with rods degenerating earlier than cones) is also observed in the 
aging human central retina and in patients with age-related macular degeneration (AMD) 
(Curcio et al., 1993; Jackson et al., 2002). In a primate study, involving 6-34 year old rhesus 
monkeys, the thickness of the ONL was shown to decrease with age as a result of apoptosis of 
photoreceptors, which distributed equally over all ages except for an increase in the number of 
TUNEL-positive cells in the oldest animals (Lambooij et al., 2000). This, together with the notion 
that wild type mice may also lose photoreceptors at high age, indicates that the selective loss of 
rods in the Csbm/m mouse and in CS patients reflect accelerated aging.  
 What is the trigger for the photoreceptor loss in the Csbm/m mouse? Preliminary data from a 
cohort study with the GG-NER/TC-NER deficient Xpa mouse model (de Vries et al., 1995) 
revealed that 7-month old Xpa-/- mice contain a normal number of photoreceptors, while the 
thickness of the ONL in Csbm/m animals of the same age was already reduced by 30% (Gorgels, 
van Steeg, van der Horst, unpublished data). This finding suggests that a NER defect is not the 
major driving force behind the CS mouse retinopathy. Rather, it appears that the severe 
photoreceptor loss in Csbm/m animals represents a CS-specific trait, related to a function of CSB 
protein outside the context of NER. The nature of this non-NER function is not yet clear, but 
there are indications that the CSB protein has an auxiliary function in transcription elongation, 
notably the bypass of pause-sites and RNA secondary structures (Balajee et al., 1997; Dianov 
et al., 1997; Licht et al., 2003; Selby and Sancar, 1997), as well as in repair of other (non-NER 
type) oxidative DNA lesions (de Waard et al., 2003; Dianov et al., 1999; Osterod et al., 2002; 
Spivak and Hanawalt, 2006). Csbm/m mouse embryonic fibroblasts, embryonic stem cells and 
keratinocytes are ionizing radiation-sensitive (de Waard et al., 2003). While IR induces a variety 
of DNA lesions, it is likely that oxidative DNA modifications determine the observed 
hypersensitivity. Indeed, γ-irradiated human fibroblasts of CS-B patients accumulate more 8-
oxoG damage than control cells (Tuo et al., 2003). Furthermore, Csbm/m mice are sensitive to 
the pro-oxidant di-(2-ethylhexyl) phthalate (DEHP) and exposed animals contain higher levels of 
8-oxoG in the liver than wt mice (de Waard et al., 2004; de Waard et al., 2003). Importantly, 
Spivak and Hanawalt (Spivak and Hanawalt, 2006) recently showed that plasmids containing 8-
oxoG are less well repaired by CS patient cells, whereas strand breaks (also produced by 
ionizing radiation) are repaired at normal rate. In view of this, and noting that the photoreceptor 
layer is oxygen rich and has a high metabolic activity, it is tempting to speculate that 
endogenous, oxidative DNA modifications contribute to the CS retinopathy. Indeed, we found 
that exposure of animals to a dose of 10 Gy caused increased cell death in the Csbm/m retina, 
while leaving the wt retina unaffected. At higher doses the Csbm/m and wt retina show equal 
sensitivity, which may be attributed to high levels of DNA strand breaks, masking the effects of 
oxidative damage. Together these findings support the hypothesis that oxidative DNA damage 
is at the basis of photoreceptor cell loss in the aging Csbm/m retina. Moreover, as shown for CSB 
cells in vitro, these data for the first time provide in vivo evidence for ionizing radiation sensitivity 
in CS. 
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 How would oxidative DNA lesions contribute to cell death in the Csbm/m retina? As shown for 
UV lesions, stalled RNA polymerase II forms a major trigger for apoptosis (Ljungman et al., 
1999), and it has been hypothesized that transcription might serve as a DNA-damage dosimeter 
where the severity of blockage acts as a go/no go decision point for the induction of cell death 
(Ljungman and Lane, 2004). One can envisage a scenario in which some oxidative lesions may 
remain unrepaired in the absence of the CSB protein, and accordingly will accumulate in time 
until the damage load reaches a threshold that sets off apoptosis. Such a mechanism would 
imply that the probability of cell death (and thus the frequency of apoptotic photoreceptors) 
would increase with age. Our observation that the frequency of apoptotic photoreceptors does 
not significantly increase between the age of 3 and 11.5 months suggests that such a scenario 
is not the major driving force. Alternatively, it could be that back-up mechanisms such as GG-
NER and GG-BER still enable the CSB-deficient cell to repair oxidative DNA lesions, albeit at a 
slower pace. In this case, the CSB-deficient mouse would have higher steady state levels of 
oxidative DNA damage, which would result in slower transcription rates with a higher 
(stochastic) risk of stalling RNA polymerase II, and subsequent induction of apoptosis. Since 
retinal photoreceptors are post-mitotic cells and are not replaced by dormant stem/progenitor 
cells (Moshiri et al., 2004), analysis of the kinetics of cell loss might discriminate between the 
two models. Curve fitting on the dataset provided in Fig. 2C showed that the relation between 
the number of photoreceptors and age is well described by a mathematical model in which the 
chance of cell death is constant in time (R2 = 0.945). In contrast, fitting to a model in which the 
risk of cell death increases with age did not yield a significant regression result, as the 
parameter reflecting the increasing risk did not significantly differ from zero (p=0.505). This 
analysis suggests that, at least within the age range investigated, the retinal photoreceptor loss 
in the Csbm/m mouse is related to higher steady state levels of oxidative DNA damage, rather 
than to the age-related accumulation of this type of lesions.   
 In conclusion, we found spontaneous age-related retinal degeneration in the Csb mouse 
model for Cockayne syndrome, along with an increased sensitivity of photoreceptor cells for 
ionizing radiation. This finding underscores the importance of DNA repair and control of 
oxidative stress levels for long-term survival of photoreceptor cells in the retina  and supports 
Harman’s “free-radical theory of aging” (Harman, 1956). In addition, it warrants further 
investigation of these mechanisms in the etiology of (age-related) retinal disease and other 
brain disorders. The recent finding that a polymorphism in the promoter region of CSB is 
associated with AMD susceptibility, strongly supports this view (Tuo et al., 2006). Finally, the 
spontaneous and induced loss of terminally differentiated, post-mitotic photoreceptor cells in the 
Csbm/m retina may serve as a sensitive readout for the screening of compounds that may retard 
or prevent onset of pathology in the (aging) retina and brain. 
 
Materials and Methods 
Mice  
The generation and PCR-mediated genotyping of Csbm/m mice has been described previously 
(Berg et al., 2000; van der Horst et al., 1997). Except for the chronic UV exposure study 
(performed with animals in a FVB and 129ola hybrid genetic background) experiments were 
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performed with animals in a C57BL/6J background. Animals are housed in a controlled 
environment (food and water ad libitum, 12h light:12 hr dark cycle, light intensity 70-90 lux) at 
the Animal Resource Center (Erasmus University Medical Center), which operates in compliance 
with the “Animal Welfare Act” of the Dutch government, using the “Guide for the Care and Use of 
Laboratory Animals” as its standard. All animal studies were approved by an independent Animal 
Ethical Committee (Dutch equivalent of the IACUC). 
 
Chronic exposure to UV-B light  
Whole body UV exposures studies were performed according to an incremental-dose protocol 
as described previously (van der Horst et al., 1997). In brief, 9 Csbm/m, 7 Csb+/m, and 7 Csb+/+ 
mice (age 20 weeks) received an initial daily dose of 100 J/m2 UV-B (250-400 nm; American 
Philips F40 sunlamps; dose rate 8.3 J/m2/min), gradually increasing up to 250 J/m2. Animals 
were thoroughly screened twice a week for the occurrence of skin and eye abnormalities. Mice 
that developed tumors were sacrificed by CO2 inhalation and subsequent cervical dislocation. 
Eyes were isolated and processed for histopathological examination as described below. After 
38 weeks (cumulative dose received: ≈ 50 kJ/m2) remaining animals were sacrificed and eyes 
were processed for histopathological analysis. 
 
Exposure to ionizing radiation  
Animals (5-8 weeks old; n=4-6/genotype) were anaesthetized by intraperitoneal injection of 
pentobarbital (50 mg/kg), positioned with the left eye in focus of a 50 kV X-ray source (diameter 
1.5 cm, 1 mm aluminum filter, 40 mm final optics assembly, dose rate 830 R/min, 7.47 Gy/min), 
and exposed at doses as indicated in the text. Animals were sacrificed 7 days after exposure 
and the exposed eye was further processed for histopathological analysis. In a second 
experiment, mice (8-10 week old; n = 6/genotype) received a brief (13 min) total body irradiation 
of 10 Gy using a 137Cs source. After 20 hrs, animals were sacrificed and eyes were processed 
for further analysis. 
 
Isolation of the eyes  
Animals were anaesthetized by CO2 inhalation, followed by cervical dislocation. Eyes were 
marked on the nasal side with Alcian blue (5% Alcian blue in 96% ethanol) and subsequently 
enucleated and fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer. After rinsing in buffer, 
the anterior segment was removed and the eye cup was postfixed in 1% OsO4  and embedded 
in epon. Horizontal sections of 1 μm thickness were cut, stained with toluidine blue and 
examined with a light microscope. Alternatively, for the chronic UV exposure study, enucleated 
eyes were fixed in 2% glutaraldehyde and 2% paraformaldehyde in 0.1 M cacodylate buffer, and 
either embedded in paraffin, or postfixed in 1% OsO4 in Na-cacodylate buffer, and embedded in 
epon. For TUNEL staining (see below) eyes were fixed in 4 % paraformaldehyde in 0.1 M 
phosphate buffer and embedded in paraffin. 
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Quantification of retinal cell loss and visualization of apoptosis  
Digital images of the retina (horizontal, central sections, passing through the optic nerve head) 
were taken at 200 μm nasally and temporally of the optic nerve head, using a microscope 
equipped with a high resolution camera (Prog/Res/3012, Kontron, Germany). The number of 
nuclei in the outer and inner nuclear layer (ONL and INL, respectively) within a rectangular field 
of 500 μm2 was counted. For each mouse two sections (separated by 15 μm) were analysed 
and counts were averaged. In addition, an estimate of the number of cones was obtained by 
specifically counting ONL profiles with the characteristic heterochromatin distribution (Carter-
Dawson and LaVail, 1979). For an estimate of the number of ganglion cells we counted the 
nuclei in the ganglion cell layer in the whole horizontal section.  
 Apoptotic cells were visualized in horizontal paraffin sections (5 μm thick) of 
paraformaldehyde fixed eyes using the TdT-mediated dUTP Nick-End Labeling (TUNEL) 
method, according to the specifications of the manufacturer of the kit (Fluorescein Apoptosis 
Detection System, Promega; Apoptag Plus Peroxidase In Situ Apoptosis Detection Kit, 
Chemicon). 
 The observed differences in cell densities and the number of apoptotic cells were tested for 
significance using a Student t-test and one-way analysis of variance (ANOVA). In case of 
statistical significance the ANOVA was followed by the post hoc test of Student-Newman-Keuls 
(S-N-K). Two-way ANOVA was used to determine the independent effects of ionizing radiation 
and genotype on apoptosis in the various retinal layers, as well as the interaction between these 
two variables. Significance was accepted at p < 0.05. 
 The decrease in photoreceptor number in Csbm/m mice with increasing age (Fig. 2C, dotted 
line) was fitted to a mathematical model with constant risk of cell death  
( teONLtONL .0).0()( μ−= ) 
as well as to a model with age-related increasing risk of cell death  
( R
e tR
eONLtONL
0)1( .
).0()(
μ−−= ) 
using non-linear regression (SPSS, version 11.5.1). A model was considered appropriate when 
all parameter estimates differed significantly from zero (Clarke et al., 2000). 
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Abstract  
Cockyane Syndrome (CS) is a severe inherited progeroid disorder, resulting from a defect in 
genes involved in transcription-coupled nucleotide excision repair. Hallmark features of CS are 
a sun-sensitive skin, early cessation of growth, progressive neurodegeneration and premature 
death. Recently, we have shown that whereas Csbm/m animals display only mild CS features, 
Csbm/m/Xpa-/- mice, which are further compromised in repair, recapitulate many symptoms of this 
disease. As the extremely short lifespan of Csbm/m/Xpa-/- mice precludes studies on brain and 
other CS-associated pathology, we now generated a Cre-lox-based conditional Xpa knock-out 
mouse in which the Xpa gene can be inactivated in a time- and/or tissue-specific manner. 
Importantly, specific inactivation of the conditional Xpa allele in the cerebrum of Csbm/m animals 
triggers dramatic CS-like neurological features, including dilated ventricles and cerebral atrophy. 
This mouse model shows that the CS neuropathology is a direct consequence of the DNA repair 
defect, ruling out indirect systemic causes, points to spontaneous, endogenous DNA damage as 
the underlying culprit and supports the idea that DNA damage contributes to aging. 
Furthermore, it provides an important new tool to selectively study the etiology of CS 
(neuro)pathology, including progeroid features in a setting in which accelerated aging in other 
organs and tissues is absent. 
  
 
Conditional Csb/Xpa mice reveal cerebral atrophy 
91 
Introduction 
Preservation of the genetic information encrypted in the DNA is of utmost importance as DNA 
contains the blueprint of life. Yet, the genome of every living organism is continuously 
challenged by environmental physical and chemical genotoxins (e.g. ultraviolet light (UV), 
ionizing radiation, industrial pollutants, solvents, cigarette smoke) that damage the DNA. Even 
more, as a direct consequence of normal metabolism, the genome is daily assaulted by 
superoxide anions, hydroxyl radicals, hydrogen peroxide (commonly referred to as reactive 
oxygen species or ROS), reactive nitrogen species, malondialdehyde and other (side) products 
of cellular metabolism (Beckman and Ames, 1998; Davies, 1995; Fridovich, 1995). Replication 
of damaged DNA can cause mutations, which ultimately can result in the onset of 
carcinogenesis (Hoeijmakers, 2001).  DNA lesions can also obstruct progressing DNA and RNA 
polymerases during the essential process of replication and transcription respectively, which 
can lead to cellular senescence or apoptosis, and this is believed to contribute to aging (Mitchell 
et al., 2003). DNA, in contrast to other biomolecules (e.g. RNA, proteins), can not be replaced 
once damaged. Therefore, cells have acquired a variety of complex repair systems with 
overlapping substrate specificities to counteract the harmful events of DNA injuries (for review 
(Friedberg, 2006; Hoeijmakers, 2001)). The importance of genome maintenance as anti-cancer 
and anti-aging strategy is highlighted by a series of inherited disorders, associated with cancer 
predisposition and/or early onset of aging-associated symptoms (Hoeijmakers, 2001; Kipling et 
al., 2004; Martin, 2005; Puzianowska-Kuznicka and Kuznicki, 2005).  
 Cockayne Syndrome (CS; complementation group A and B) is an autosomal recessive 
photosensitive disorder, arising from a partial defect in nucleotide excision repair (NER), 
responsible for the elimination of UV-induced photoproducts, as well as a wide variety of other 
structurally unrelated, distorting DNA lesions, like chemically-induced bulky adducts and intrastrand 
crosslinks (for review see (Friedberg, 2006; Hoeijmakers, 2001)). CS patients are specifically 
defective in transcription-coupled NER (TC-NER), a sub-pathway preferentially focusing on 
transcription-blocking lesions in the template strand of active genes (Hanawalt et al., 1994), while 
global genome NER (GG-NER), covering lesions in the entire genome, is intact (van Hoffen et al., 
1993; Venema et al., 1990). As a consequence, CS patients display a photosensitive skin, likely 
because stalled RNA polymerase II is an efficient inducer of apoptosis (Hamdi et al., 2005). Unlike 
Xeroderma Pigmentosum (XP; complementation group A through G; reviewed by (Bootsma, 
2001)), another photosensitive disorder caused by a GG-NER or combined GG-NER/TC-NER 
defect (as in XP-C and XP-A, respectively), CS is not associated with UV-mediated skin cancer 
predisposition (Nance and Berry, 1992), which may be attributed to the fact that CS cells are still 
GG-NER proficient (van Hoffen et al., 1993; Venema et al., 1990). 
 Remarkably, despite the notion that CS carries only a partial NER defect, the clinical symptoms 
are more severe and different from those observed in XP, in which a combined GG-NER/TC-NER 
defect occurs. CS is a highly pleiotropic disorder, generally characterized by severe (postnatal) 
growth failure and wasting (cachectic dwarfism), physical and mental retardation, and progressive 
neurological abnormalities (i.e. delayed psychomotor development, mental retardation, 
microcephaly, gait ataxia, sensorineural hearing loss, retinal degeneration), impaired sexual 
development, kyphosis, osteoporosis and an average life span of 12.5 years, with pneumonia 
Chapter 4 
92 
(resulting from cachexia) as the most common cause of death (reviewed by (Bootsma, 2001; Nance 
and Berry, 1992)). Neuropathological examination revealed multifocal patchy demyelination in 
cerebral and cerebellar cortex, dilated ventricles, calcium deposits in basal ganglia and cerebral 
cortex, and loss of neurons near calcium deposits, which is most pronounced in the cerebellum. 
Peripheral nerve defects, like reduced velocity of nerve conduction, sensorineuronal hearing loss, 
and changes in muscle innervation are often observed (Itoh et al., 1999; Nance and Berry, 1992; 
Rapin et al., 2000). In some cases, CS features combine with cancer-prone XP (XP/CS), due to 
mutations in the XPB, XPD or XPG genes. Since patients have many, but not all characteristics 
of natural aging, CS (and XP/CS) is considered a segmental progeroid syndrome, suggesting a 
link between defective DNA repair and aging (Martin, 2005).  
 Animal models for photosensitive disorders have contributed substantially to our understanding 
of the function of NER proteins and their involvement in battling cancer and aging. Xpa-/- and Xpc-/- 
knock-out mice reliably recapitulate the UV-sensitivity and skin cancer predisposition of XP-A and 
XP-C patients respectively, and do not show any other overt phenotype (Cheo et al., 1996; de Vries 
et al., 1995; Nakane et al., 1995; Sands et al., 1995). Mice carrying an inactivated Csa gene or a 
Csb gene with a premature stop codon similar as found in patient CS1AN, also have a UV-sensitive 
skin, but in contrast to human CS, display a mild UV skin cancer susceptibility (van der Horst et al., 
2002; van der Horst et al., 1997). This can be attributed to the fact that rodents do not show efficient 
GG-NER of cyclobutane pyrimidine dimers (the most abundant UV-induced photoproduct and the 
primary lesion responsible for photocarcinogenesis; (Jans et al., 2005)), and thus entirely depend 
on TC-NER for removal of this lesion (Bohr et al., 1985). In contrast to the severe growth defect and 
neurological problems associated with human CS, Csa-/- and Csbm/m animals only display mild other 
features of human CS, as evident from the slight reduction in body weight, and minor neurological 
abnormalities such as reduced motor coordination  (van der Horst et al., 2002; van der Horst et al., 
1997), and age-related loss of photoreceptor cells (Chapter 3). 
 Along the lines of Harman’s “free radical theory of aging” (Harman, 1956), we recently 
hypothesized that (oxidative) DNA lesions, originating from reactive oxygen species (ROS) and 
other by-products of cellular metabolism, are at the basis of the etiology of progeroid DNA repair 
disorders. Such endogenously produced lesions are hypothesized to hamper transcription and 
replication, resulting in enhanced apoptosis and/or cellular senescence, eventually followed by 
loss of tissue homeostasis and onset of (aging-related) pathology (Hasty et al., 2003; Mitchell et 
al., 2003). In this scenario, the onset of tissue/organ-specific pathology is expected to relate to 
the level of genotoxic stress, notably endogenous oxidative stress (the net result of metabolic 
ROS production and anti-oxidant capacity) and (residual) DNA repair capacity in the specific 
organ or tissue. This well explains the segmental character of the progeroid features and the 
striking link between genome stability disorders and premature aging syndromes. The 
involvement of oxidative DNA lesions in the onset of (non-UV-related) CS features is well 
supported by the observations that (i) Csbm/m mouse embryonic fibroblasts, as well as cells from 
human CS-B patients and CSB siRNA-silenced HeLa cells, are susceptible to known sources of 
oxidative DNA damage such as ionizing radiation, and paraquat (de Waard et al., 2004; de 
Waard et al., 2003; Deschavanne et al., 1984; Liu et al., 2006), (ii) Csbm/m animals show 
increased apoptosis of retinal cells in response to ionizing radiation exposure (Chapter 3), (iii) 
Csbm/m mice are sensitive to chronic exposure to the pro-oxidant di(2-ethylhexyl)phthalate 
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(DEHP) (de Waard et al., 2004), and, as discussed in detail below, (iv) further impairment of 
repair dramatically aggravates the phenotype of Csbm/m mice (Chapter 2).   
 When Csbm/m or Csa-/- mice were crossed into an Xpc-/- or Xpa-/- background (resulting in 
complete inactivation of NER), double mutant mice display a segmental premature aging 
phenotype similar to that of CS patients, as evident from the dramatic postnatal growth 
retardation, cachexia, kyphosis, ataxia, photoreceptor loss, abnormal locomotor activity, as well 
as progressive weight loss, and premature death around weaning (Murai et al., 2001; van der 
Horst et al., 2002), (Chapter 2). Analysis of the Csbm/m/Xpa-/- mouse liver transcriptome revealed 
a systemic suppression of the GH/IGF1 somatotroph axis and oxidative metabolism, along with 
an increased antioxidant response. Importantly, a similar response is observed in old wild type 
mice and in pro-oxidant treated young wild type mice (Chapter 2). Additionally, down-regulation 
of the somatotroph axis in C.elegans and mice is associated with enhanced longevity (Andersen 
et al., 1995; Carter et al., 2002; Li et al., 1990; Liang et al., 2003; Longo and Finch, 2003). On 
this basis, we hypothesized that this response is (i) intrinsic to natural aging, (ii) can be triggered 
by DNA lesions (iii) may act as a feed back regulatory mechanism to diminish damage levels in 
the genome by ROS and other reactive metabolites via reduction of metabolism and up-
regulation of anti-oxidant response, and (iv) intends to extend life span (Chapter 2). Thus, the 
increased genotoxic stress initiates the adaptive response shortly after birth, allowing CS 
patients and Csbm/m/Xpa-/- mice to live longer at the expense of early cessation of growth 
resulting in the characteristic dwarfism. A similar transcriptional response has been documented 
in Ercc1 knockout and XpdXPCS mouse models (Andressoo et al., Niedernhofer et al., pending 
revision) and likely extends to other NER models (e.g. XpdTTD/Xpa and Xpg mice; de Boer et al., 
2002; Harada et al., 1999).  
 Evidently, the short life span of Csbm/m/Xpa-/- animals hampers further studies on the etiology 
of CS. Here, we describe the generation, characterization and use of a loxP/Cre-recombinase 
conditional Xpa mouse model to study in a time- and tissue-specific manner the onset of the 
Csbm/m/Xpa-/- (aging) phenotype, and the role of apoptosis therein. Particularly, by crossing 
conditional Csbm/m/Xpac/- mice with CamKII-promoter-driven Cre transgenic mice (expressing 
the Cre-recombinase predominantly in cerebrum, and to a lesser extent in the cerebellum), we 
focus on the brain, as it is a tissue with one of the highest levels of oxygen consumption 
(Halliwell, 1985; Halliwell, 1989), and progressive neurological dysfunction is a hallmark feature 
of CS (Nance and Berry, 1992). 
 
Results 
Generation and characterization of a conditional Xpa mouse model 
To establish a conditional Xpa mouse model, we generated a targeting construct in which exon 
4 was fused in frame to the mouse Xpa cDNA (including a synthetic polyA sequence), followed 
by a PGK promoter-driven hygromycin (Hygro) selectable marker gene (see Fig. 1A). LoxP sites 
were introduced in intron 3 and downstream the Hygro marker to allow Cre-mediated excision of 
the Xpa cDNA part and Hygro marker gene and concomitant formation of an Xpa null allele 
lacking exon 4, which is known to act as a functional null allele (de Vries et al., 1995).  
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Figure 1. Targeting of the mouse Xpa allele with a floxed genomic/cDNA fusion construct. A) Schematic representation of 
the wild type mouse Xpa locus (exon 2 to 6), the targeting construct, the conditional Xpa allele, and conditional Xpa allele 
following Cre-recombinase-mediated inactivation. For completeness, we also have indicated the classical knock out allele, 
as generated by de Vries et al.,1995. Open and gray boxes represent exon and cDNA sequences, respectively. 
Hygromycin (HYGRO) and neomycin (NEO) marker cassettes (for selection of targeted ES clones) as well as the 
LacZ/GFP fusion reporter gene (used to report successful inactivation of the conditional allele) are indicated as gray stripes, 
gray squares, and dark/light gray shaded boxes respectively. Triangles represent LoxP sites, while the position of splice 
acceptor, ochre multiple reading frame insertion (Murfi) linker (containing stopcodons in all three reading frames), and 
Internal Ribosomal Entry Site (IRES) are indicated as light and dark gray colored squares, and a light gray triangle, 
respectively. Polyadenylation sites are indicated by AATAAA. Probes are indicated by black shaded bars. R and RV 
represent EcoRI and EcoRV restriction sites. B) Southern blot analysis of Xpa-/- (left panel) and wild type (right panel) ES 
cell DNA after transfection of cells with the conditional Xpa construct. DNA was digested with EcoRI and hybridized with an 
intron 5/exon 6 probe, external to the targeting construct. Wild type and targeted alleles gave fragments of 12 and 16 kb, 
respectively. C) Survival curves of wt (circles), Xpa-/- (diamonds and triangles) and Xpac/- (squares) ES cells, exposed to 
increasing doses of UV-C light 
 
To visualize inactivation of the conditional Xpa allele at the cellular level, we inserted a LacZ-
GFP fusion marker gene, preceded by splice acceptor (SA) and internal ribosomal entry site 
(IRES) sequences to allow translation of the marker. A multiple reading frame insertion (Murfi) 
linker with stopcodons in all 3 reading frames was placed between the SA and IRES to prevent 
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translation of potential read-through transcripts from the Hygro marker gene, which would cause 
false positive staining.  
 To test the functionality of the genomic/cDNA fusion allele, we first transfected Xpa-/- ES 
cells (de Waard et al., 2003) with the conditional Xpa construct and obtained targeted ES clones 
at a frequency of 20%, as detected by Southern blot analysis using an intron 5/exon 6 probe, 
which hybridizes downstream of the targeting site and is external to the targeting construct (Fig. 
1B; left panel). As shown in Fig. 1C, replacement of one knockout allele by the conditional Xpa 
allele (as in Xpac/- ES cells) fully averted the previously described extreme UV sensitivity of Xpa-
/- ES cells (de Waard et al., 2003), while subsequent transient transfection of the corrected cells 
with a Cre-recombinase expression construct reinstated UV-hypersensitivity (data not shown), 
thus proving functionality of the conditional Xpa allele.  
 We next transfected ES line IB10 with the conditional Xpa construct and obtained 
heterozygous Xpac/+ ES cells (Fig. 1B, right panel) at a frequency of 17%. After confirming the 5’ 
region excluding chromosomal abnormalities and additional random integrations (data not 
shown), two independent Xpac/+ ES cell clones were used for blastocyst injections and the 
generation of chimeric mice. Germ line transmission was obtained for both clones and 
subsequent experiments with heterozygous (Xpac/+) and homozygous (Xpac/c) offspring yielded 
identical results, indicating that the findings reported below are not due to uncontrolled events 
that might have occurred in one targeted ES clone.  
 In line with observations made previously for Xpa-/- animals (de Vries et al., 1995), Xpac/+, 
Xpac/- and Xpac/c animals do not show any overt phenotype, at least up to an age of 20 months 
(data not shown). To show that CRE recombinase can also excise the floxed Xpa sequence in 
vivo, we bred Xpac/+ mice with Xpa+/- mice carrying a Cag-promoter-driven Cre transgene that is 
expressed immediately after conception (Sakai and Miyazaki, 1997)) to obtain E13.5 Xpac/- and 
Xpac/-/Cag-Cre embryos and mouse embryonic fibroblasts (MEFs). Using a LacZ probe, we 
confirmed by Southern blot analysis that expression of the Cre-recombinase transgene in Xpac/- 
embryos resulted in excision of the floxed sequence at near 100% recombination efficiency (Fig. 
2A). Staining with X-gal only yielded blue Xpac/- embryos and MEFs when recombination had 
occurred in the presence of the Cag-Cre transgene (Fig. 2B), which proves the usefulness of 
the LacZ/GFP reporter. However, it should be noted that LacZ staining patterns are relatively 
weak, and only visible after overnight staining, while GFP signals did not exceed 
autofluorescent background levels (data not shown), which may be attributed to the relatively 
low expression efficiency of the endogenous Xpa promoter (Layher and Cleaver, 1997). As 
expected, inactivation of the conditional allele in Xpac/- MEFs triggered UV-sensitivity (Fig. 2C), 
as evident from our observation that the UV survival of Xpac/- and Xpac/-/Cag-Cre MEFs was in 
the same range as reported for wild type (wt) and Xpa-/- MEFs respectively (de Vries et al., 
1995). 
 
Chapter 4 
96 
 
   
Figure 2. Characterization of conditional Xpac/- and Csbm/mXpac/- mice. A) Southern blot analysis of DNA from E13.5 Xpac/- 
and Xpac/-/Cag-Cre embryos, the latter ubiquitously expressing the Cre-recombinase immediately after conception. DNA 
was digested with EcoRV and hybridized with a LacZ probe. Conditional and recombined (inactivated) conditional Xpa 
alleles gave fragments of 2.4 and 10 kb, respectively. B) LacZ staining of E13.5 Xpac/- and Xpac/-/Cag-Cre embryos (left 
panel) and mouse embryonic fibroblasts (right panel), indicating inactivation of the conditional Xpa allele in Xpac/-/Cag-Cre 
embryos only. C) Survival of wild type, Xpac/- and Xpac/-/Cag-Cre MEFs (genotypes indicated in figure), exposed to 
increasing doses of UV-C light. D) Picture of 16-day old Csbm/mXpac/- and Csbm/m/Xpac/-/Cag-Cre littermates, the latter 
phenocopying the non-conditional Csbm/mXpa-/- mouse. E) Picture of an 8 week old Csbm/m Xpac/- mouse, showing complete 
rescue of the Csbm/m/Xpa-/- premature aging phenotype by the conditional Xpa allele. 
 
 We next generated Csbm/m/Xpac/- and Csbm/m/Xpac/-/Cag-Cre mice. As predicted on the basis 
of the phenotype of the classical (non-conditional) Csbm/m/Xpa-/- mouse model (van der Pluijm et 
al, submitted), Csbm/mXpac/-/Cag-Cre pups display the severe postnatal growth retardation (as 
illustrated in Fig. 2D), cachexia, disturbed gait, and die before weaning. In contrast, 
Csbm/m/Xpac/- littermates do not show any overt phenotype, and importantly, remain devoid of 
any overt (aging-associated) pathology or neurological deficits other than that of Csbm/m single 
mutants when developing into adulthood (8 weeks, see Fig. 2E), or when reaching high age 
(over 2 years; data not shown). From these data, we conclude that the conditional Xpa mouse 
represents a valid animal model to study the Csbm/m/Xpa-/- double mutant phenotype, including 
premature aging, in a time- and tissue-specific manner. 
 
Post-juvenile growth defect and premature death of brain-specific conditional 
Csbm/m/Xpac/- mice 
Progressive neurological dysfunction is a hallmark feature of CS. Csbm/m/Xpa-/- animals also 
display a neurological phenotype, as evident from tremors and flexion rather than extension of 
hind limbs (pointing to motor coordination problems), and disturbed gait (indicative for ataxia). 
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Moreover, reduced neurogenesis and increased apoptotic cell death in the cerebellar external 
granular layer have been observed in Csbm/m/Xpa-/- newborns (Murai et al., 2001). Since 
Csbm/m/Xpa-/- pups die before weaning, and therefore might not develop the full spectrum of CS-
associated neuropathology, we first aimed at ubiquitously inactivating the conditional Xpa allele 
after animals reached adulthood. To this end, we generated Csbm/m/Xpac/-/Cre-ERT mice, 
expressing a Cre-recombinase that remains inactive until the non-steroidal estrogen analog 4-
hydroxytamoxifen (OHT) is given to the animal (Vooijs et al., 2001). However, administration of 
tamoxifen to 2-month old Csbm/m/Xpac/-/Cre-ERT animals appeared lethal. Subsequent 
investigation revealed severe intestinal pathology. On the basis of preliminary findings we 
attribute this dramatic outcome to enhanced sensitivity of double mutant animals to tamoxifen-
induced DNA damage (for details, see Chapter 4 Appendix).  
 We next generated a brain-specific Csbm/m/Xpac/- mouse by crossing in the CamKIIα-Cre 
recombinase transgene (courtesy of S. Zeitlin). The transgenic mouse line used, L7ag#13, 
expresses the Cre-recombinase from postnatal day 5 throughout the adult brain, with high levels 
in all forebrain structures and low/moderate levels in the cerebellum (Dragatsis and Zeitlin, 
2000). Attempts to visualize LacZ or GFP in Csbm/m/Xpac/-/CamKIIα-Cre brains (indicative for 
successful recombination) rendered negative results, except for moderate LacZ staining of the 
Lateral Septum (connected to the hippocampus). Nevertheless, when L7ag#13 mice were 
crossed with a LacZ reporter mouse (carrying a floxed LacZ gene, targeted to the highly 
expressed Rosa26 locus and activated upon Cre recombination), we observed ubiquitous LacZ 
staining of the cerebrum (Elgersma, unpublished results), which confirmed previously published 
findings (Dragatsis and Zeitlin, 2000). We therefore envisage that the conditional Xpa allele has 
been inactivated throughout the forebrain of Csbm/m/Xpac/-/CamKIIα-Cre animals, but that 
apparently only in the hippocampus the Xpa allele is sufficiently highly expressed to visualize 
the recombination event by LacZ staining. This explanation is supported by a database search 
of the Allen Brain Atlas (an interactive genome-wide image database of gene expression in the 
mouse brain; http://www.brain-map.org/welcome.do) (data not shown). In addition, we were able 
to show by PCR analysis that Cre-dependent recombination of the floxed Neo marker in the 
mutant Csb allele occurred in all brain regions, except for the cerebellum (data not shown).  
 Csbm/m/Xpac/-/CamKIIα-Cre pups were obtained at Mendelian ratio (data not shown), and 
grew into young adulthood without noticeable phenotype (Fig. 3A shows a 6 month old 
Csbm/m/Xpac/-/CamKIIα-Cre mouse). Next, we monitored CamKIIα-Cre (serving as NER-
proficient “wild type” control), Csbm/m/CamKIIα-Cre, Xpac/-/CamKIIα-Cre and Csbm/m/Xpac/-
/CamKIIα-Cre mice in time for the appearance of a phenotype. As evident from body weight 
measurements, Csbm/m/Xpac/-/CamKIIα-Cre mice initially show normal bodyweight (Fig. 3B) and 
size. However, clear differences became apparent after animals passed the age of 8 months. 
From that moment, in line with a previous Csbm/m cohort study (Wijnhoven, van Steeg, 
unpublished results), Csbm/m/CamKIIα-Cre, animals gain weight at slower pace than CamKIIα-
Cre and Xpac/-/CamKIIα-Cre animals. Interestingly, Csbm/m/Xpac/-/CamKIICre animals lag further 
behind in bodyweight, as compared to the Csbm/m/CamKIICre littermates, and from the age of 
10 months even start to lose weight.  
 At an age of about 15 months, Csbm/m/Xpac/-/CamKIICre animals (n=6) started to display 
reduced motility and seizures, the latter being well illustrated by the frequent loss of 
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consciousness during bodyweight measurements. As shown in Fig. 3C, Csbm/m/Xpac/-
/CamKIICre animals became moribund and had to be sacrificed between 16 and 22 months of 
age, whereas wt and single mutant littermates (n=18) show a normal life span. Strikingly, 
between 1 and 2 months before death, all Csbm/m/Xpac/-/CamKIICre male mice developed 
priapism, a persistent penal erection as a consequence of disease, rather than sexual arousal 
(Fig. 3C). This phenomenon, which was not observed in Wt/CamKIICre, Csbm/m/CamKIICre or 
Xpac/-/CamKIICre males, most likely is due of neurogenic origin, although other possibilities are 
currently not excluded. 
 
 
 
Figure 3. Post-juvenile growth defect and premature death of brain-specific conditional Csbm/m/Xpac/- mice. A) Photograph 
of a Csbm/m/Xpac/-/CamKIIα-Cre animal at the age of 6 months. B) Body weight curves of wt/CamKIIα-Cre, Csbm/m/Xpac/-
/CamKIIα-Cre, Xpac/-/CamKIIα-Cre and Csbm/m/Xpac/-/CamKIIα-Cre. Note that beyond the age of 8 months, the weight of 
Csbm/m/Xpac/-/CamKIIα-Cre animals starts to differ substantially from their control littermates, including Csbm/m/Xpac/-
/CamKIIα-Cre animals. C) Representative photograph of 15 month old Xpac/-/CamKIIα-Cre and Csbm/m/Xpac/-/CamKIIα-Cre 
animals, showing priapism in the latter. D) Survival curve showing premature death of Csbm/m/Xpac/-/CamKIIα-Cre animals 
(n=6) as compared to littermate controls (n=18). 
 
Brain-specific conditional Csbm/m/Xpac/- mice show anxiety-like behavior 
During handling of the Csbm/m/Xpac/-/CamKIICre animals, we frequently observed freezing 
behavior, as well as excessive escape behavior when the researcher attempted to lift the animal 
from the cage, which we subjectively interpreted as anxiety-like behavior. This feature appeared 
to be progressive with time. We therefore subjected Csbm/m/Xpac/-/CamKIICre and littermate 
controls to an open-field exploratory behavior test at the age of 3, 6, and 12 months. In this 
assay, ‘anxious’ mice avoid exploration of the central (exposed) part of the open field, and show 
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thigmotactic behavior (taxis in which contact with a solid body is the directive factor) along the 
walls of the apparatus (Holmes, 2001). Computer-derived movement plots after recording the 
activity of animals for 30 minutes in the open field (example shown in Fig. 4A), clearly 
demonstrate that Csbm/m/Xpac/-/CamKIICre mice are less active in the center than wt 
(CamKIICre) and single mutant animals (n=6 per genotype). Calculation of the anxiety ratio 
(AR) by dividing the ambulatory activity in the center by the total distance moved, revealed that 
Csbm/m/Xpac/-/CamKIICre animals tend to have a lower AR than the control mice at 3 months of 
age (p=0.056; Mann-Whitney-U test), the difference becoming significant at 6 and 12 months of 
age (p=0.003 and p=0.02, respectively) (Fig. 4B).  
 
 
 
Figure 4. Brain-specific conditional Csbm/m/Xpac/- mice show anxiety-like behavior. A) Representative examples of open 
field plots of a wt and a Csbm/m/Xpac/-/CamKIIα-Cre animal. Note the relative avoidance of the center by the mutant mouse 
when compared to the wt control. B) Bar graphs depicting the anxiety ratio (AR), calculated as center distance divided by 
total distance, of CamKIIα-Cre (wt), Csbm/m/CamKIIα-Cre, Xpac/-/CamKIIα-Cre and Csbm/m/Xpac/-/CamKIIα-Cre animals at 
the age of 3 and 6 and 12 months (n=6 at all timepoints, except for Csbm/m/Xpac/-/CamKIIα-Cre animals at the age of 12 
months: n=3). A low AR is indicative of anxiety-like behavior. At 3 months the AR of and Csbm/mXpac/-CamKIIα-Cre animals 
is lower than that of the control groups (p<0.056), which becomes significantly at the age of 6 months (p=0.003) and 12 
months of age (p=0.02) as compared to CamKIIα-Cre (wt) animals. 
 
 Noteworthy is that at 12 months of age, we had to exclude 3 animals from the assay 
because they repeatedly displayed seizures during the assay. Ambulatory activity in an open 
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field is likely to be the result of both anxiety-related approach/avoid conflict and levels of basal 
locomotor activity (Holmes, 2001). However, locomotory activity differences could be excluded 
since at a given age (irrespective of the genotype) total movement time and distance was 
approximately the same. Interestingly, whereas the AR of wild type and single mutant animals is 
constant over time (and even shows a tendency to increase), the AR of Csbm/m/Xpac/-
/CamKIICre animals steadily drops with age, indicating that the anxiety-like behavior of 
Csbm/m/Xpac/-/CamKIICre animals worsens progressively (Fig. 4B). In addition, we noticed that 
Csbm/m/Xpac/-/CamKIICre animals do not display normal nest building behavior, which was 
apparent from their disinterest in, and urine disposal on tissues, provided as nest bedding and 
cage enrichment material.  
 
Brain-specific conditional Csbm/m/Xpac/- mice mimic the brain deficits of 
Cockayne Syndrome  
To investigate whether the neurological features, as encountered in the conditional brain 
Csbm/m/Xpac/- mouse model, were accompanied by anatomical anomalies, we next performed a 
neuropathological examination of Csbm/m/Xpac/-/CamKIICre and age-matched Xpac/-/CamKIICre 
control mice at various ages. To this end, we perfused 6 and 16 month old Csbm/m/Xpac/-
/CamKIICre and Xpac/-/CamKIICre mice and isolated the brains. The brain of 16 month old 
Csbm/m/Xpac/-/CamKIICre mice weighed considerably less than that of Xpac/-/CamKIICre animals 
(0.372 vs. 0.436 gram). From the macroscopic pictures shown in Fig. 5B it is obvious that the 
brain of 16 month old Csbm/m/Xpac/-/CamKIICre mice is strikingly small, particularly the 
cerebrum. This finding fits well with the observed enlarged subarachnoidal space between the 
brain and the skull, observed during the autopsy procedure. Slight differences in outer 
appearance, along with a reduced brain weight are already visible at the age of 6 months. In 
general, Csbm/m/Xpac/-/CamKIICre brains have an atrophic appearance, which is most 
pronounced at old age and thus points to a progressive deterioration of the brain. Coronal 
sections of the brain revealed dilated ventricles and a thin cerebral cortex (Figure 5B), features 
described as hydrocephalus ex vacuo. Microcephaly was not apparent at the ages examined. In 
addition, the inner lining of the skull did not show signs of increased intracranial pressure, as 
evident from the smooth appearance and absence of erosion of the skull. The cerebrum had a 
general atrophic appearance, including the hippocampal area, which was due to the loss of both 
white and grey matter. Furthermore, the hippocampus showed disorganization of the neural 
tissue (Fig. 5B), loss of neuronal cells, and was dramatically reduced in size. There were no 
obvious signs of infarction and no neurofibrillary tangles were found, whereas signs of gliosis 
and demyelination were evident. The ependymal cells, both in the lining of the ventricles and the 
choroid plexuses, were swollen and vacuolated. It remains to be examined whether the 
pathology observed in the cerebrum of Csbm/m/Xpac/-/CamKIICre animals is also present at an 
earlier age. Preliminary macroscopical data on the brain of 1 month old Csbm/m/Xpac/-
/CamKIICre animals did not reveal signs of cerebral atrophy and dilated ventricles, which 
suggests that the observed severe brain pathology is not of developmental origin and develops 
between 1-6 months of age.  
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Figure 5. Brain-specific conditional Csbm/m/Xpac/- mice mimic the brain deficits of Cockayne Syndrome. A) Macroscopic 
picture of the brain of 6 and 16 month old Xpac/-CamKIIα-Cre and Csbm/mXpac/-CamKIIα-Cre brains showing cerebral 
atrophy in the latter. Pictures were taken at the same magnification. B) Histological micrographs of 16 month old Xpac/-
CamKIIα-Cre (left) and Csbm/mXpac/-CamKIIα-Cre (right) brains, showing dilated ventricles (1), thin cortex (2), small 
hippocampus (3) and vacuolated ependymal cells (4) in the cerebrum of Csbm/mXpac/-CamKIIα-Cre animals (right panel). 
Similar numbers are used to point out the corresponding structures in the cerebrum of Xpac/-CamKIIα-Cre animals (left 
panel), where these abnormalities are not found. 
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Discussion  
The conditional Xpa mouse model and its applications 
Recently, have shown that the Csbm/m/Xpa-/- mice provide a better model for human CS than 
Csbm/m single mutant mice (Chapter 2). Apparently, further impairment of repair capacity in 
Csbm/m mice is prerequisite to obtain sufficiently elevated levels of endogenous DNA damage to 
drive early onset of CS features (including aging-associated pathology) in the absence of a 
functional CSB protein. To overcome the perinatal lethality associated with Csbm/m/Xpa-/- mouse 
model, and thus to facilitate analysis of the etiology of (progeroid) CS features in a time- and 
tissue-specific manner, we now have generated a loxP/Cre recombinase-based conditional Xpa 
mouse model. Xpac/- ES cells and fibroblasts do not display UV sensitivity, unless the 
conditional Xpa allele is recombined out by (transient) expression of a Cre recombinase, 
showing that the conditional allele is functionally NER-proficient. Moreover, Xpac/- mice, and 
particularly Csbm/m/Xpac/- animals, remain devoid of any prominent phenotype for at least 2 
years, while Csbm/m/Xpac/-/Cag-Cre newborns (expressing the Cre-recombinase immediately 
after conception), again show the runted growth, cachexia, and premature death, characteristic 
of non-conditional Csbm/m/Xpa-/- pups. The complete rescue of the severe Csbm/mXpa-/- 
phenotype by one Xpa allele, as well as the absence of hypo- or hypermorphic effects, best 
illustrates the proper expression of the genomic/cDNA fusion allele. Visualization of CRE-
mediated inactivation of the conditional Xpa allele through expression of the LacZ/GFP reporter 
gene in recombined alleles appeared difficult. Despite CRE-mediated recombination events in 
virtually all cells, Csbm/m/Xpac/-/Cag-Cre embryos and MEFs displayed weak LacZ staining (and 
in the case of MEFs, only in a limited number of cells) while GFP fluorescence remained below 
detection limits, which we attribute to low expression levels of the reporter gene. Indeed, human 
and mouse cells have been reported to contain on average 5 to 8 Xpa transcripts (Layher and 
Cleaver, 1997). Taken together, these data convincingly demonstrate the validity of the 
conditional Xpa model. 
 A conditional Xpa mouse model that allows induction of a complete NER deficiency in a 
time- and tissue-dependent manner constitutes a powerful tool mouse in cancer and aging 
research. By only inducing the Xpa knockout status in defined tissues, one could refine 
carcinogenesis studies by for instance (i) zooming in on specific tumors types in NER-deficient 
tissues in an otherwise ‘healthy’ body, or (ii) by using low doses of genotoxic agents for which 
the repair-defective organ or tissue is highly sensitive without the chance that animals die due to 
secondary toxic effects in tissues of non-interest. Moreover, tumors in the above animals can be 
induced by natural endogenous or exogenous carcinogenic agents, instead of using transgenic 
animals in which all cells carry already an oncogenic step in the cancer process. In this respect, 
it is interesting to note that Csbm/m/Xpa-/- cells display increased UV-sensitivity, as compared to 
single mutant cells (Chapter 2). A keratinocyte-specific conditional Csbm/m/Xpac/- mouse model 
would provide an ideal platform to investigate in vivo the effect of UV-induced lesions on 
apoptosis and on the kinetics of tumor induction and progression in skin carcinogenesis. 
Additional evidence for enhanced sensitivity of Csbm/m/Xpa-/- cells to genotoxic agents was 
obtained from our unsuccessful attempt to induce the Csbm/m/Xpa-/- phenotype at an older stage 
by using a ubiquitously expressed tamoxifen-activated CRE recombinase. Exposed 
Conditional Csb/Xpa mice reveal cerebral atrophy 
103 
Csbm/m/Xpac/- animals showed severe intestinal pathology, most probably due to genotoxic 
effects of tamoxifen (see appendix). 
 In the present study, using a brain-specific conditional Csbm/m/Xpac/- model, we have made a 
start with the analysis of the etiology of neurological features in the Csbm/m mouse model. To 
specifically knock out the Xpa gene in the brain, we have crossed Csbm/m/Xpac/- animals with the 
CamKIIα-Cre (L7ag#13) transgenic mouse, which expresses the Cre-recombinase in the 
cerebrum, and to a lesser extent, the cerebellum (Dragatsis and Zeitlin, 2000). Likely due to the 
low Xpa expression levels (Layher and Cleaver, 1997), we could not detect LacZ expression 
(indicative of Xpa recombination in the brain) except for very moderate staining of the lateral 
septum, where Xpa is expressed at relatively higher levels (Allen Brain Atlas http://www.brain-
map.org/welcome.do). Nevertheless, when CamKIICre (L7ag#13) mice were crossed with a 
high-expressor Cre-inducible LacZ reporter mouse, we observed ubiquitous LacZ staining of the 
brain, except for the cerebellum (Elgersma, unpublished results) (Dragatsis and Zeitlin, 2000). 
In addition, we were able to show Cre-dependent recombination of the Neo marker in the 
targeted Csb (null) mutant allele in each brain region, except for the cerebellum. Taken 
together, these data suggest that the conditional Xpa allele has been inactivated in the 
Csbm/m/Xpac/-/CamKIIα-Cre brain. We are currently quantifying the recombination efficiency in 
various brain regions by other means (e.g. quantitative genomic PCR).   
 
Retarded growth, premature death and neurological dysfunction in the brain-
specific conditional Csbm/m/Xpac/- mouse model  
Csbm/m/Xpac/-/CamKIIα-Cre animals develop into adulthood without any overt phenotype. 
However, from the age of 8 months on the animals failed to further gain weight. Late onset 
growth retardation has also been observed for Csbm/m mice (Wijnhoven et al, unpublished 
results), but is more pronounced in Csbm/m/Xpac/-/CamKIIα-Cre mice than in Csbm/m/CamKIICre 
animals. Furthermore, also in contrast to Csb single mutant animals, Csbm/m/Xpac/-/CamKIIα-Cre 
mice display premature death before the age of 2 years. The precise cause of death remains to 
be resolved. These data imply that long term induction of the Xpa knock-out status in the Csb-/- 
brain has an adverse effect on both growth and life span. Recent liver transcriptome analysis of 
the non-conditional Csbm/m/Xpa-/- mouse model, together with physiological studies, pointed to a 
scenario where these DNA repair deficient animals mount a systemic response, comprising 
downregulation of the somatotrophic axis and oxidative (oxidative) metabolism, and 
upregulation of the anti-oxidant defense system (Chapter 2). This response is hypothesized to 
be initiated by oxidative stress and/or DNA lesions and is an adaptive event aiming at reducing 
the DNA damage load and prolonging lifespan. It is still unclear whether this response is 
initiated tissue-autonomously, or whether enhanced DNA damage levels in defined tissues and 
organs signal to the remainder of the body. With respect to the latter scenario, it is of prime 
importance to investigate (e.g. by liver transcriptome analysis) whether a brain-specific 
Csbm/m/Xpac/- defect can trigger a systemic response of the somatotrophic axis, metabolism and 
anti-oxidant defense system.  
 Interestingly, Csbm/m/Xpac/-/CamKIIα-Cre mice show a clear neurological phenotype. 
Animals displayed seizures, aberrant nest building behavior, and in case of male mice, 
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priapism. Moreover, during handling of the animals, we noticed anxiety-like behavior, which was 
further investigated using the open field assay. We noticed a progressive decrease in the 
anxiety ratio (AR) in Csbm/m/Xpac/-/CamKIIα-Cre mice, which was not observed in 
Csbm/m/CamKIICre, Xpac/-/CamKIICre or (wildtype control) CamKIICre animals. Although a low 
AR is indicative of anxiety-like behavior (Holmes, 2001), the open field activity test (along with 
the tail suspension test) is used as a primary screen (Tucci, 2006). Secondary screens, such as 
the Elevated-plus Maze test, should be performed to find out whether Csbm/m/Xpac/-/CamKIIα-
Cre animals indeed display signs of increased anxiety.  
 To examine whether other neurological abnormalities occur in Csbm/m mice following brain-
specific inactivation of the conditional Xpa allele, we are currently expanding the behavioral 
analysis of Csbm/m/Xpac/-/CamKIICre and littermate controls with other assays. For instance, in a 
pilot study with a limited number of animals, hind paw footprint ink tests (as previously 
performed with the non-conditional Csbm/mXpa-/- mouse; Chapter 2) did not reveal obvious 
abnormalities at adult age, which may point to the absence of disturbed gait and ataxia in 
Csbm/m/Xpac/-/CamKIICre mice, and which could be explained by low CamKII-induced 
recombination levels in the cerebellum. Similarly, initial rotarod studies did not disclose any 
signs of motor coordination or balance problems up to an age of 6 months. Yet, we noticed that 
older (12-16 months) Csbm/m/Xpac/-/CamKIICre animals failed to increase time spent on the bar 
in consecutive days of the test, whereas in the initial training session the retention time on the 
rotarod bar was similar to that of littermate controls, which could point to slightly impaired motor 
learning skills.  
 
Brain pathology in the brain-specific conditional Csbm/m/Xpac/- mouse model  
Interestingly, macroscopic analysis of the brain at 16 months revealed an atrophic cerebral 
cortex, the latter resulting from a loss of neurons and glial cells. Furthermore, the ventricular 
system was dilated. These observations together can be described as hydrocephalus ex vacuo. 
There were no obvious signs of infarction, whereas signs of gliosis and demyelination were 
evident. The hippocampal area was reduced in size due to loss of neuronal cells and showed 
disorganization of the various layers. The very thin and disorganized cortex might explain the 
seizures, observed in Csbm/m/Xpac/-/CamKIICre animals. Notably, the cerebral atrophy was less 
pronounced in animals at 6 months and most probably absent in animals of 1 month old 
underlining the progressive nature of the neurodegenerative process. Sofar, we do not know 
what causes the observed priapism. It could be due to a) loss of vasomotor neurons; b) 
degeneration of peripheral and/or autonomous nerves; c) disorganization or loss of cerebral 
nuclei in the brain stem or hypothalamus that control sexual activity or blood pressure. 
Oxytocinergic neurons, originating in the paraventricular nucleus, that project to extra-
hypothalamic brain areas (e.g., hippocampus, medulla oblongata and spinal cord) are known to 
control penile erection in male rats (Argiolas and Melis, 2005). Priapism may therefore point to 
neurological malfunction, or in other words continuous neurologic erectogenic stimulation due to 
loss of the medullary reticular formation neurons which normally inhibit male spinal sexual 
reflexes (Adams et al., 2001).  
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 As anxiety-like behavior has been associated with defects in the hippocampal area, (Gray, 
1982), it is tempting to speculate that the progressive deterioration of the hippocampus 
underlies the anxiety-like behavior of Csbm/m/Xpac/-/CamKIIα-Cre mice. However, as mentioned 
previously, we need to do more behavioral tests and study the brain pathology at an earlier age 
to see if we can make such a connection.  
 
The conditional Csbm/m/Xpac/- mouse model and human CS neuropathology  
How do the neuropathological findings in the Csbm/m/Xpac/-/CamKIIα-Cre mouse model relate to 
human CS? Importantly, dilated ventricles and cerebral atrophy are prominent 
neuropathological features of Cockayne Syndrome, observed in almost each CS patient 
analyzed (Nance and Berry, 1992; Ozdirim et al., 1996; Pasquier et al., 2006). In early case 
reports of CS, these observations were referred to as hydrocephalus ex vacuo (Brumback et al., 
1978), but as the primary changes observed in the CS brain suggest that hydrocephalus is not 
likely to play a major pathogenetic role (Soffer et al., 1979), this term is no longer used.  
 Due to the very limited availability of histopathological reports on brains of CS patients 
(reviewed by (Soffer et al., 1979)), it is difficult to compare the microscopic pathology and draw 
conclusions on possible similarities between mouse an human CS. However, in the few detailed 
reports that are available on brain pathology in CS patients, gliosis, reduction in gray and white 
matter, demyelination, and disorganization as well as reduced amounts of neuronal cells in the 
hippocampus, were observed (Leech et al., 1985; Levinson et al., 1982; Soffer et al., 1979; 
Woody et al., 1991). As these features were also present in the cerebrum of the Csbm/m/Xpac/-
/CamKIIα-Cre mouse, this suggests that this mouse recapitulates the CS brain pathology to a 
large extent, and is therefore a good model to study the etiology of CS neurodegeneration. This 
also holds for abnormal neurological behavior such as seizures, observed in the Csbm/m/Xpac/-
/CamKIIα-Cre mouse, as well as in 10% of the CS patients (Nance and Berry, 1992). Obviously, 
more detailed analysis is required to elucidate the full spectrum of neurological deficits and the 
timeframe of onset.  
 It is also not yet clear whether in CS aforementioned neuropathological features (e.g. dilated 
ventricles and cerebral atrophy) are already present at birth, since most CS patients are usually 
not diagnosed before the age 1,5-2 years (for review see (Nance and Berry, 1992)). 
Analogously, we observed similar features in some (but not all) Csbm/m/Xpac/-/CamKIICre 
animals at the age of 6 months; the cerebral atrophy, however, appeared pronounced. Although 
detailed pathology needs to be awaited, preliminary data suggests that at 1 month of age, no 
overt abnormalities are present.  
 The absence of microcephaly in Csbm/m/Xpac/-/CamKIICre animals (a feature observed in 
many CS patients (Nance and Berry, 1992)) might be explained by the fact that the CamKII 
promoter driven Cre recombinase transgene becomes active at postnatal day 1 (P1), with 
highest levels at P5. Thus, the skull is able to develop normally until birth. Similarly, the fact that 
the Xpa gene is inactivated after birth may well explain the “delayed” general brain atrophy in 
these animals. To investigate the time scale of onset of the neurological phenotype, we are 
currently setting up a large cohort study.  
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 It is tempting to speculate on the etiology of the observed neurological phenotype in both 
human CS and the Csbm/m/Xpac/-/CamKIICre mouse model. In CS, pathology occurs 
simultaneously in a number of organs and tissues and it is not excluded that the neurological 
features are an indirect consequence of dysfunction of other parts of the body. In our conditional 
mouse model the repair defect is limited to the brain only. Thus, our findings using the 
conditional mutant support the idea that the neurodegeneration in CS is an organ-autonomous 
consequence of the repair defect. In view of the DNA repair function of the defective genes, 
unrepaired DNA damage must play an important role (Chapter 2), (Hasty et al., 2003; Mitchell et 
al., 2003). The brain is one of the most oxygen-demanding tissues and is therefore very 
sensitive to oxygen radical generation (Halliwell, 1985). Thus, it is likely that the brain is 
especially vulnerable to genotoxic insults, since the available repair pathways for a post-mitotic 
tissue are limited to mechanisms that do not depend on replication. Also, the repair of actively 
transcribed genes becomes most important, since these are the genes necessary for the brain 
to function properly. Interestingly, in in vitro differentiated neuronal cells both the transcribed as 
well as non-transcribed strands of active genes have been found to be repaired in contrast to 
the remainder of the genome. This unusual form of repair has been designated differentiation 
associated repair (DAR) (Nouspikel and Hanawalt, 2002). Genes involved in NER, or more 
specifically TC-NER, which can repair damage in the transcribed strands of active genes, might 
contribute substantially to repair in the brain. Thus, deficiency of these genes might result in the 
neurodegenerative phenotype observed in CS patients as well as in the Csbm/m/Xpac/-
/CamKIICre mouse.  
 In further support, neurodegeneration is observed in many syndromes with a defect in 
genome maintenance, e.g. Trichothiodystrophy, Xeroderma Pigmentosum (XP-DSC), Ataxia 
Telangiectasia (AT), spinocerebellar ataxia with axonal neuropathy (SCAN1) and ataxia-
oculomotor apraxia (AOA1) (Boder and Sedgwick, 1958; Caldecott, 2004; El-Khamisy et al., 
2005; Itoh et al., 1999; Kraemer et al., 1987; Shiloh, 1997). Additionally, oxidative stress has 
been implicated to play a role in other neurodegenerative disorders (Betarbet et al., 2002). Also, 
mouse models with defects in genome maintenance show neurological phenotypes. For 
example, mice deficient in Ku-70 and Ku-80 gene (involved in Non homologous end joining 
(NHEJ)) show aberrant neuronal apoptosis (Gu et al., 2000). Moreover, the complete inactivation 
of Ligase IV or XRCC4 (also involved in NHEJ) resulted in embryonic lethality most probably 
due to aberrant neuronal apoptosis (Barnes et al., 1998; Gao et al., 1998). Finally, multiple 
mouse models with genes that are defective in NER, show a neurological phenotype from mild 
to severe, like the Csbm/m (van der Horst et al., 1997), Ercc1Δ7/Δ7, Ercc1-/- (Weeda et al., 1997), 
(Niedernhofer et al., unpublished results), Csbm/m/Xpa-/- (Murai et al., 2001), (Chapter 2) mouse 
models. These findings in toto underscore the importance of DNA repair for normal functioning 
of the neurological system and highlight the significance of spontaneous DNA damage.  
 In conclusion, we have shown that induction of the Xpa knock-out status (and therefore 
complete inactivation of NER) in the brain of Csbm/m animals provides a mouse model that 
recapitulates most of the neuropathological features of CS. Furthermore, the conditional 
Csbm/m/Xpa-/- mutant now allows in depth behavioral, physiological, and transcriptome profiling 
studies, needed to further unravel the etiology of CS.  
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Materials and Methods  
Generation of a mouse conditional Xpa targeting construct  
A genomic clone containing 10 kb of the 129ola mouse Xpa locus (pMMXP3-6#13; (de Vries et 
al., 1995)), was used to re-clone an approximately 10 kb size BamHI fragment, containing 
exons 3 to 6, into the psp72 vector. Following XbaI digestion, part of exon 4 and intron 4 was 
replaced by a cassette containing the mouse Xpa cDNA (ensuing in frame fusion of genomic 
and cDNA sequences), including the natural 3’ UTR and polyadenylation signal, followed by a 
PGK promoter-driven Hygromycin selectable marker and a LoxP site respectively. Next, the 
SmaI site downstream the LoxP site was used to introduce a cassette containing a splice 
acceptor sequence (SA), an ochre stopcodon multiple reading frame insertion (Murfi) linker, a 
ribosomal entry site (IRES), and a LacZ/GFP fusion reporter gene (as a blunted SalI fragment). 
The SmaI site in intron 3 was used to insert a blunted XhoI-SalI loxP fragment from pGEM30 
(kindly provided by Dr. W. Gu, University of Cologne). This targeting construct, which was 
designated pIP-Xpa-con, contains homologous arms of 4kb (5’ end) and 5kb (3’ end), 
respectively.  
 
ES cell culture and transfection 
The 129ola-derived ES cell line IB10 was electroporated with NotI linearized pIP-Xpa-con DNA 
and cultured in gelatin-coated dishes as described before (van der Horst et al., 1997). 
Hygromycin (Roche, 843555) was added 24 hr after electroporation to a final concentration of 
100 μg/ml. Cells were maintained under selection for 7-8 days, after which clones were isolated 
and expanded in 24-well plates. Genomic DNA from individual Hygromycin-resistant clones was 
digested with EcoRI and analyzed by Southern blotting using a 500 bp DraI fragment (“intron 
5/exon 6” probe; obtained from a 7.5 kb PCR fragment spanning exon 5 and 6). EcoRI digested 
DNA from targeted ES clones was subsequently screened with the hygro (cDNA) probe to 
confirm proper homologous recombination at the 5’ end of the targeting construct. 
 For the generation of Xpac/- ES cells, we followed the same procedure as described above, 
except that Xpa-/- ES cells (de Waard et al., 2003) were used.  
  To test the functionality of the loxP sites, Xpac/+ ES cells were electroporated with a purCre 
plasmid (kindly provided by Dr. M. Jaegle, Erasmus MC) and cultured on gelatin dishes as 
described. Puromycin (Sigma, P7255) was added 24 hr after electroporation to a final 
concentration of 100 μg/ml. Cells were maintained under selection for 3 days. Genomic DNA 
from individual puromycin-resistant  clones was digested with EcoRV and analyzed by Southern 
blotting using a 500 bp  PCR fragment of the LacZ gene. 
 
Generation of mutant mice 
Properly targeted IB10 ES clones were karyotyped and cells from two independent clones 
(selected for the presence of 40 chromosomes) were injected into 3.5-day-old C57BL/6J 
blastocysts. Male chimeric mice were mated with C57BL/6J females to obtain heterozygote 
offspring. Heterozygous males and females were bred to Xpa+/- as well as Csbm/+ animals to 
ultimately obtain Xpac/-, Xpac/+ and Csbm/m/Xpac/- animals. Genotyping was initially performed by 
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Southern blot analysis of genomic DNA obtained from tail biopsies of 8-10-day-old born pups. A 
description of PCR-based genotyping methods is given below. 
 Xpac/- and Csbm/m/Xpac/- animals were also interbred with Cag-Cre (Sakai and Miyazaki, 
1997) and CamKII-Cre (L7ag#13) (Dragatsis and Zeitlin, 2000) Cre-recombinase transgenic 
mice, which were kindly provided by A. de Wit (ErasmusMC) and S. Zeitlin (Columbia 
University), respectively. 
 Primary mouse embryonic fibroblasts from the various mouse single and double mutant 
mouse models (three independent lines per genotype) were isolated from day 13.5 embryos 
and cultured as described before (Ng et al., 2002).  
 Mice and cells were genotyped by PCR for the wild type and (conditional) mutant Xpa or 
Csb alleles using a primer mix that (per genotype) amplifies both the wild type and targeted 
alleles in a single reaction (Berg et al., 2000; de Vries et al., 1995). The presence or absence of 
the conditional Xpa allele was detected by PCR using primers XPAFex3 (5’-TTT GAT CTG CCA 
ACG TGT G-3’) and XPARex4 (5’-GCT TCG CTT CTG TCT TGG T-3’). The presence or 
absence of the Cre transgene was detected by PCR using primers 5’-GCA CGT TCA CCG GCA 
TCA AC-3’ and 5’-CGA TGC AAC GAG TGA TGA GGT TC-3’ Both products were amplified 
with the same PCR program: 5 min. 93oC, 1 min. 93oC, 1 min. 58oC , 2.5 min. 72oC (35 cycles 
of the latter three steps), 5 min. 72oC.   
 As required by Dutch law, the generation of genetically modified mice was approved by the 
Dutch Ministry of Agriculture, Nature and Food Quality.  
 
LacZ staining of embryos and cells 
Cells or embryos were fixed for 30 minutes at 4 oC in a buffer containing 1% paraformaldehyde, 
and subsequently washed 3 x 15 minutes with PBS/0.01% NP40. Cells or embryos were 
stained overnight at 37oC in dark in a staining solution containing 3.1 mM K3Fe(CN)6, 3.1 mM 
K4Fe(CN)6, 0.15 M NaCl, 1 mM MgCl2 and 1 mg/ml X-gal (Roche Applied Sciences, USA, IN).  
For tissues, the same procedure was used, except that the fixation time was extended to 3 
hours. 
 For LacZ staining of the brain, animals were perfused with a 1% paraformaldehyde/ 0.5% 
glutaraldehyde solution. The isolated brains were fixed for another hour at 4 oC and washed 
overnight in a 10% sucrose/0.1 M phosphate buffer solution at 4 oC. Then, brains were 
embedded in 11% gelatin/10% sucrose. Sections (40 μm) were stained for lacZ as described 
above, and counterstained in 1% neutral red. 
 
DNA repair assays 
Sparsely seeded cultures at a density of 1000 spontaneously immortalized MEFs  on a 6 cm 
dish were exposed to different doses of UV-C (254 nm, Philips TUV lamp). The cells were 
allowed to grow for another 7 days after which the resulting clones were fixed, stained and 
counted. For each independent cell line, the amount of surviving clones at each dose of UV, 3 
dishes per dose, was calculated as the percentage of clones on the plate without UV.  
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Behavioral assays 
For the open field test, animals were placed for 30 min in a square (26cm x 26cm x 26cm) open 
field box, equipped with photobeam sensors (TruScan E63 10-12, Coulbourn Instruments), and 
attached to a computer to record the following ambulatory parameters: total distance, center 
distance, total move time, center time and corner time. Each test session was 30 minutes long, 
and data were collected in 5 minute intervals. The anxiety ratio was calculated by dividing 
center distance by total distance. Significance was determined by Mann-Whitney-U test for two 
independent samples. All animal studies were approved by an independent Animal Ethical 
Committee (Dutch equivalent of the IACUC). 
 
Pathology  
Animals were sacrificed by O2/CO 30 minutes after injection with BrdU (40 mg/kg body weight) 
and perfused with 20 ml of Phosphate Buffered Saline (PBS), followed by 20 ml of 4% 
phosphate buffered formalin at room temperature. Internal organs were isolated and weighed, 
paraffin-embedded, sectioned at 4 μm and stained with haematoxylin/eosin solution for 
histopathological analysis. For the isolation of the brain, skin was removed from the head and 
the skull was incubated overnight in 4% phosphate buffered formalin. After this post-fixation 
step, brains were removed form the skull, weighed, paraffin-embedded, sectioned at 4 μm and 
stained with haematoxylin/eosin solution for histopathological analysis. Serial sections of the 
brains were made with a 100 μm interval. 
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As discussed in Chapter 4, we attempted to induce the Xpa knock-out status in Csbm/m mice 
over time by crossing in an ubiquitously expressed Cre-ERT transgene that can be activated by 
tamoxifen (Vooijs et al., 2001). This appendix describes the results in more detail. 
 
Results 
We first tested whether tamoxifen resulted in inactivation of the conditional Xpa allele in Xpac/-
/Cre-ERT animals. On the basis of the available literature (Kuhbandner et al., 2000), we first 
injected animals intraperitoneally (i.p.) with 1 or 2 mg tamoxifen (per 25 g). Although this dose 
has been reported to work efficiently, we did not observe significant recombination of the Xpa 
allele in liver, kidney, spleen, heart and lung (data not shown). As higher doses of tamoxifen 
administration via i.p. injection can have deleterious effects (LD50 dose 200 mg/kg = 5 mg for a 
mouse of 25 g), we next tried oral administration of tamoxifen by gavage (p.o.) (Seibler et al., 
2003). We compared 2 mg i.p. versus 5 mg p.o. for two times 5 days, with a rest period of two 
days in between. Since the LD50 dose for oral administration of tamoxifen in mice is 5 g/kg (125 
mg for a mouse of 25g) (Furr and Jordan, 1984), this method should avoid toxic side-effects. 
We checked for recombination of the conditional allele in liver, kidney, spleen, heart and lung. 
Oral administration did give better recombination of the conditional Xpa allele, although the 
efficiency (estimated 15-30%) was not very high (Fig. 1A). 
 To investigate whether inactivation of the Xpa allele in approximately one third of the cells of 
Csbm/m/Xpac/- mice would provoke additional pathology, we next crossed Csbm/m/Xpac/- mice 
with Cre-ERT transgenic animals and orally administered tamoxifen (2 x 5 days, 5 mg/injection, 
as indicated above) to 18-week old Csbm/m/Xpac/-/Cre-ERT mice (n=14) and Csbm/m/Xpac/- 
animals (n=6), the latter serving as a control for the effect of tamoxifen. As negative controls, we 
took along age-matched Csbm/m/Xpac/- animals (n=12) that were not given tamoxifen. While 
untreated Csbm/m/Xpac/- animals were still gaining body weight, we noticed that tamoxifen-
treated Csbm/m/Xpac/- and Csbm/m/Xpac/-/Cre-ERT mice lost weight, the effect being most severe 
in Csbm/m/Xpac/-/Cre-ERT animals (Fig. 1B). Moreover, 13 out of 14 tamoxifen-treated 
Csbm/m/Xpac/-/Cre-ERT animals died two weeks after the first tamoxifen treatment (Fig. 1C), 
while tamoxifen treated Csbm/m/Xpac/- animals remained alive. Histopathological examination of 
the tamoxifen-treated Csbm/m/Xpac/-/Cre-ERT animals revealed increased apoptosis in the 
gastro-intestinal tract, along with atypical hyperproliferative crypts reminiscent of carcinoma in 
situ (Fig. 1D), liver toxicity (mild hepatitis), bone marrow depression and an atrophic skin (data 
not shown). BrdU and TUNEL staining of these tissues showed that proliferation was reduced to 
a large extent, whereas the amount of apoptotic cells was increased dramatically (data not 
shown). Although in the tamoxifen-treated Csbm/m/Xpac/- animals the same tissues were 
affected, the pathological findings were by far not as severe as in the tamoxifen-treated 
Csbm/m/Xpac/-/Cre-ERT animals, while proliferation was only slightly reduced. From these data 
we conclude that Csbm/m animals are sensitive to the toxic effects of tamoxifen, and that 
inactivation of Xpa by Cre recombinase further boosts this sensitivity. 
 In parallel, we already had initiated breedings to obtain Csbm/m/Xpac/- mice for time specific 
inactivation of Xpa in the liver. To this end, we used αAT-Cre-ERT transgenic mice that express 
the Cre-recombinase from the human hepatocyte specific α1-antitrypsin promoter, and allow 
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excision of floxed genes at an average yield of 40-50% (Imai et al., 2000). Csbm/m/Xpac/-/αAT-
Cre-ERT (conditional liver-specific Csbm/m/Xpa-/-), Csb+/m/Xpac/+/αAT-Cre-ERT (wild type), 
Csbm/m/Xpac/+/αAT-Cre-ERT (Csbm/m), Csb+/m/Xpac/-/αAT-Cre-ERT (conditional liver-specific Xpa-
/-) and Csb+/m/Xpa-/-/αAT-Cre-ERT (Xpa-/-) animals (n=4 per group, age 36 weeks) were treated 
with tamoxifen (2 x 5 days, 5 mg p.o., as indicated above) and body weight was recorded at 7 
and 14 days after the first tamoxifen treatment. Whereas tamoxifen treatment had little effect on 
the body weight of wt (Csb+/m/Xpac/+/αAT-Cre-ERT) animals, all repair deficient mice 
substantially lost weight after the first series of administrations, which further increased when 
the treatment was repeated  (Fig. 1E). Classical (e.g. non-conditional) Xpa-/- mice are clearly 
more sensitive than Csbm/m animals, which suggests that both global NER and transcription-
coupled repair defects must contribute to the weight loss. Moreover, liver-specific Xpa-/- mice 
lose less weight than non-conditonal Xpa-/- animals, which suggests that in addition to the liver, 
other tissues (e.g. the intestine) could be involved. Weight loss in Csbm/m animals in which Xpa 
was inactivated in the liver (Csbm/m/Xpac/-/αAT-Cre-ERT) was almost two-fold stronger than in 
the single mutant Csbm/m (Csbm/m/Xpa+/c/αAT-Cre-ERT) and conditional Xpa-/- (Csb+/m/Xpac/-/αAT-
Cre-ERT) animals, which further points to additive effects of the GG-NER and TCR defects in 
tamoxifen induced weight loss. We are currently performing histopathological analysis of the 
liver and intestine. 
 Taken together, these data demonstrate that GG-NER and TCR defects render the liver and 
other tissues sensitive to tamoxifen. Given the repair defect, these cytotoxic effects are likely to 
originate from unrepaired DNA damage. 
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Figure 1. Tamoxifen-induced Cre recombination of the conditional Xpa conditional allele in the mouse. A) Southern blot 
analysis of DNA from different tissues of Xpac/+/Cre-ERT animals that were given tamoxifen via i.p. injection (i) or oral 
gavage (o) to compare recombination efficiency. Size-separated EcoRV digests were hybridized with a LacZ probe. 
Recombination of the Xpa allele causes a conversion of a 2.4 kb EcoRV fragment into a 10 kb EcoRI fragment. B) Relative 
body weight of Csbm/m/Xpac/- and Csbm/m/Xpac/-/Cre-ERT (n=14 at 7 days, n=9 at 14 days) animals after one and two weeks 
in presence (+) or absence (-) of tamoxifen treatment (*: p<0.01). C) Survival of tamoxifen treated Csbm/m/Xpac/- and 
Csbm/m/Xpac/-/Cre-ERT animals. D) Representative pictures of HE stained duodenum of tamoxifen treated Csbm/m/Xpac/- and 
Csbm/m/Xpac/-/Cre-ERT animals. The arrow indicates atypical hyperplasia reminiscent of carcinoma in situ. E) Relative body 
weight loss of Csb+/m/Xpac/+/αAT-Cre-ERT (wild type), Csb+/m/Xpac/-/αAT-Cre-ERT (conditional liver-specific Xpa-/-), 
Csb+/m/Xpa-/-/αAT-Cre-ERT (Xpa-/-), Csbm/m/Xpac/+/αAT-Cre-ERT (Csbm/m), and Csbm/m/Xpac/-/αAT-Cre-ERT (conditional liver-
specific Csbm/m/Xpa-/-) animals (n=4 per group) after one and two weeks of tamoxifen administration (*: p<0.05). 
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Discussion 
Timed recombination of floxed genes using a tamoxifen-activated Cre-recombinase has been 
frequently used as a method to generate mutant mice in a time dependent manner and 
deleterious side-effects have not been reported in literature (Seibler et al., 2003). Nevertheless, 
attempts to generate Csbm/m/Xpa-/- mice with this approach remained unsuccessful. Tamoxifen 
treated Csbm/m/Xpac/-/Cre-ERT mice displayed severe weight loss and ultimately died from 
severe intestinal pathology, consisting of massive apoptosis and reduced proliferation. 
Surprisingly we also observed atypical hyperplasia, reminiscent of intestinal carcinoma in situ in 
these animals, which is a rare finding in mice, especially when one considers that it must have 
developed within two weeks. Tamoxifen-treated Csbm/mXpac/- mice also displayed weight loss 
and reduced proliferation of the intestinal epithelium, but apparently the effect was not severe 
enough to cause lethality. The latter also applies to tamoxifen treated non-conditional Xpa-/- 
mice and liver specific Xpac/- animals. Taken together, these data indicate that a combined GG-
NER/TC-NER defect (as in Xpa-/- mice), as well as a TCR defect (as in Csbm/m animals) causes 
tamoxifen sensitivity in an additive manner (as shown by NER/TCR-deficient Csbm/m/Xpac/-/Cre-
ERT and Csbm/m/Xpac/-/αAT-Cre-ERT mice). Although we can not yet exclude that the observed 
toxic effects are originating from sunflower seed oil (used to dissolve tamoxifen, and containing 
polyunsaturated fatty acids that after lipid peroxidation may cause oxidative DNA damage), our 
data point to tamoxifen induced DNA lesions as the underlying cause. 
 Tamoxifen and its derivative metabolites can damage DNA, which has been shown both in 
vitro and in vivo (McLuckie et al., 2005; McLuckie et al., 2002; Mizutani et al., 2004; Shibutani et 
al., 2000a). Also, NER has been shown to be involved in the removal of such tamoxifen-induced 
DNA adducts (McLuckie et al., 2005; Shibutani et al., 2000b). Moreover, tamoxifen is a known 
carcinogen, as shown by (i) the increased occurrence of endometrium cancer in estrogen 
receptor positive breast cancer patients treated with this drug, and (ii) the induction of liver 
carcinomas in rats that are chronically exposed to high doses tamoxifen (reviewed in (White, 
1999)). However, since tamoxifen is not carcinogenic in adult mice, even after 1-2 years 
administration at a dose of 40 mg/kg, or when given together with tumor promoting agents 
(White, 1999), and since our pilot study with Xpac/- did not point to severe side-effects, this 
approach could have worked. On the other hand, the Csbm/m/Xpac/-/Cre-ERT and Csbm/m/Xpac/-
/αAT-Cre-ERT mouse models may well serve to further delineate the mechanism of cytotoxic 
and genotoxic effects of tamoxifen and its derivatives. 
 Evidently, other approaches should be taken to establish spatiotemporal inactivation of the 
conditional Xpa allele in the Csbm/m/Xpac/- mouse model. For example, one could use transgenic 
Cre-recombinase mice that express the enzyme from a tetracyclin-inducible (Tet-On system) 
promoter, or in which the Cre-recombinase transgene is kept silent in the presence of the 
antibiotic (Tet-Off system), although one might have a toxicity problem there too. For a 
comprehensive review on methods of conditional gene silencing, see (Porter, 1998). 
Alternatively, to obtain a Csbm/m/Xpac/- mouse model that survives weaning, one could use the 
Balancer Cre-recombinase mouse (Betz et al., 1996), which would lead to chimaeric double 
mutant animal in which the faith of Csbm/m/Xpa-/- cells (and thus the onset and progress of 
pathology) in a Csbm/m tissue can be monitored.  
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Materials and Methods  
Tamoxifen treatment 
Tamoxifen (Sigma) was dissolved in 100% ethanol and dispersed in sunflower seed oil (Sigma) 
to a final concentration of 1, 2 or 5 mg/100 μl. Mice were administered tamoxifen through i.p. 
injection (1 or 2 mg tamoxifen per day for 5 days), or gavage (2 or 5 mg per day for 5 days) 
(Kuhbandner et al., 2000; Seibler et al., 2003). This treatment was repeated after two days.  
 
Cre mice 
Cre-ERT and αAT-Cre-ERT mice were kindly provided by J. Jonkers and P. Chambon, 
respectively (Imai et al., 2000) (Vooijs et al., 2001). 
 
Pathology 
Animals were sacrificed 45 min. after injection with BrdU at an amount of 50 μg per gram 
bodyweight. Internal organs were isolated and weighed, then fixed in 10% phosphate-buffered 
formalin, paraffin-embedded, sectioned at 5 μm and stained with haematoxylin/eosin solution for 
histopathological analysis. Paraffin sections (5 μm) were dewaxed and rehydrated. Antigen 
retrieval used a 0.01M sodium citrate buffer with treatment for 1 x 7 and 2 x 3 minutes in a 700-
W microwave. Sections were washed in PBS for 2 minutes. Endogenous peroxidase activity 
was blocked in PBS: 30%H2O2: 12.5%sodiumazide (100:2:1) for 30 minutes. Sections were 
washed in PBS for 2 minutes, then washed in a 1xPBS, 0.5% protifar, 0.15% glycine (PBS+) 
buffer 2 x 2 minutes. For detection of BrdU, prior to the first antibody, sections were covered 
with 0.1M HCl for 60 minutes at 37 oC with humidity and rinsed with PBS. Sections were then 
incubated with the primary antibody against BrdU (Bu20a, mouse, DAKO, dilution 1:100) in 
PBS+ overnight at 4 oC. Sections were washed in PBS+ 3x 5 minutes before incubation for 1 
hour at room temperature in rat-anti-mouse Immunoglobulin antibody (1:1000) coupled to 
horseradish peroxidase (DAKO). Sections were washed 3 X 5 minutes in PBS+ and 2 minutes 
in PBS. Color was developed for 8 minutes in 3,3’-diaminobenzidine solution (DAKO Liquid Dab 
substrate-chromogen system), all according to manufacturers’ instructions. Sections were 
counterstained in hematoxylin before dehydratation and mounting. All histology images were 
acquired on an Olympus (London, United Kingdom) BX40 with a ccd camera at x40 objective 
magnification. Apoptotic cells were detected using a TdT-mediated dUTP Nick-End Labeling 
(TUNEL) assay as described by the manufacturer (Apoptag Plus Peroxidase In Situ Apoptosis 
Detection Kit, Chemicon). 
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Abstract 
Cockayne Syndrome is a human progeroid disorder, caused by mutations in the CSB or CSA 
gene, leading to a defect in transcription-coupled DNA excision repair. In addition to a sun-
sensitive skin, patients display early cessation of growth and progressive neurodegeneration, 
followed by death at young age. No therapy is available. Mouse models for CS display mild CS-
like pathology if the Csb gene is mutated (Csbm/m), which is dramatically aggravated by 
additional inactivation of the Xpa repair gene (Csbm/m/Xpa-/-). Both models have pointed to 
oxidative DNA damage (originating from reactive oxygen byproducts of metabolism) as 
important underlying cause of the observed progeria. In the present study, the frequency of 
Csbm/m/Xpa-/- pups surviving birth stress and their life span was utilized to explore the use of 
radical scavengers as potential preventive agents that alleviate CS pathology. Intervention 
studies, in which pregnant/lactating females were given high concentrations of D-mannitol or L-
proline, revealed a significant increase in the percentage of surviving Csbm/m/Xpa-/- offspring, 
while D-mannitol also significantly extended their lifespan. Moreover, we provide evidence that 
differences in food composition can influence the frequency and life span of Csbm/m/Xpa-/- pups, 
as well as accelerated photoreceptor-loss observed in Csbm/m mice. Taken together, these data 
provide a basis for antioxidant-based interventions in CS and further strengthen the idea that 
oxidative DNA damage is the underlying cause of CS, including its aging-associated pathology. 
The Csbm/m/Xpa-/- model may prove suited for assessing the protective effect of food 
components for aging-associated pathology in general. 
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Introduction 
Many theories exist concerning the cause of aging, a complex and multifactorial process. One 
prevailing hypothesis is the “Free radical Theory of Aging” (Harman, 1956), which proposes that 
free radicals continuously damage biomolecules, thereby setting off aging, as well as aging-
associated degenerative diseases (reviewed by (Balaban et al., 2005)). Well-known free 
radicals are reactive oxygen species (ROS; e.g. singlet oxygen, hydroxyl radicals, superoxide 
anions, nitric oxide, hydrogen peroxide) that are byproducts of cellular metabolism. ROS can 
damage biomolecules like lipids, proteins and DNA, which all may contribute to aging.  Also, 
increased resistance to oxidative stress can extend the life-span of C. elegans, Drosophila, and 
rodent mutants (Melov et al., 2000; Orr and Sohal, 1994; Schriner et al., 2005), while 
hypersensitivity to oxygen, significantly reduces the life-span, as shown for nematodes (Ishii et 
al., 1998). There are many clues pointing to the involvement of DNA damage in the aging 
process. For example, DNA damage levels (i.e. 8-OH-G) have been found to increase with age 
(Hamilton et al., 2001), reviewed in (Lombard et al., 2005) and DNA damage triggers cellular 
senescence (Campisi, 2001). Moreover, cancer increases with age and is found to be due to 
acquired mutations in the genome, highlighting genome maintenance and the importance of 
DNA damage.  
 The relation between DNA damage and aging is further underscored by the fact that many 
human inherited syndromes with defective DNA repair display progeroid symptoms (Kipling et 
al., 2004; Martin, 2005; Puzianowska-Kuznicka and Kuznicki, 2005). One such condition is 
Cockayne Syndrome (CS), a rare autosomal recessive disorder in which mutations in the CSA 
or CSB gene eliminate the transcription-coupled repair (TC-) sub-pathway of nucleotide excision 
repair (NER). NER is a complex mechanism that removes helix-distorting DNA damages that 
are induced by UV and numerous chemicals. This repair machinery consists of two sub-
pathways: global genome NER (GG-NER) and TC-NER. GG-NER removes DNA lesions from 
the entire genome, whereas TC-NER removes lesions from the transcribed strand of active 
genes that are actually arresting transcription (Hanawalt, 2002) and is believed to also apply to 
transcription-blocking oxidative DNA lesions (de Waard et al., 2003; Spivak and Hanawalt, 
2006). As a consequence of the repair defect, CS patients have a sun-sensitive skin resulting 
from enhanced apoptosis, triggered by stalled transcription due to unrepaired UV-induced DNA 
damage. In addition, CS patients experience growth retardation, notably in the first or second 
year of life, cachexia, dwarfism, and develop skeletal abnormalities (e.g. a bird-like face, 
kyphosis, and in older patients, osteoporosis), retarded psychomotor development, 
microcephaly, and progressive neurological features (e.g. disturbed gait, ataxia, 
sensorineuronal hearing loss, pigmentary retinopathy). Patients die at an average age of 12 
years (Lehmann, 2003; Nance and Berry, 1992; Rapin et al., 2000). As CS patients display 
some, but not all features of accelerated aging, this disorder is considered a “segmental 
progeroid syndrome” (Martin, 2005). Whereas the UV-sensitive skin is readily explained by the 
TC-NER defect of UV-induced lesions, the progeroid symptoms are difficult to explain with this 
scenario. Therefore unrepaired endogenous DNA damage could be the underlying cause of 
these symptoms. 
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 Aiming at understanding the etiology of CS, we have previously generated transgenic mice 
with a premature stopcodon in the Csb gene, as also found in a patient (CS1AN), belonging to CS 
complementation group B (van der Horst et al., 1997). Although the Csbm/m mouse model reliably 
mimics the repair defect and UV-sensitive phenotype of the patient, animals show only mild 
growth retardation and neurological abnormalities, which is accompanied by age-related retinal 
degeneration due to photoreceptor loss by enhanced apoptosis (van der Horst et al., 1997) 
(Chapter 3). Interestingly, a mouse genetic approach in which TCR-defective Csbm/m mice were 
crossed with completely NER-deficient Xpa-/- animals (de Vries et al., 1995), yielded a double 
mutant model that surprisingly well phenocopies human CS, including its age-related pathology 
(Chapter 2). Although devoid of any aberrant embryonic developmental phenotype, Csbm/m/Xpa-
/- pups display severe postnatal growth retardation, impaired psychomotor development, ataxia, 
progressive cachexia, and kyphosis. Loss of retinal photoreceptors is also further accelerated, 
as compared to Csbm/m animals (Chapter 2). Moreover, most Csbm/m/Xpa-/- newborns die during 
or shortly after birth, whereas animals that survive birth stress do not get older than three 
weeks.  
 The premature aging phenotype of Csbm/m/Xpa-/- pups is further underlined by the marked 
resemblance of their liver transcriptome to that of old, rather than young wild type mice (Chapter 
2). Importantly, this genomic approach uncovered a systemic response, comprising attenuation 
of the GH/IGF-1 somatotroph axis, down-regulation of oxidative metabolism, and up-regulation 
of antioxidant defense (the latter was not observed in aging mice), together with hypoglycemia 
and hepatic glycogen and fat accumulation. A comparable response is, to a large extent, also 
seen in pro-oxidant treated wild type animals (Chapter 2), in NER/crosslink repair-deficient 
Ercc1-/- mice (Niedernhofer et al., pending revision), and – paradoxically – also in long-lived 
Ames and Snell dwarf mice, characterized by an attenuated GH/IGF-1 axis (Andersen et al., 
1995; Brown-Borg et al., 1999; Brown-Borg and Rakoczy, 2000; Li et al., 1990). Taken together, 
these observations prompted us to hypothesize that an enhanced damage load in the genome, 
including in the transcribed strand of active genes, triggers an adaptive response. This response 
encompasses reduction of metabolic activity through down-regulation of the somatotrophic axis, 
and improvement of antioxidant defense and aims at slowing down aging-related pathology and 
postponing death by reducing ROS, and accordingly DNA damage levels (Chapter 2). Although 
Csbm/m/Xpa-/- animals (and likely CS patients) initiate this response constitutively at very early 
age, with early cessation of growth (dwarfism) as a consequence, loss of tissue homeostasis via 
enhanced apoptosis or cellular senescence eventually can not be prevented, as illustrated by 
the enhanced photoreceptor loss. In this scenario and in agreement with the segmental 
character of aging in CS, the spectrum and time of onset of pathological events will largely 
depend on how individual tissues and organs cope with the unrepaired DNA damage and on 
their individual regeneration potential. 
 Currently, the prognosis for CS patients is poor and there is no treatment for the disease, 
other than avoidance of sun exposure (to prevent sunburn) and, if possible, treatment of the 
individual symptoms as they present themselves. The Csbm/m/Xpa-/- mouse data (Chapter 2), 
together with the observation that exposure to low doses of ionizing radiation enhances 
photoreceptor loss in the Csbm/m mouse retina (Chapter 3), point to the involvement of 
endogenous (ROS-induced) DNA damage in the etiology of CS. To test the hypothesis that the 
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Csbm/m/Xpa-/- phenotype is caused by the accumulation of unrepaired endogenous damage, and 
to investigate whether lowering the intracellular level of ROS and other harmful reactive 
byproducts of metabolism can attenuate the premature onset of age-related features in this 
mouse model, we set out to explore the possibilities of antioxidant-based intervention. 
Ultimately, this approach is expected to result in the identification of components that may help 
to alleviate the symptoms in CS patients. The current manuscript describes the effects of two 
compounds with radical scavenger properties, as well as the effect of different brands of mouse 
chow on the phenotype of Csbm/m/Xpa-/- mice. In addition, we investigated whether 
photoreceptor-loss in the Csbm/m or Csbm/m/Xpa-/- retina could serve as a parameter for 
intervention studies. 
 
Results 
Principle of the intervention study 
As a basis for radical-scavenger intervention studies with the Csbm/m/Xpa-/- mouse model, we 
used a breeding protocol, comprising matings between Csbm/-/Xpa-/- and Csbm/m/Xpa+/- animals 
to always obtain Csbm/m/Xpa-/- pups at a maximum (Mendelian) frequency of 25%. In this 
protocol, Csb+/m/Xpa+/- mice served as “wild type” littermate controls, as animals were devoid of 
any overt phenotype. As biological readouts for the effect of antioxidants we used “frequency” 
and “survival” (see also Experimental Procedures section). Frequency was chosen because 
Csbm/m/Xpa-/- newborns (in contrast to wild type or single mutant littermates) show considerable 
lethality during or shortly after birth (60-80% loss of pups) (Chapter 2). Survival was measured 
because Csbm/m/Xpa-/- pups that survive birth usually die in their 3rd week of life (Chapter 2). 
Any positive effect of radical scavengers is expected to result in a higher frequency of viable 
Csbm/m/Xpa-/- pups and/or increased survival in or beyond week 2 after birth. 
 
D-mannitol administered via an osmotic pump postpones premature death of 
Csbm/m/Xpa-/- pups 
Antioxidants are often administered via an osmotic pump by dissolving them in D-mannitol (Liu 
et al., 2003). Since D-mannitol itself can function as a hydroxyl radical scavenger, we also 
tested the effect of this often used dissolvent via an osmotic pump. On the basis of a literature 
study on application methods for D-mannitol, we decided to provide pregnant females from 
Csbm/-/Xpa-/- x Csbm/m/Xpa+/- matings with osmotic pumps with 270 mM (5%) D-mannitol or PBS 
(control) (Liu et al., 2003). Pumps were implanted four days after detection of the copulatory 
plug and released the injected substance at a constant rate of (68 nmol/hour) for 4 weeks, 
meaning release of the injected compound till 11 days after birth. 
 We first determined the frequency of Csbm/m/Xpa-/- pups in the control and treated groups. In 
the control group (PBS only), we noticed a frequency of 3% (n=3/87) (Fig. 1A), which is slightly 
lower than what we normally observed. As it has recently been shown that exposure of rats to 
isoflurane increases malondialdehyde (MDA) and DNA damage levels in a variety of tissues, 
this difference might be due to the anesthesia required for the insertion of the pump (Kim et al., 
2006). Nevertheless, in the group treated with 270 mM D-mannitol, the frequency of 
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Csbm/m/Xpa-/- pups showed a significant 6-fold increase (p < 0.05) to 18% (n=11/61) (Fig. 1A). 
Litter sizes were not significantly different (4.7+/-1.8 for the PBS group and 5.0+/-1.6 for the D-
mannitol group), excluding effects of D-mannitol on litter size. This finding shows that D-
mannitol can rescue the low frequency of Csbm/m/Xpa-/- pups. 
 
 
 
Figure 1: Effect of D-mannitol on frequency and survival of Csbm/m/Xpa-/- pups. Csbm/-/Xpa-/- x Csbm/m/Xpa+/- breeding 
couples were set up. Pregnant females (identified by the presence of a copulatory plug) were given osmotic pumps with 
either PBS, or 270 mM D-mannitol in PBS, implanted under the skin at post-coital day 3.5. A) Frequency of Csbm/m/Xpa-/- 
pups. For explanation of error bars, see experimental procedures (*; p<0.05). B) Kaplan-Meier plot of the survival of 
Csbm/m/Xpa-/- animals that reached postnatal day 8 from untreated mothers (diamonds) and mothers treated with D-mannitol 
(circles). Note: due to the low frequency of double knockout pups in the untreated groups, we have included survival data 
from other breeding programs, performed in the same period and with the same batch of food. 
 
 We next determined the survival of Csbm/m/Xpa-/- pups and noticed that all double mutant 
animals survived for minimally 18 days (Fig. 1B). Mean, median and maximal lifespan were 20.8 
+/- 1.5, 21 and 23 days respectively. Due to the low frequency of Csbm/m/Xpa-/- pups in the 
untreated group, we did not have enough animals to reliably determine the survival. We 
therefore included data from other Csbm/m/Xpa-/- breeding programs and untreated experimental 
groups, performed in the same period and in which animals were given the same batch of food. 
Mean, median and maximal lifespan in this control group were 15.6 +/- 3.4, 15 and 21 days, 
respectively. The ages of Csbm/m/Xpa-/- pups from the treated mothers differed significantly (p< 
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0.05) from that of Csbm/m/Xpa-/- pups from untreated mothers. Although it is not yet clear 
whether this effect can be attributed to its radical scavenger function, D-mannitol does not only 
rescue birth frequency, but also increases lifespan of Csbm/m/Xpa-/- pups. 
 
D-mannitol and L-proline administered via water rescue the perinatal lethality of 
Csbm/m/Xpa-/- pups 
As the previous experiment shows that D-mannitol, when given to pregnant and lactating 
females via an osmotic pump, increases the survival and lifespan of Csbm/m/Xpa-/- pups, we next 
investigated whether other simpler application methods could also have this same positive 
effect. 
D-mannitol can be supplied via food and drinking water and is not toxic up to a concentration of 
5% (Abdo et al., 1983). After having excluded potential addictive or aversive effects of water 
containing D-mannitol (data not shown), we chose 110 mM (2%) D-mannitol for this intervention 
experiment as this was the highest possible concentration without aversive effects. Thus, 
matings between Csbm/-/Xpa-/- and Csbm/m/Xpa+/- animals were started, and after detection of a 
copulatory plug, breeding couples were given normal water or water containing 110 mM (2%) D-
mannitol. We observed a 5% frequency of Csbm/m/Xpa-/- pups (n=6/118) in the group that was 
given normal water (i.e. in the same range as found in matings before), whereas in the D-
mannitol treated group, we registered a frequency of 14% (n=12/85) (Fig. 2A). Again, litter sizes 
were not significantly different between groups (4.7+/-1.7 for the control group and 4.9+/-1.6 for 
the D-mannitol group). Although D-mannitol has a significant effect on the number of 
Csbm/m/Xpa-/- pups (2.8-fold increase; p< 0.05), the effect seems not as profound as when D-
mannitol was administered via an osmotic pump, which suggests that for D-mannitol the 
osmotic pump is the best way of administration. 
We next wished to investigate whether a different type of molecule with radical scavenger 
properties could have a similar effect on the frequency of Csbm/m/Xpa-/- pups. The amino acid L-
Proline has been shown to act as a singlet oxygen radical scavenger (Alia et al., 2001), but, as 
with D-mannitol, has many other functions. L-proline is a non-toxic natural compound, and can 
be easily administered via the drinking water. Therefore, we first chose to test L-Proline via 
water administration, as this is less laborious and less stressful for the animals. To investigate 
whether the results of an L-proline intervention study could be influenced by aberrant drinking 
behavior of treated animals, we first provided wild type mice with either normal water or water 
containing 200 mM L-proline (n=8 per group). As we could not detect any difference in water 
consumption (data not shown), potential addictive or aversive effects of L-proline are not likely 
to interfere.  
Matings between Csbm/-/Xpa-/- and Csbm/m/Xpa+/- animals were started, and after detection of a 
copulatory plug, breeding couples were given normal water or water containing 200 mM L-
proline. In the untreated group, we observed a 4.2% frequency of Csbm/m/Xpa-/- pups (n=2/47), 
consistent with earlier findings. Interestingly, the frequency of double mutant pups in the L-
proline group was 3.2-fold increased (p < 0.01) to 20% (n=17/84) (Fig. 2A). Litter sizes were not 
significantly different between groups (5.0+/-1.6 for the control group and 5.6+/-1.6 for the L-
Proline group), which excluded a positive effect of L-Proline on litter size. 
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Figure 2: Effect of L-proline and D-mannitol on frequency and survival of Csbm/m/Xpa-/- pups. Csbm/-/Xpa-/- x Csbm/m/Xpa+/- 
breeding couples were given ad libitum access to either normal water, or water with 200 mM L-proline or 110 mM D-
mannitol. A) Frequency of Csbm/m/Xpa-/- pups in litters given D-mannitol (*; p<0.05). B) Frequency of Csbm/m/Xpa-/- pups in 
litters given L-proline (*; p<0.01). For explanation of error bars, see experimental procedures. C) Kaplan-Meier plot of the 
survival of Csbm/m/Xpa-/- animals that reached postnatal day 8 from untreated mothers (diamonds) and mothers treated with 
D-mannitol (circles) or L-proline (squares). Note: due to the low frequency of double knockout pups in the untreated groups, 
we have included survival data from other breeding programs, performed in the same period and with the same batch of 
food (as in Fig1B). 
 
 As we also recorded the age at death of Csbm/m/Xpa-/- that survived beyond 8 days in the D-
mannitol and L-proline intervention experiments, we next asked whether these compounds also 
affect the life span of the double knockout pups. Due to the low frequency of Csbm/m/Xpa-/- pups 
in the untreated groups, we again did not have enough animals to reliably determine the 
survival. We therefore included the same data for the control group as in the previous 
experiment. We did not detect any significant difference in the mean, median or maximal age of 
death of Csbm/m/Xpa-/- pups in the control (15.6 +/- 3.4 15 and 21 days, respectively), L-proline 
(16.5 +/- 4.2, 16 and 22 days, respectively) or D-mannitol group (15.7 +/- 4.2, 15 and 22 days, 
respectively) (Fig. 2C).  
 Taken together, the L-proline and D-mannitol data demonstrate that administration of these 
compounds to pregnant/lactating females significantly rescues the perinatal loss of Csbm/m/Xpa-/- 
pups. Moreover, since both compounds have radical scavenging properties, this finding might 
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point to the fact that reduction of endogenous (oxidative) DNA damage can attenuate the severe 
Csbm/m/Xpa-/- phenotype. 
 
Frequency and survival of Csbm/m/Xpa-/- animals is affected by food 
During subsequent experiments we noted that there was variation in the frequency of 
Csbm/m/Xpa-/- pups surviving birth stress in our normal breeding programs. After careful 
investigation of what could be the cause of the variation it became clear that the fluctuations 
correlated with changes in the food composition. Similar effects had been observed for 
Csbm/m/Xpa-/- breeding programs at another facility (i.e. National Institute of Public Health and 
the Environment, Bilthoven, the Netherlands). Standard laboratory mouse chow diets (i) contain 
many antioxidants and vitamins, the latter (depending on the concentration) acting as anti- or as 
pro-oxidants, and (ii) are formulated from natural ingredients (e.g. grains, fruits, and 
vegetables), resulting in inter-brand as well as inter-batch (e.g. seasonal effects) variation (e.g. 
vitamin A; see Table 1). 
 
contents jan-03/mar-03 apr-03/jun-03 jul-03/sep-03 okt-03/dec-03 jan-04/mar-04 apr-04/jun-04 okt-04/dec-04 jan-05/mar-05 jul-sept 2005 okt-dec 2005
CRM (P)
moisture % 10,80 11,50 10,30 11,30 12,20 12,50 - 12,30 12,30 - 11,00 13,20
crude fat % 2,80 4,80 - - - - - - - - - -
crude fibre 3,70 % - - 3,37 3,90 4,10 3,60 - 3,20 3,20 - 3,70 3,60
ash 3,80 % - - 5,14 5,10 5,30 5,00 - 5,10 5,10 - 5,60 4,80
oil 3,40 % - - 3,20 3,80 4,00 3,90 - 3,80 3,80 - 3,40 3,00
crude protein 18,80 % 19,10 18,70 18,70 19,00 18,00 19,20 - 18,70 18,70 - 18,50 18,20
calcium 0,80 % 0,85 0,77 0,78 0,76 0,96 0,86 - - - - 1,00 -
phosphorus 0,64 % 0,62 0,64 0,58 0,61 0,65 0,66 - - - - 0,65 -
vitamin A 16,80 iu/g 16,00 8,60 12,00 15,00 13,00 17,00 - 20,00 20,00 - 23,00 9,40
vitamin E 103,20 mg/kg 116,00 62,00 111,00 101,00 - - - - - - - 92,00
  
Table 1. Fluctuation in food composition of CRM with time. Mixtures of batches form a period of two months were analyzed 
after use. 
 
 We therefore set out to test the effect of mouse chow in a controlled study, using CRM(P) 
batch 4873 (Special Diets Services) and Diet: SRM(A) (Hope Farms), hereafter referred to as 
CRM and SRM. We set up two subsequent rounds of matings with Csbm/-/Xpa-/- x Csbm/m/Xpa+/- 
breeding couples that were fed either CRM or SRM. We obtained double knockout pups at a 
frequency of 17% (n= 13/75) for breeding couples that were given CRM batch 4873 (Fig. 3A). In 
marked contrast, breeding couples that were given SRM yielded Csbm/m/Xpa-/- pups at a low 
frequency of 2.7%  (1/37) (Fig. 3A), which was a statistically significant difference (p<0.05). 
Litter sizes were not significantly different between groups (4.5+/-1.2 for the SRM and 4.4+/-1.6 
for the CRM group), which excluded effects of these two types of food on litter size. 
 To see whether the animals yielding a low frequency of Csbm/m/Xpa-/- pups were actually 
able to produce a higher number of double mutant offspring we switched the group that received 
the SRM chow to CRM food and allowed them to deliver two more litters. The CRM fed 
breeding couples were kept on CRM to assess reproducibility. As shown in Fig 3A, breeding 
couples that were maintained on CRM gave Csbm/m/Xpa-/- pups at a frequency of 9.1% (n=8/88) 
which is lower but not significantly different as compared to the first part of this experiment. 
Animals that were previously kept on SRM chow now yielded Csbm/m/Xpa-/- offspring at a 
frequency of 9.2% (n=6/65) (Fig 3A) i.e. very similar to the other group, indicating reproducibility 
under identical conditions. These data show that different types of food and perhaps other 
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unknown factors can influence the frequency of Csbm/m/Xpa-/- pups, underscoring that 
intervention experiments should be done in parallel at the same time with the same batch of 
food, as done for the D-mannitol and L-proline experiments. 
 
 
  
Figure 3: Effect of food on frequency and survival of Csbm/m/Xpa-/- pups. Csbm/-/Xpa-/- x Csbm/m/Xpa+/- breeding couples were 
maintained on regular CRM or SRM chow and were allowed to mate. Note that throughout the experiment food was 
obtained from the same batches. A) Frequency of Csbm/m/Xpa-/- pups on CRM or SRM chow and after transfer to CRM 
chow (transfer indicated by lines underneath the figure). For explanation of error bars, see experimental procedures. B) 
Body weight of a male and female Csbm/m/Xpa-/- mouse (and littermate controls) that survived beyond weaning when 
animals were given moisturized, crunched AIN93-G pellets. C) Photographs of a Csbm/m/Xpa-/- male mouse that survived on 
moisturized, crunched AIN93-G pellets, and a control mouse, age 72 days, displaying kyphosis in the first, together with a 
photograph of the Csbm/m/Xpa-/- male mouse, displaying imbalance D) Photographs of the same 72 day old Csbm/m/Xpa-/- 
male and control mouse. Note the abnormal posture during the tail suspension assay (crossing rather than spreading of 
hind limbs) and priapism as compared to the littermate control. 
  
 Since the above used mouse chow is subject to batch-to-batch variation (Table 1), we next 
investigated whether a synthetic food, which is expected to experience less variation between 
batches, would be a better alternative for intervention based on frequency of Csbm/m/Xpa-/- pups. 
AIN93-G was chosen, as it is a fixed formula synthetic diet that contains all necessary 
constituents and, in contrast to regular laboratory mouse chow, is of constant quality. Litters 
from breeding couples that were given AIN-93G resulted in a frequency of double knockout 
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pups of 11.1% (n=4/36). This is a relatively high number when one would like to study the effect 
of compounds and such a frequency in the control group would demand a high number of pups 
to reach statistical significance. However, other formulas may be more suitable for this purpose. 
  
A synthetic diet dramatically extends the lifespan of some Csbm/m/Xpa-/- 
animals  
Previously, we have made several attempts to postpone the premature death of Csbm/m/Xpa-/- 
pups to beyond the weaning period. For example, newborn mice switch from milk to solid food 
in their third week of life. Reasoning that the fragile condition and short stature of Csbm/m/Xpa-/- 
animals might prevent them from properly doing so, we have provided litters with double 
knockout pups with a mixture of crunched CRM or SRM chow pellets and water from day 15 
onwards, to exclude malnutrition or dehydration as a cause of death. Also we provided 
Csbm/m/Xpa-/- pups new lactating mothers. However, we were never able to obtain animals that 
lived longer than 23 days (Chapter 2 and data not shown). Surprisingly, when we performed a 
similar pilot experiment with the synthetic AIN-93G diet, 2 out of 4 Csbm/m/Xpa-/- pups (one male 
and one female) survived for over 2 months, which is a near 3 to 4-fold increase in life span. 
Similar to their short-lived double mutant littermates, the surviving Csbm/m/Xpa-/- animals 
displayed severe post-natal growth retardation (Fig. 3B) and from weaning on maintained a 
constant (low) body weight for 10 to 20 days, after which animals started to gain weight again 
(i.e. 2-3-fold increase as compared to body weight at weaning). In addition, animals developed 
kyphosis (Fig 3C) and displayed pronounced ataxia or inability to keep in balance (Fig 3C). We 
also observed dystonia, (i.e. abnormal posture in the tail suspension assay, with hindlimbs 
crossed together rather than wide compared to the normal posture exhibited by the littermate 
control, Fig 3D) and waltzing type behavior. Both Csbm/m/Xpa-/- animals showed paralysis of one 
of their hind limbs, which in case of the female progressed into muscular atrophy. Furthermore, 
the Csbm/m/Xpa-/- male developed priapism (a persistent erection of the penis as a consequence 
of disease, rather than sexual arousal), the latter first noticed at day 58 (Fig 3D). Eventually, 
after some loss of body weight, both Csbm/m/Xpa-/- mice became moribund and were sacrificed 
at day 72 and 100, respectively. For both cases, autopsy revealed food in the stomach of the 
animal, excluding malnutrition as the cause of weight loss and physical deterioration. A detailed 
histopathological examination of the Csbm/m/Xpa-/- mice is in progress. 
 
Apoptosis of photoreceptor cells as a possible read-out of intervention 
Given the observed variation in birth frequency of Csbm/m/Xpa-/- pups, we searched for 
independent additional parameters to monitor potential effects of intervention. Retinal 
degeneration is a hallmark of CS, reported in 55% of the patients (Nance and Berry, 1992) 
(Dollfus et al., 2003; Levin et al., 1983), and is also observed in Csbm/m animals, which display 
spontaneous photoreceptor-loss that can be can be amplified by the effects of low-dose ionizing 
radiation induced (oxidative) DNA damage (van der Horst et al., 1997), (Chapter 3). Moreover, 
the retina appears particularly susceptible to oxidative stress because of its high consumption of 
oxygen, high concentration of polyunsaturated fatty acids, and exposure to light (Beatty et al., 
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2000). Taken together, photoreceptor loss in CS mouse models may constitute a relevant 
additional assay for intervention screens in the intact animal.  
 We thus performed a pilot study in which newborn wild type (wt) and Csbm/m animals were 
placed on CRM, SRM or AIN93-G food. At the age of 10 weeks, animals were sacrificed and the 
retina was subjected to TUNEL staining, followed by quantification of the number of apoptotic 
cells in the outer nuclear layer (ONL, containing the photoreceptor cells) and inner nuclear layer 
(INL, containing the cell bodies of bipolar, horizontal, amacrine and Müller cells).  
 
 
 
Figure 4. Photoreceptor cell loss in mouse models for CS. A) Quantification of apoptotic (TUNEL-positive) cells in the outer 
(ONL) and inner nuclear layer (INL) of Csbm/m mice, maintained on CRM or SRM chow, or on a synthetic AIN93-G diet. The 
observed differences in the number of apoptotic cells were tested for significance using a Student t-test and one-way 
analysis of variance (ANOVA). In case of statistical significance the ANOVA was followed by the post hoc test of Student-
Newman-Keuls (S-N-K). Significance was accepted at p < 0.05. B) Number of TUNEL positive photoreceptor cells in the 
ONL of Csbm/m/Xpa-/- pups and control littermates at various ages. Animals were fed with CRM chow. Error bars indicate 
standard errors of the mean. 
 
 In Csbm/m animals that were given CRM chow, we observed on average 2.7 ± 1.0 TUNEL 
positive cells in ONL and 0.1 ± 0.2 in the INL (Fig. 4A, n=4). Strikingly, and in line with the lower 
performance of Csbm/m/Xpa-/- pups on this food, SRM fed Csbm/m animals showed on average 
9.5 ± 2.5 and 0.4 ± 0.3 TUNEL-positive cells in ONL and INL, respectively (Fig. 4A, n=6), which, 
at least for the ONL, is significantly increased (p<0.05) compared to Csbm/m animals maintained 
on CRM chow. Interestingly, wt animals did not show any food-related differences in apoptosis 
in the ONL and INL (Fig. 4A). Csbm/m animals fed with AIN93-G on average had 3.2 ± 0.9 
TUNEL positive cells in ONL and 0.6 ± 0.5 in the INL (Fig. 4A, n=6), which was similar to the 
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data obtained with the CRM food. In conclusion, the diet offered to the animal appears to have 
an influence on the amount of apoptotic photoreceptor cells in the Csbm/m retina.  
 Recently, we have demonstrated that 15-day old Csbm/m/Xpa-/- mice show enhanced 
photoreceptor loss, as compared to Csbm/m single mutant littermates (Chapter 2). Therefore, we 
now determined the amount of TUNEL-positive photoreceptor cells in the ONL retina of wt and 
Csbm/m/Xpa-/- animals at day 13, 15, 17, 18 and 19 to investigate whether photoreceptor-loss 
progressively worsens in time. As shown in Fig. 4B, starting at day 15, the number of apoptotic 
photoreceptor cells in the Csbm/m/Xpa-/- retina rapidly increases in time, while apoptosis in the 
wild type retina remains constant. This result was confirmed by staining for Active Caspase 3 
(data not shown), which is a specific marker for apoptosis. From this finding we conclude that 
the kinetics of onset of photoreceptor loss in the Csbm/m/Xpa-/- retina could be a valuable 
endpoint in intervention studies. 
 
Discussion 
Cockayne Syndrome is a rare, autosomal inherited DNA repair deficient disorder, characterized 
by (early onset) disturbed growth, progressive neurodegeneration and premature death, along 
with many progeroid features (Martin, 2005; Nance and Berry, 1992). Up to now there is no 
therapy for this disease other than treatment of individual symptoms when possible. 
Csbm/m/Xpa-/- animals share many similarities with CS, including postnatal growth retardation, 
skeletal abnormalities, retinal degeneration, Purkinje cell loss, ataxia and premature death, and 
therefore seem a good animal model to test possible therapeutical intervention strategies to 
alleviate CS symptoms. Since our previous (transcriptome) analysis of Csbm/m/Xpa-/- mice points 
to unrepaired endogenous DNA damage (inflicted by reactive oxygen species), as a likely 
trigger for CS pathology (Chapter 2), we now have explored the effect of compounds with 
radical scavenger properties on the Csbm/m/Xpa-/- phenotype. 
 
D-mannitol and L-proline alleviate early perinatal death and postpone premature 
death in Csbm/m/Xpa-/- mice  
We have shown that D-mannitol and L-proline significantly increase the yield of Csbm/m/Xpa-/- 
offspring when pregnant/lactating females are given these compounds via drinking water. 
Moreover, when D-mannitol was delivered to the mother subcutaneously (through an osmotic 
pump), we observed additionally a significant increase in the lifespan of Csbm/m/Xpa-/- animals. It 
remains to be seen whether L-proline will have a similar effect, when provided via an osmotic 
pump. Importantly, as previously hypothesized (Chapter 2), these intervention studies provide 
evidence that compounds with radical scavenger properties can have a positive effect on the 
phenotype of Csbm/m/Xpa-/- animals.  
 However, besides the scavenging properties it is possible that the positive effects of L-
proline and D-mannitol originate from or are strengthened by other properties of these 
molecules. For instance, D-mannitol has been shown to increase glucose transport and open 
the blood-brain barrier (Cosolo et al., 1989; Hwang and Ismail-Beigi, 2001), whereas L-proline 
was found to inhibit ROS-mediated apoptosis and to act as an activator of transcription (Chen 
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and Dickman, 2005; Sellick and Reece, 2003). For this it would be helpful to test compounds 
with a similar structure, but lacking scavenging activity.  
 Still, the common property of both compounds is radical scavenging. Therefore, it is 
tempting to speculate that this is the property that contributes to the observed effects. The most 
plausible scenario would then be that radical scavenging lowers the intracellular ROS level, and 
as an immediate consequence, the harmful side effects of these metabolic byproducts on 
cellular macromolecules. In view of the repair defect of the CS mouse models, it is reasonable 
to assume that the positive effect of such radical scavenging is exerted through reducing the 
amount of DNA damage, which would strengthen the idea that the accumulation of unrepaired 
DNA damage is at the basis of the etiology of CS pathology. 
 Besides the mechanism of action of both compounds, we would also like to know if the 
observed effects display dose-dependency, by repeating the experiment with varying doses of 
L-proline and D-mannitol. In parallel, such studies will reveal the optimal dose that should be 
given to pregnant/lactating mothers, which subsequently will also allow us to investigate 
whether combined administration of L-proline and D-mannitol has additive/synergistic effects. In 
addition, we want to obtain insight in the actual concentration of L-proline and D-mannitol in 
blood and tissues of Csbm/m/Xpa-/- pups. To address this question, we have performed a study in 
which pregnant/lactating wild type females were given three different doses of L-proline or D-
mannitol via drinking water, and in which serum levels of these compounds in mother and 
offspring were measured. These experiments point to a rapid clearance of these compounds by 
the kidney (as we found detected both in urine) and/or a fast metabolic conversion or uptake in 
organs and tissues. Therefore constitutive serum levels appeared low. Since we observed a 
clear biological effect, these compounds apparently already exert an effect at a low serum dose. 
We are now using radiolabeled D-mannitol and L-proline, to determine relevant pharmacokinetic 
and -dynamic parameters of these compounds. This will provide insight in the clearance rates 
and transmission efficiency via placenta and mother milk.  
 
Food influences the severe pathology of Csbm/m/Xpa-/- mice  
We uncovered inter-brand (i.e. CRM vs. SRM) effects of chow diets on the yield of double 
knockout offspring. Moreover, we obtained indications for time-dependent changes in 
frequencies of Csbm/m/Xpa-/- pups, while using one and the same batch of food. These data not 
only point to sensitivity of the Csbm/m/Xpa-/- mouse model to food components, but more 
generally, may also explain discrepancies between observed phenotypes when a particular 
mouse model is studied in different labs. Thus, particularly when studying animal models in 
which the phenotype may depend on, or may be influenced by pro- and anti-oxidants (e.g. 
neurodegeneration, carcinogenesis, life span), the effect of food should be considered. More 
importantly, when testing intervention in the above described endpoints, this should be done in 
parallel at the same time with the same batch of food, as was done for the D-mannitol and L-
proline studies, to exclude these variable factors. 
 Since the Csbm/m/Xpa-/- pups might be expected to encounter difficulties in reaching the food 
compartment and/or chewing the solid food pellets due to their severe phenotype, we also 
attempted to extend the life span of these animals by giving moisturized, crunched food pellets. 
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When performed with CRM or SRM chow, this approach did not have any effect. However, in a 
first experiment in which a litter was given moisturized crunched AIN-93G pellets, two out of four 
Csbm/m/Xpa-/- animals lived way beyond the age of 21 to 23 days. Apart from the known 
Csbm/m/Xpa-/- features (i.e. postnatal growth retardation, ataxia, progressive cachexia, and 
kyphosis, see Chapter 2), the long-lived animals also showed new phenotypical features such 
as hind limb paralysis, waltzing behavior, and aberrant tail suspension behavior. In addition, the 
male mouse developed priapism, which is also observed in the brain conditional Csbm/m/Xpac/- 
mouse model (Chapter 4), and thus further points to neurological dysfunction. Animals became 
moribund at the age of 72 and 100 days, and are currently subjected to detailed 
histopathological analysis. A possible explanation for the prolonged survival of Csbm/m/Xpa-/- 
mice on the moisturized crunched AIN-93G diet (in contrast to regular chow) could be that food 
components might dissolve more easily. These findings once more show what impact food can 
have on the phenotype of the Csbm/m/Xpa-/- mouse. In addition, we conclude that apparently 
Csbm/m/Xpa-/- animals encounter at least two critical stages early in life, the first being birth, the 
second being weaning when animals change from milk to solid diets. Apparently both (stressful) 
events can be modulated. 
 
Food modulates mild pathology of the Csbm/m mouse  
Although the Csbm/m/Xpa-/- mouse model represents a suitable tool for intervention studies that 
aim at alleviating the pathology of CS, we wished to find additional CS-related endpoints to 
study the effects of intervention compounds. Preferably, candidate phenotypes should develop 
in a relatively short time to avoid unnecessarily long experiments. Furthermore, statistical 
significance of interventions should be reached with relatively low numbers of animals. 
Detection of retinal photoreceptor loss in the Csbm/m mouse model (Chapter 3) well fits these 
criteria. Since the number of TUNEL-positive photoreceptor cells was found to differ when 
Csbm/m animals are placed on different types of mouse chow, this suggests that apoptotic cells 
in the retina may serve as a good endpoint. Thus, we are currently testing the effect of D-
mannitol and L-proline on retinal degeneration in the Csbm/m mouse model. Moreover, as we 
have shown that photoreceptor loss in Csbm/m animals is dramatically enhanced by inactivation 
of Xpa (Chapter 2 and this study), and as we have generated a conditional Xpa mouse model 
(Chapter 4), the assay could be further sensitized by using a photoreceptor-specific conditional 
Csbm/m/Xpac/- mouse model. Such a mouse model will make it possible to study the effects of 
compounds on enhanced photoreceptor cell loss in an adult Csbm/m mouse. 
 
Towards clinical application 
Our finding that mouse CS features can be modulated by scavengers and possibly also food 
composition provides a clear hint that human CS pathology might be alleviated by nutraceutical 
or pharmaceutical intervention strategies that attempt to lower the accumulation of unrepaired 
DNA damage. Although this strategy will probably not cure the disease, it hopefully may help to 
improve quality of life of CS patients. Extensive follow-up research in animal models is needed 
to find the most favorable compound and to define the optimal concentration and delivery 
method, along with detailed studies that exclude negative side effects of chronic administration 
Chapter 5 
138 
of the compound of choice. Furthermore, as the limited number of CS patients precludes 
double-blind placebo-controlled treatment studies, a start should be made to determine 
parameters that report on successful intervention in clinical trials with human CS patients. On 
the basis of our previous work, circulating IGF1 levels (detected in serum) and brain atrophy 
(detected by MRI) may well serve that purpose (see also Chapters 2 and 3). Finally, once 
intervention in CS patients will turn out to be successful, we anticipate that the identified 
compounds will not only be beneficial to other ROS/DNA damage based (progeroid) disorders, 
but (when provided as food supplements) will also promote healthy aging in general.  
 
Materials and Methods 
Mice  
The generation and characterization of NER-deficient Csbm/m and Xpa-/- mice has been 
described previously (de Vries et al., 1995; van der Horst et al., 1997). All mice were kept in a 
homogeneous C57BL/6J genetic background. Mice were genotyped by PCR using a primer mix 
that amplifies both the wild type and targeted alleles in a single reaction (de Vries et al., 1995; 
van der Horst et al., 1997). Animals are maintained in a controlled environment (19-24 oC, 12h 
light: 12 hr dark cycle), received CRM(P) standard rodent maintenance chow (Special Diets 
Services, Witham, UK) and water ad libitum, and were housed at the Animal Resource Center 
(Erasmus University Medical Center), which operates in compliance with the “Animal Welfare Act” 
of the Dutch government, using the “Guide for the Care and Use of Laboratory Animals” as its 
standard.  
 
Intervention studies  
For intervention studies, we used a breeding protocol involving matings between Csbm/-/Xpa-/- 
and Csbm/m/Xpa+/- animals, which yields Csbm/m/Xpa-/- pups at a maximum (Mendelian) 
frequency of 25%. Animals were daily screened for discomfort and weighed once a week, except 
for Csbm/m/Xpa-/-, which after identification (see below) were weighed every day. The number of 
Csbm/m/Xpa-/- pups was recorded, as well as their age at death. Food and water consumption by 
the pregnant/lactating female were registered by weighing the food pellets and drinking bottle.  
 Experimental animals were fed ad libitum with CRM(P) standard rodent maintenance chow 
batch 4873 (Special Diets Services, Witham, UK) or Diet: SRM(A) (Hope Farms/Arie Blok, 
Woerden, the Netherlands). Alternatively, animals were given the (fixed formula) synthetic 
pelleted diet AIN-93G, lacking antioxidant tertiary-butylhydroquinone (TBHQ) (Harlan Teklad, 
Horst, the Netherlands). As transfer of pups from milk to solid food occurs around day 18, in 
some experiments pups were given a mixture of crunched food pellets and water from day 15 
onwards to exclude malnutrition as a cause of death. 
 L-proline (Sigma, P5607) and D-mannitol (Sigma, M4125) were provided via drinking water 
at concentrations of 200 and 110 mM, respectively, using normal water as a control. Bottles 
were refreshed twice a week. Alternatively, pregnant females (as determined by the presence of 
a vaginal copulatory plug) received an ALZET 2004 osmotic pump (DURECT Corporation, 
Cupertino CA, USA) with 270 mM D-mannitol in phosphate-buffered saline (PBS) or PBS only, 
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that was implanted under the skin under anesthesia with isoflurane. Release rates were 0.25 
μl/hr, as indicated by the manufacturer.  
 
Biological parameters tested 
As biological readouts for the effect of antioxidants and food, we used “frequency”, “survival”, 
and “retinal cell loss”.  
 The frequency represents the number of Csbm/m/Xpa-/- pups that reach post-partum day 8 
(the age at which genotyping is performed), and expressed as percentage of the total number of 
newborns at that age. Observed differences in frequency were tested for significance using a 
simple z-test and validated with the Chi-square test. Significance was accepted at p < 0.05. 
Standard errors are calculated with the formula √[(f)*(1-f)/n] based on number of animals (n) and 
frequency (f). To exclude that the observed Csbm/m/Xpa-/- frequencies between treated and 
untreated groups were influenced by litter size, average litter size per group was calculated for 
the non-Csbm/m/Xpa-/- pups, by correcting for the amount of Csbm/m/Xpa-/- pups with the formula 
(‘total number of pups’ – ‘number of Csbm/m/Xpa-/- pups’)/’number of litters’. This number should 
be constant between treated and untreated groups if the treatment does not influence litter size. 
Differences in litter size were tested for significance using a Student t-test. Significance was 
accepted at p < 0.05. 
 Survival was determined by the Kaplan–Meier method, using the SSPS statistics program 
version 11.01 (SPSS Inc., Chicago, IL USA). Animals that became moribund were killed and 
therefore were counted as dead in the survival analysis. Mean and median age were calculated 
with the formulas ‘mean=sum of ages/sample size’ and ‘median= 0.5*(n+1)st observation’.  
 Retinal cell loss was determined by TUNEL staining of horizontal sections of the eye, as 
described in more detail below. Observed differences in the number of apoptotic cells were 
tested for significance using a Student t-test and one-way analysis of variance (ANOVA). In 
case of statistical significance the ANOVA was followed by the post hoc test of Student-
Newman-Keuls (S-N-K). 
 As required by Dutch law, all animal studies were approved by an independent Animal Ethical 
Committee (Dutch equivalent of the IACUC).  
 
Immunohistological procedures 
The isolation of the eye and visualization of apoptosis in the retina have been described in detail 
elsewhere (Chapter 3). In short, animals were anaesthetized by CO2 inhalation, followed by 
cervical dislocation. Eyes were marked on the nasal side with Alcian blue, enucleated, fixed in 4 
% paraformaldehyde (in 0.1 M phosphate buffer), washed in PBS, and embedded in paraffin. 
Horizontal sections (5 μm thick) of the retina were cut and sections in the middle of the retina 
were selected by Alcian blue marking and proximity of the optic nerve. Sections were stained for 
degenerating cells by TdT-mediated dUTP Nick-End Labeling (TUNEL), according to the 
manufacturer’s instructions (Apoptag Plus Peroxidase In Situ Apoptosis Detection Kit, 
Chemicon). For quantification, the number of TUNEL-positive cells in the inner nuclear layer 
(INL) and outer nuclear layer (ONL) were counted in 6 whole sections per mouse.  
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Concluding remarks and perspectives 
 
DNA damage can be deleterious to both cells as well as the entire organism. Thus, it is of vital 
importance that the genome is protected from genotoxic insults. Unrepaired DNA damage can 
interfere with cellular key processes like transcription and replication, resulting in cell death by 
apoptosis, and growth arrest or they induce mutations that ultimately may result in the onset of 
cancer (see (Hoeijmakers, 2001)). Accumulation of DNA damage has also proposed to be a 
major contributor to age-related diseases (e.g. (Hasty et al., 2003; Mitchell et al., 2003)). This is 
demonstrated by Cockayne Syndrome (CS), an inherited progeroid disorder, which is caused by 
a defect in the transcription coupled repair subpathway of nucleotide excision repair (TC-NER) 
CS is characterized by UV-sensitivity of the skin, progressive growth failure, together with many 
neurological symptoms. CS is recognized as a “segmental” progeroid syndrome, as evident 
from the observation that patients show early onset of a subset, but not all features of normal 
aging. No cure is available for this disease other than treatment of the symptoms that present 
themselves. In this thesis we set out to investigate the underlying mechanism that results in the 
very severe progeroid phenotype observed in CS by use of existing and new mouse models. 
 
Repair deficiency 
In line with the transcription-coupled NER defect, patients with CS have a UV-sensitive skin. 
However, these patients do not develop skin cancer (reviewed by (Nance and Berry, 1992)). 
Similarly, the skin of Csbm/m mice (and cells derived thereof) is hypersensitive to UV and easily 
gets sunburned. In contrast to CS patients, Csbm/m animals do get skin cancer after chronic UV-
irradiation (van der Horst et al., 1997). In Chapter 3, we show that carcinogenic events in 
Csbm/m mice are not limited to the skin, but also occur in the eye. Chronically UV-exposed 
Csbm/m animals develop corneal hyperplasia and squamous cell carcinomas. These data show 
that TC-NER acts as a tumor suppressor mechanism.  The difference in cancer susceptibility in 
human and rodent CS is well explained by the fact that UV-induced cyclobutane pyrimidine 
dimers are the major causative lesion for UV-skin cancer (Jans et al., 2005) and that rodents 
lack efficient GG-NER for removal of this lesion from the DNA and thus primarily rely on TC-
NER (Bohr et al., 1985).   
 Using a panel of Csbm/m/Xpa-/-, Csbm/m/Xpc-/-, and Xpa-/-/Xpc-/- mouse embryonic fibroblasts, 
obtained from intercrosses between Csbm/m (TC-NER defect), Xpa-/-, Csbm/m/Xpc-/-, (complete 
NER defect) and Xpc-/- (GG-NER defect) animals, we have shown that inactivation of GG-NER 
in a Csbm/m background renders cells even more UV-sensitive than Xpa-/- cells (Chapter 2). This 
hypersensitivity may be attributed to other DNA damage than photolesions (e.g. oxidative DNA 
damage). Although CS patient fibroblasts as well as Csbm/m MEFs have been shown sensitive 
to γ-irradiation (de Waard et al., 2003; Deschavanne et al., 1984), reservations exist with 
respect to the oxidative DNA damage sensitivity of CS cells. In Chapter 3, we provide clear 
evidence for increased apoptosis in the retina of Csbm/m animals after exposure to low doses of 
ionizing radiation. Interestingly, exposure of 18 day old Csbm/m/Xpa-/- mice to ionizing radiation 
(Chapter 2), resulted in a higher frequency of apoptotic cells as compared to wild type or Csbm/m 
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and Xpa-/- single mutant mice. These data suggest that at the organismal level Csbm/m/Xpa-/- 
mice are even more sensitive to oxidative DNA damage than Csbm/m mice. 
 
Progeroid symptoms 
CS pathology includes retarded growth and cachexia (cachectic dwarfism), along with kyphosis 
and variety of neurological abnormalities such as deafness. In contrast to human CS, Csbm/m 
mice only display a very mild CS phenotype, which includes body weight retardation and retinal 
degeneration. In Chapter 3, we have investigated in detail the spontaneous photoreceptor loss 
in Csbm/m mice. The increased apoptosis in the retina of ionizing radiation exposed eyes 
suggests that the retinal cells loss implies that endogenous (oxidative) DNA damage is the 
underlying trigger. Importantly, as shown in Chapter 2, inactivation of (global genome) NER 
dramatically aggravates the mild Csbm/m phenotype. Csbm/m/Xpa-/- animals display an extremely 
short lifespan of about 3 weeks and display many (progeroid) features of CS: normal embryonic 
development followed by progressive postnatal growth failure, cachexia, ataxia, kyphosis, 
relatively large limbs compared to a small body, and retinal degeneration.  
To provide insight in the etiology of CS, we have examined the liver transcriptome of 
Csbm/m/Xpa-/- and single mutant and wild type littermates, as well as that of wild type animals at 
various ages (Chapter 2). Interestingly, the liver transcriptome of Csbm/m/Xpa-/- animals 
resembles that of old wild type animals, which further points to premature aging in the double 
mutant mice. Surprisingly, we found systemic suppression of the GH/IGF1 somatotroph axis 
and oxidative metabolism, along with an increased antioxidant response. Moreover, serum 
glucose and IGF1 levels were reduced, whereas glycogen and fat accumulated in the liver. This 
response is reminiscent of a lifespan-prolonging effect as observed in Snell and Ames dwarf 
animals (Carter et al., 2002; Longo and Finch, 2003). Taken together, our data suggest that 
unrepaired endogenous DNA damage can induce a systemic response, which we hypothesize 
to serve as an adaptive response attempting to reduce the level of reactive oxygen species (and 
as a consequence lower DNA damage levels) to prolong lifespan. This scenario was further 
supported by the finding that a similar response can be induced in wild type animals that were 
treated with the pro-oxidant DEHP (Chapter 2). Similar data were obtained with Ercc1-/- and 
XpdTTD/XPCS/Xpa-/- animals, pointing to a shared general response induced by DNA damage. 
Moreover, as Csbm/m/Xpa-/- tune down the somatotrophic axis while still growing into adulthood, 
this model could explain the dwarfism associated with CS. In this regard, it will be very 
interesting to investigate whether in CS patients a similar response underlies the observed 
phenotype.   
 
Neurodegeneration 
Neurological abnormalities represent a prominent feature of CS. From the work presented in 
Chapters 2 and 3 it became clear that whereas proliferative tissues like liver and kidney did not 
display increased apoptotic death, a post-mitotic tissue like the retina does show an increase in 
apoptotic cells. Moreover, Csbm/m/Xpa-/- animals are ataxic and were shown to have increased 
apoptosis in the cerebellum (Murai et al., 2001).  
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 These observations together led us to speculate that the brain would be an important tissue 
to study the CS phenotype in more detail. However, the Csbm/m mouse has only a mild 
neurological phenotype (assayed by behavioral studies) and so far no aberrant brain pathology 
was found in these animals. Whereas the Csbm/m/Xpa-/- mouse model forms a better phenocopy 
of CS than the Csbm/m model, the short life span of Csbm/m/Xpa-/- animals precludes detailed 
research on the etiology of brain (and other) pathology. We therefore generated a conditional 
Xpa mouse for time and tissue specific induction of the Csbm/m/Xpa-/- status (Chapter 4). 
Interestingly, Csbm/m/Xpac/-/CamKIIα-Cre mice (in which Xpa is specifically inactivated in the 
cerebrum), display many CS-like neurological symptoms at older age, including cerebral atrophy 
and dilated ventricles, the two major neurological deficits reported in the CS brain (Nance and 
Berry, 1992; Ozdirim et al., 1996; Pasquier et al., 2006). In addition, animals display seizures 
and anxiety-like behavior, while male mutant mice develop priapism. Although we still need to 
determine the responsible brain area, as well as time window in which these abnormalities 
arise, preliminary data suggests that it starts as early as 1 month after birth. As Xpa was not 
knocked out in the cerebellum, it is not surprising that Csbm/m/Xpac/-/CamKIIα-Cre animals do 
not show ataxia. However, it will be interesting to see whether the ataxic phenotype will arise 
when we only knock out Xpa in the cerebellum. Along these lines, we could specifically 
inactivate Xpa in the retina, hippocampus, and so on. These animal models would provide 
essential tools in further understanding of the different CS neurological aspects. 
 Neurodegenerative disorders represent a remarkably heterogeneous group of neurological 
deficits with diverse, but often overlapping clinical features that render their classification 
challenging (Przedborski et al., 2003). Yet, a large group of neurodegenerative diseases 
appears to follow a recurrent theme. For instance, neurological deficits often develop in 
numerous human pathological conditions associated with genetic defects in genome 
maintenance. Trichothiodystrophy (TTD) patients, as well as patients with some forms of 
Xeroderma Pigmentosum (XP), also characterized by defects in NER, demonstrate neurological 
symptoms as a prominent feature of their phenotypes (Bootsma et al., 2002; Bootsma, 1998; 
Cleaver, 2005), supporting a link between defective NER and neurodegeneration. Furthermore, 
defects in genes involved in DSB or SSB repair, like ataxia telangiectasia (AT) (Boder and 
Sedgwick, 1958; Shiloh, 1997), oculomotor apraxia (AOA1) and spinocerebellar ataxia with 
axonal neuropathy (SCAN1) (Caldecott, 2004), results in neurodegeneration. This insinuates a 
selective vulnerability of neurons to DNA damage and draws attention to the importance of DNA 
damage processing for long-lasting neuronal function.  
 TCR, part of which is TC-NER, appears not restricted to NER and can remove transcription-
blocking lesions from the transcribed strand of active genes (Hanawalt, 2002; Hanawalt et al., 
1994). For instance, limited evidence suggests that the function of the CSB protein might not 
only be restricted to TC-NER but that it also acts in other repair pathways (e.g. BER) aimed at 
repairing (non-NER) lesions that could still interfere with ongoing transcription (Stevnsner et al., 
2002; Thorslund et al., 2005; Tuo et al., 2002). In addition, it has been previously suggested 
that TCR might also apply to oxidative DNA lesions, a likely scenario that has not been, 
however, formally proven so far (de Waard et al., 2003; Dianov et al., 1999; Spivak and 
Hanawalt, 2006). We have similarly shown that the Csbm/m and Csbm/m/Xpa-/- animals is 
sensitive to oxidative DNA damage (Chapter 2 and 3). 
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 The most obvious endogenous source of DNA damage appears to be reactive oxygen 
species (ROS) and other natural by products of (redox) metabolism. Owing to their 
extraordinary high metabolic rate, neurons are thought to be particularly susceptible to the 
damaging effects of ROS, the natural by products of oxidative metabolism (Limoli et al., 2004). 
These observations together with our data (Chapters 2, 3 and 4) suggest that the observed 
neurological phenotype of CS patients and the corresponding Csbm/m/Xpa-/- and Csbm/m/Xpac/-
/CamKIIα-Cre mouse models is caused by unrepaired endogenous DNA damage. 
 
CS and intervention 
Since ROS represent a major source of endogenous damage, we hypothesized that lowering 
ROS levels would result in reduced DNA damage levels, and as a consequence, would alleviate 
the phenotype of the Csbm/m/Xpa-/- mouse. Indeed, when we tested two small compounds with 
radical scavenging properties, we were able to increase the yield and survival of Csbm/m/Xpa-/- 
pups significantly (Chapter 5). In addition, we observed that food composition has a huge effect 
on the Csbm/m/Xpa-/- phenotype, and as a consequence, the intervention assay. Moreover, we 
were even able to increase the lifespan of Csbm/m/Xpa-/- animals from a maximum of 23 days to 
at least 72 days by changing food composition. Interestingly, a male Csbm/m/Xpa-/- mouse that 
survived beyond weaning, displayed priapism later in life, a feature also observed in the brain-
specific Csbm/m/Xpac/-/CamKIIα-Cre mouse and which points to neurological dysfunction 
(Chapter 5). 
 These findings pave the path for the development of cellular and animal screening assays 
for compounds that have a beneficial effect on the CS phenotype. Considering that the 
Csbm/m/Xpa-/- survival/lifespan assay is very sensitive, we need to develop more specific and 
more robust assays. We suggested that the increase in apoptotic cell death (either naturally with 
age or induced by DNA damage) could be a possible better read-out system. Importantly, since 
animal experiments cannot be performed at high throughput scale, one would like to employ a 
cell-based pre-screening system to find potential candidate compounds for intervention studies 
in the live animal. To this end, we may use Csbm/m and Csbm/m/Xpa-/- MEFs, but also CS patient 
fibroblast cell lines in a semi-high throughput system. We could then challenge these cells with 
chronic doses of genotoxic agents and see which compounds have a positive counter-acting 
effect on cellular endpoints like cell viability and cell death. Since the brain seems to play a key 
role in the observed phenotypes, one could ideally implement such an assay on retinal cell 
layers or brain slices kept in culture. To study more suitable endpoints in the described CS 
mouse models, and to find compounds that have a positive effect, it will be crucial to uncover as 
many parallels with CS as possible. Preferably, one would want to study non-invasive 
parameters to monitor the alleviating effect of administered nutraceuticals and pharmaceuticals 
on the progression of the disease. In this regard, IGF-1 and glucose serum levels (without 
fasting; see also Chapter 2) could be measured in CS patients. Also, we should aim at finding 
CS-associated biomarkers in urine of patients. Last but not least, by using conditional 
Csbm/m/Xpac/- mouse models, we will be able to focus intervention strategies on specific CS 
features, such as neurodegeneration (as in Csbm/m/Xpac/-/CamKIIα-Cre animals), photoreceptor-
loss, and other tissues and symptoms. 
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In conclusion, the findings described in this thesis have elucidated several important questions 
as to the how and why of the CS phenotype and could together open perspectives towards an 
intervention strategy. But, as it often happens in science, we answered some important 
questions, yet we opened the door to many more that need to be answered in the future.  
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Inleiding 
Het lichaam van de mens is opgebouwd uit miljoenen cellen die elk een unieke functie 
vervullen. Er bestaan ongeveer 200 verschillende soorten cellen, waaronder zenuwcellen, 
huidcellen en levercellen. Al deze cellen samen vormen een organisme. Cellen zijn opgebouwd 
uit lipiden (vetten), eiwitten en DNA. Deze structuren worden continu beschadigd tijdens het 
leven van een organisme. In dit proefschrift bespreken we voornamelijk de gevolgen van 
schade aan het DNA, met nadruk op de erfelijke ziekte Cockayne syndroom. Patienten met 
deze ziekte kunnen DNA schade niet goed repareren, met als gevolg groeiproblemen, ernstige 
neurologische achteruitgang, alsmede een groot aantal symptomen die duiden op vroegtijdige 
veroudering.  
  DNA is een macromolecuul dat zich bevindt in de kern van iedere cel.  Het bevat de erfelijke 
informatie voor het uitgroeien van een bevruchte eicel tot een volwaardig individu, alsmede voor 
het specifiek functioneren van cellen (bijv. spier-, bloed-, zenuwcellen) in de verschillende 
organen waaruit het lichaam is opgebouwd. Er zijn echter heel veel stoffen en stralingsbronnen 
die het DNA kunnen beschadigen en daardoor een gevaar vormen voor de integriteit van het 
DNA, en dus voor het functioneren van de cellen. Hierbij moet men niet alleen denken aan 
toxische stoffen en stralingsbronnen uit het milieu (bijvoorbeeld zonlicht, röntgenstraling, 
uitlaatgassen, sigarettenrook, chemische oplosmiddelen), maar ook aan stoffen die door het 
lichaam zelf worden geproduceerd (zuurstofradikalen). Schade aan het DNA kan verstrekkende 
gevolgen hebben. Zo kunnen bij het kopiëren van beschadigd DNA permanente veranderingen 
in de genetische code (mutaties) ontstaan waardoor cellen ongeremd kunnen gaan delen en 
uiteindelijk kanker kunnen veroorzaken. Ook kunnen DNA beschadigingen leiden tot het 
stoppen van celdeling of zelfs resulteren in celdood, waardoor de weefselsamenstelling wordt 
verstoord, met als consequentie veroudering.  
 Gelukkig heeft de cel meerdere methodes ontwikkeld om DNA beschadigingen te 
verwijderen. Het DNA herstel mechanisme dat uitgebreid wordt besproken in dit proefschrift is 
‘Nucleotide Excision Repair’ (Nucleotide Excisie Herstel), ook wel afgekort als NER. Dit 
mechanisme verwijdert een groot scala aan DNA lesies (zoals  beschadigingen veroorzaakt 
door zonlicht en veel chemische stoffen) en bestaat uit twee onderdelen. Globaal genoom NER 
(GG-NER) verwijdert schade in al het DNA, maar heeft als nadeel dat het niet altijd even 
efficient werkt. Transcriptie-gekoppeld NER (TC-NER) zorgt voor het schadevrij houden van 
actieve genen om te voorkomen dat DNA beschadigingen het overschrijven van het DNA in 
boodschapper RNA moleculen (transcriptie, nodig voor het aanmaken van eiwitten) 
belemmeren. 
 Defecten in NER kunnen ernstige gevolgen hebben voor de gezondheid, wat wordt 
geïllustreerd door een groep van erfelijke ziekten, bestaande uit Xeroderma Pigmentosum (XP, 
veroorzaakt door mutaties in de genen XPA tot en met G), Trichothiodystrofie (TTD, veroorzaakt 
door mutaties in de genen XPB, XPD en TTDA) en Cockayne Syndrome (CS, veroorzaakt door 
mutaties in de genen CSA en CSB). XP patiënten zijn erg gevoelig voor zonlicht en kunnen UV-
geïnduceerde DNA lesies niet repareren, waardoor ze een sterk verhoogd risico hebben op het 
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krijgen van huidkanker op zon-geëxposeerde delen van het lichaam. CS patiënten zijn ook 
gevoelig voor zonlicht, maar krijgen geen huidkanker. Wel hebben deze patiënten een groot 
aantal andere ernstige symptomen, zoals groeiachterstand, botproblemen, neurologische 
afwijkingen en een sterk verkorte levensduur (gemiddelde leeftijd van overlijden 12 jaar). TTD 
patiënten vertonen vergelijkbare symptomen als CS patiënten, maar hebben daarbij ook een 
geschilferde huid en breekbaar haar. Zowel TTD als CS worden beschouwd als 
verouderingssyndromen.  
 
Dit proefschrift 
In dit proefschrift hebben we gebruik gemaakt van muismodellen voor CS om inzicht te 
verkrijgen in het ontstaan en verloop van de ziekte. Bovendien zijn de diermodellen gebruikt om 
te onderzoeken of het mogelijk is om het verloop van de ziekte te vertragen. 
 
Resultaten en conclusies 
De Csbm/m muis (een van de twee eerder in ons laboratorium gegenereerde diermodellen voor 
CS) heeft, net als CS patiënten, alleen een defect in TC-NER en een UV-gevoelige huid. De 
dieren vertonen echter nauwelijks andere CS symptomen zoals groeiproblemen en 
neurologische afwijkingen. In hoofdstuk 2 laten we zien dat uitschakeling van GG-NER in de 
Csbm/m muis (door gelijktijdige inactivatie van het Xpa gen) resulteert in een muis die heel veel 
overeenkomst vertoont met de CS patiënt. Csbm/m/Xpa-/- muizen hebben een sterke 
groeiachterstand en overlijden binnen 3 weken na geboorte. Verder hebben we door middel van 
micro-array analyse gekeken naar de boodschapper RNA profielen in de lever van de 2 weken 
oude Csbm/m/Xpa-/-  muis. Deze methode laat zien welke genen actief zijn en of die genen in de 
Csbm/m/Xpa-/- muis juist meer of minder actief zijn dan in de lever van een even oude normale 
nestgenoot. Uit deze experimenten bleek allereerst dat het gen expressie patroon van de 
Csbm/m/Xpa-/-  lever sterk overeenkwam met dat van een normale lever van een zeer oude muis. 
Bovendien bleek in het gehele lichaam van de Csbm/m/Xpa-/- dieren een respons te zijn 
opgewekt (verlaging GH/IGF1 as en metabolisme, verhoging anti-oxidant respons) die probeert 
het niveau van reactieve metabolieten (en daardoor DNA schade) te verlagen. Deze response 
verklaart ook de groeiproblemen in CS. Een zelfde respons is ook aangetoond in muizen die 
door mutaties van bepaalde genen langer leven en werd door ons ook gevonden in normale 
muizen die waren behandeld met DNA beschadigende stoffen. Hieruit bleek dat een hoger DNA 
schade niveau, veroorzaakt door het transcriptie-gekoppeld DNA herstel defect, een respons 
induceert die het leven zou moeten verlengen. Omdat de Csbm/m/Xpa-/- muizen niet waren 
blootgesteld aan DNA beschadigende stoffen, moet de oorzaak voor deze schade van binnen 
af komen (bijvoorbeeld via reactieve zuurstof radikalen). De conclusie van deze bevindingen is 
dus dat DNA schade, in combinatie met een TC-NER defect bijdraagt aan het proces van 
veroudering. 
 In hoofdstuk 3 hebben we ons gericht op een bepaald aspect van het ziektebeeld van CS, 
namelijk oogafwijkingen. We vonden dat blootstelling van de Csbm/m muis aan UV in het oog 
resulteerde in ernstige oogtumoren. Bovendien vonden we dat de Csbm/m muis van nature 
fotoreceptor cellen verliest uit de retina van het oog, naarmate deze ouder wordt. Dit 
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verschijnsel, retinale degeneratie, is een veel voorkomende oogafwijking bij CS. Het verlies van 
fotoreceptor cellen kon ook worden geïnduceerd door middel van DNA beschadigende stoffen. 
Dit betekent dat (ongerepareerde) DNA schade de onderliggende oorzaak van de retinale 
degeneratie zou kunnen zijn. 
 In hoofdstuk 4 hebben we het ontstaan van neurologische afwijkingen in CS nader 
onderzocht. Omdat de Csbm/m muis nauwelijks een neurologisch phenotype vertoont, en 
Csbm/m/Xpa-/- muizen te kort leven om neurologische afwijkingen tot in detail te bestuderen, 
hebben we een conditionele Xpa muis gegenereerd. In dit diermodel kan het Xpa gen naar 
keuze worden uitgeschakeld in bepaalde weefsels. We hebben gevonden dat inactivatie van 
het Xpa gen in de grote hersenen van de Csbm/m  muis tot gevolg heeft dat in oudere dieren de 
hersenen kleiner worden (atrofie) en dat de ventrikels sterk vergroot waren. Deze pathologische 
afwijkingen worden ook gevonden in de CS patiënt. Deze resultaten tonen wederom aan dat 
aspecten van het CS ziektebeeld kunnen worden veroorzaakt door ongerepareerde endogene 
DNA schade. Dit nieuwe muismodel zal in vervolgonderzoek worden gebruikt om het 
neurologische aspect van CS verder te onderzoeken. 
 CS een zeer ernstige ziekte, waarvoor geen behandeling bestaat, maar waarbij wel wordt 
geprobeerd de afzonderlijke symptomen te verlichten (bijvoorbeeld het geven van een rolstoel 
wanneer de patiënt  niet meer kan lopen). Derhalve bestaat er behoefte aan een interventie 
methode, waarbij het ontstaan van de symptomen zo lang mogelijk wordt uitgesteld en de ernst 
van de symptomen wordt afgezwakt. Een dergelijke methode zou kunnen bestaan uit het 
verlagen van de kans op het ontstaan van DNA schade door reactieve metabolieten. Radicalen 
kunnen worden weggevangen door radicaal scavengers. In hoofdstuk 5 hebben we aangetoond 
dat behandeling van Csbm/m/Xpa-/- muizen met twee stoffen met een scavenger functie een 
positief effect had op de overleving. Verder bleek ook dat de samenstelling van het muisvoer 
van invloed is op de levensverwachting van de Csbm/m/Xpa-/- muis. Deze bevindingen openen 
mogelijk nieuwe deuren voor het ontwikkelen van een interventiestrategie voor CS.
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Eindelijk kan ik dan het belangrijkste gedeelte van dit proefschrift schrijven; het dankwoord. Het 
heeft lang geduurd voordat dit boekje af was en er zit veel bloed, zweet en tranen in. Zonder de 
hulp van heel veel mensen had ik het niet gered. Ik moet zeggen dat ik zo langzamerhand geen 
inspiratie meer over heb om te schrijven (het komt mijn neus en oren uit), maar ik zal mijn best 
doen om iedereen die hierbij betrokken was te bedanken en niemand te vergeten. Ik heb zes 
jaar met veel plezier bij de afdeling Genetica (samen)gewerkt met veel verschillende mensen. 
Allereerst wil ik Renata (paranimf) ontzettend bedanken: jij hebt zo enorm geholpen bij elk 
aspect van dit proefschrift. Je hebt keihard gewerkt om te zorgen dat elk experiment goed en op 
tijd plaatsvond en verder ben je een enorme steun en toeverlaat en een hele goede vriendin. Je 
hebt zelfs onze zwerfkat Dommel overgenomen! Natuurlijk wil ik ook Bert, copromotor en 
directe begeleider, enorm bedanken voor al je hulp. Het enige waar ik nooit aan zal kunnen 
wennen is dat je alles op het laatste moment doet (dan ben je op je best), zodat ik daardoor 
alles net te laat moet doen. Ik heb je dan ook op het laatst in gedachten meerdere malen met 
een betonnen versie van mijn proefschrift afgeranseld. Desalniettemin ben ik blij dat jij mijn 
begeleider bent geweest. Je zit vol goede ideeën en je bent niet bang om iets compleet nieuws 
uit te proberen. Ook heb je me gesteund in alles wat ik deed; ik heb veel van je geleerd. Op 
deze plek moet ik natuurlijk ook mijn promotor, Jan bedanken: Jan, je was altijd een bron van 
inspiratie en ik wil je bedanken dat ik zo lang op de afdeling met veel plezier heb mogen werken 
en dat je me vrij liet om qua onderzoek mij eigen weg in te slaan. Nils, andere paranimf, ik ken 
je al zo lang als ik werk bij Genetica. In het begin dronken we heel vaak koffie samen, jammer 
genoeg is dat er het laatste jaar bij ingeschoten. Je stond altijd voor me klaar; als ik weer een 
teen had gebroken of wilde drinken tijdens een feestje, dan reed jij naar huis. Heel erg bedankt! 
Then of course I would like to thank George; I learned a lot from you the past two years and not 
only about science. We’ve had numerous (endless) scientific discussions and it was a pleasure 
to work with you; I would even go as far as to say that I consider you a good friend. Toen ik bij 
Genetica kwam heb ik de eerste beginselen van muizen werk geleerd van Manja en Theo. 
Manja, bedankt voor je eindeloze geduld en uitleg. Theo, ik heb door de jaren heen veel met je 
samen gewerkt en dat altijd als prettig ervaren. Ik heb je in al die tijd geen een keer boos 
gezien; ik hoop dat ik dat ooit nog mee mag maken! Je was altijd rustig en beheerst en als ik 
weer een beetje doordraafde, wist je dat altijd goed te relativeren. Verder wil ik ook Jessie 
bedanken; we hebben samen heel veel meegemaakt op het lab en daarbuiten. Je was 
compleet gek en altijd heel gezellig. Ik vind het jammer dat je nu in Amerika zit en ik hoop dat je 
snel weer terugkomt. Hennie, Judith, Karin, Inez, Emine en Phebe, we hebben samen heel wat 
leuke dingen gedaan zowel binnen als buiten het lab; bedankt voor alle gezelligheid. Yvette, 
Phebe en Yvonne; jullie hebben me in het begin enorm geholpen met experimenten, zeker toen 
ik dat zelf door omstandigheden even niet kon; ik wil jullie daar heel erg voor bedanken; zonder 
jullie weet ik niet wat ik had moeten doen. Yvette, ik ken je al sinds dat ik stage liep bij Annelies; 
jij was een gezellige collega en ook een goede vriendin. Ik vind het jammer dat je niet meer bij 
Genetica werkt; ik mis je enorm. Laura, I learned a lot from you as well; you taught me how to 
do research and how to write. You stimulated me to think and work like a scientist. Moreover, 
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you were a good friend. You even took me to your sister and parents and showed me the other 
side of America that you normally don’t see. Thanks for everything! Roald, Roos, Michael, 
Esther en Henk, jullie waren gezellige labgenoten in 1018; bedankt voor alle lol. Roald, ik mis 
alle scheldpartijen die we hadden; je kon schelden alsof de wereld verging als je een leeg epje 
op de grond liet vallen; je hebt me vaak de slappe lach bezorgd. Ik hoop je snel weer eens 
tegen te komen. Anja, Hannie, Esther, Nicole, Jeroen, Iris, en de rest op de 6e verdieping; het 
was altijd gezellig koffie drinken en ook op feestjes zorgden jullie altijd voor veel lol. Jeroen, jij 
hebt me vaak goed advies gegeven en daar wil ik je graag nog eens extra voor bedanken. En 
natuurlijk Wim; jij zit altijd vol goed advies en dat heeft me vaak geholpen. Je bent goed in het 
aanhoren van mijn oeverloze gezeur; bedankt; hoe doe je dat toch? Steven; met jou heb ik veel 
(wetenschappelijke) discussies gehad en daar heb ik altijd veel plezier aan beleefd. Ik wil ook 
graag alle dierverzorgers en medewerkers van het muishuis bedanken, in het bijzonder Patrick, 
Vincent, Daniella, Jacqueline, Albertina en Iris (en iedereen die ik toch nog vergeten ben): 
bedankt voor al jullie goede zorgen en ook voor jullie eindeloze geduld als ik weer eens iets fout 
deed. Zonder jullie had ik nooit al deze muizen experimenten kunnen uitvoeren. Ruud; bedankt 
voor de hulp bij de muizenfoto’s, en Tom; bedankt voor de hulp bij het mooier maken van de 
figuren en de voorkant. Marcel, je hebt enorm geholpen met de pathologie van de muizen die ik 
bestudeerde. Zelfs als ik ergens op het laatste moment mee kwam, deed je altijd je best om te 
zorgen dat het toch goed kwam; bedankt voor je onuitputtelijke enthousiasme en inzet. Ik heb 
ook veel samengewerkt met de mensen van het RIVM; Harry, Susan, Conny en Dolf: bedankt 
voor de goede samenwerking. Susan, ik ben meerdere malen met je op congres geweest en 
dat was een groot succes; bedankt voor je gezelligheid. Ik wil ook graag Jasperina, Marike, Rita 
van het secretariaat enorm bedanken: zeker op het laatst moeten jullie wel gek van me zijn 
geworden; maar jullie blijven altijd volkomen kalm en regelen de meest ingewikkelde dingen in 
een handomdraai. Ook wil ik de mensen van de inkoop en de keuken bedanken; zonder jullie is 
geen een experiment mogelijk! Verder natuurlijk al mijn labgenoten op de 7e: bedankt voor de 
gezelligheid en samenwerking (for those of you that still don’t know any Dutch: I would like to 
thank all my other labmates at the 7th floor for the good cooperation and fun times we had 
together). Verder wil ik ook graag mijn nieuwe DNage medewerkers bedanken: Sander (Barnie), 
Sander, Shanoe en Mark (en natuurlijk ook weer Renata). Jullie hebben je allemaal ingezet om 
te zorgen dat alles goed verliep. Bedankt ook voor jullie eindeloze geduld; dankzij het schrijven 
van dit proefschrift had ik wel eens heel druk en dat hebben jullie goed opgevangen. Tol, ik wil 
speciaal ook jou bedanken; jij hebt me al veel geleerd over hoe het er in het bedrijfsleven aan 
toe gaat altijd en me ook ontzettend gesteund, ondanks dat ik mijn proefschrift nog moest 
schrijven. Als ik het even niet meer zag zitten wist je me altijd weer op te vrolijken (in de DE bar 
met koffie en een koekje). Irene; ik ken je nog maar net, maar ik beschouw je nu al als een 
goede vriendin; je staat altijd voor me klaar en hebt me heel veel geholpen met de lay-out van 
dit boekje; zonder jou (en je persoonlijke helpdesk) had ik het nooit gered. Je deelt een kamer 
met me en hebt zoveel gezeur aan moeten horen, dat je er onderhand immuun voor bent 
geworden. Ik hoop dat ik snel iets terug kan doen. Ook wil ik nog iedereen bedanken die ik 
vergeten ben te noemen en toch niet boos is geworden! Als laatste wil ik ook graag mijn familie 
en vrienden bedanken; sommigen van jullie weten waarschijnlijk niet eens meer hoe ik er uit zie; 
zo lang ben ik niet langs geweest. Daar ga ik in de toekomst verandering in brengen. In het 
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bijzonder wil ik ook mijn ouders, zussen en zwagers bedanken voor hun eindeloze steun en 
interesse; ook dankzij jullie heb ik volgehouden als ik het niet meer zag zitten (en dat was vaak 
het geval, zeker op het laatst). En dan natuurlijk als allerlaatst Brian; jij hebt het denk ik heel 
moeilijk gehad; al die avonden dat ik laat thuis was en al die keren dat je jezelf moest vermaken 
omdat ik het weer te druk had (al heeft de nieuwe motor de pijn vast wel iets verzacht); ik vind 
het knap dat je het met me hebt uitgehouden, want vaak was ik niet te genieten. Ik weet niet 
hoe ik je ooit kan bedanken voor al je steun en geduld; je bent de beste vriend die ik heb. 
 
Het feit dat er meer dan dertig keer bedankt staat in dit kleine stukje laat wel zien hoe belangrijk 
het is om samen te werken met mensen en interactie te hebben; hierdoor is dit proefschrift 
geworden zoals het is. Ik vond het een leuke tijd en heb er van genoten, maar het was ook 
vermoeiend en soms onmogelijk om te doen. Ik ben blij dat het eindelijk voorbij is; het werd wel 
tijd. Op naar de volgende stap… 
 
I'ma make a new plan 
Time for me to just stand up, and travel new land 
Time for me to just take matters into my own hands 
Once I'm over these tracks man I'ma never look back 
And I'm gone, I know right where I'm goin 
Sorry momma I'm grown, I must travel alone 
ain't gon' follow the footsteps I'm making my own 
Only way that I know how to escape from this 8 Mile Road 
(Eminem, 8 mile 
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